Document:

Purchase and Sale Agreement

 Exhibit 10.1 
  
 Execution Copy 
  
 PURCHASE AGREEMENT 
  
 by and between 
  
 HEALTHTRONICS, INC. 
  
 as “Seller” 
  
 and 
  
 SANUWAVE, INC., 
  
 as “Buyer” 
  
 Dated as of August 1, 2005 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page

	ARTICLE I DEFINITIONS	  	1
	        1.1	  	Definitions	  	1
	        1.2	  	Certain Interpretation Matters	  	9
		
	ARTICLE II PURCHASE AND SALE OF SHARES AND ASSETS	  	10
	        2.1	  	Sale of Acquired Assets	  	10
	        2.2	  	Excluded Assets	  	10
	        2.3	  	Assumed Liabilities	  	10
	        2.4	  	Excluded Liabilities	  	11
	        2.5	  	Transfer of Acquired Assets and Assumed Liabilities	  	12
	        2.6	  	Post-Closing Transfer of Acquired Assets	  	13
	        2.7	  	Closing	  	14
	        2.8	  	Deliveries at the Closing.	  	14
	        2.9	  	Payment of Purchase Price.	  	14
	        2.10	  	Working Capital Purchase Price Adjustment	  	15
	        2.11	  	Purchase Price Allocation	  	16
		
	ARTICLE III REPRESENTATIONS AND WARRANTIES REGARDING SELLER, THE PARTNERSHIPS AND HTO	  	17
	        3.1	  	Organization and Qualification	  	17
	        3.2	  	Capitalization of HTO and the Partnerships	  	17
	        3.3	  	Corporate Books and Records	  	18
	        3.4	  	Authorization; Enforceability	  	18
	        3.5	  	No Conflict or Violation	  	18
	        3.6	  	Consents and Approvals	  	19
	        3.7	  	Financial Statements	  	19
	        3.8	  	Absence of Certain Changes or Events	  	19
	        3.9	  	No Undisclosed Liabilities	  	20
	        3.10	  	Litigation	  	20
	        3.11	  	Compliance with Laws; Permits	  	21
	        3.12	  	Contracts	  	21
	        3.13	  	Suppliers	  	23
	        3.14	  	Title to Acquired Assets	  	23
	        3.15	  	Environmental Matters.	  	23
	        3.16	  	Intellectual Property.	  	24
	        3.17	  	Labor Relations	  	25
	        3.18	  	Taxes.	  	26
	        3.19	  	Employee Matters and Seller Plans.	  	27
	        3.20	  	Contracts with Affiliates	  	29
	        3.21	  	No Brokers, Finders, etc.	  	29
	        3.22	  	Insurance	  	29
	        3.23	  	Fixed Assets.	  	30
	        3.24	  	Equity Interests	  	30
	        3.25	  	Sufficiency of Assets	  	30
	        3.26	  	Limited Partners	  	30
	        3.27	  	Certain Regulatory Matters.	  	30
	        3.28	  	Transferred Accounts Receivable	  	32

  

 i 

					
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF BUYER	  	32
	        4.1	  	Organization	  	32
	        4.2	  	Authorization; Enforceability	  	33
	        4.3	  	No Conflict or Violation	  	33
	        4.4	  	Consents and Approvals	  	33
	        4.5	  	No Brokers, Finders, etc.	  	34
	        4.6	  	Investment Intent	  	34
	        4.7	  	No Outside Reliance	  	34
		
	ARTICLE V COVENANTS	  	34
	        5.1	  	Access; Investigation	  	34
	        5.2	  	Further Actions.	  	35
	        5.3	  	Joint Public Announcement	  	36
	        5.4	  	Employee Matters.	  	36
	        5.5	  	Non-Disparagement	  	37
	        5.6	  	Insurance	  	37
	        5.7	  	Non-Competition.	  	37
	        5.8	  	Transition Services Agreement	  	38
	        5.9	  	License Agreement	  	38
	        5.10	  	Anti-Dilution	  	38
	        5.11	  	Use of Name.	  	39
	        5.12	  	Permits; Certain Regulatory Matters.	  	39
	        5.13	  	Tax Matters.	  	39
		
	ARTICLE VI INDEMNIFICATION	  	40
	        6.1	  	Survival of Representations, Etc.	  	40
	        6.2	  	Indemnification by Seller	  	40
	        6.3	  	Indemnification by Buyer.	  	41
	        6.4	  	Notice of Indemnity Claims	  	42
	        6.5	  	Indemnification Procedures	  	42
	        6.6	  	Settlement of Indemnity Claims	  	43
	        6.7	  	Exclusivity of Indemnification Remedy	  	44
		
	ARTICLE VII TAX MATTERS	  	44
	        7.1	  	Liability and Indemnification for Taxes	  	44
	        7.2	  	Assistance and Cooperation	  	44
	        7.3	  	Confidentiality of Tax Information	  	45
	        7.4	  	Termination of Tax Sharing Agreements	  	45
		
	ARTICLE VIII GENERAL PROVISIONS	  	45
	        8.1	  	Expenses	  	45
	        8.2	  	Notices	  	46
	        8.3	  	Severability	  	46
	        8.4	  	Counterparts	  	47
	        8.5	  	Assignment; Successors and Assigns	  	47
	        8.6	  	No Third Party Beneficiaries	  	47
	        8.7	  	Descriptive Headings	  	47
	        8.8	  	Schedules and Exhibits; Construction of Certain Provisions	  	47
	        8.9	  	No Implied Representation	  	48
	        8.10	  	Waivers	  	48
	        8.11	  	Governing Law; Jurisdiction; Waiver of Jury Trial.	  	48

  

 ii 

					
	        8.12	  	Enforcement	  	49
	        8.13	  	Entire Agreement; Amendments; Electronic Signatures	  	49
	        8.14	  	Construction; Joint Drafting	  	49

  
 EXHIBITS AND SCHEDULES

  

					
	Exhibit A	 	-	  	Bill of Sale
	Exhibit B	 	-	  	Assignment and Assumption Agreement
	Exhibit C	 	-	  	Transferred Intellectual Property Rights
			
	Disclosure Schedules	 	 	  	 
	Schedule 1.1(a)	 	-	  	Excluded Contracts
	Schedule 1.1(b)	 	-	  	Transferred Contracts
	Schedule 1.1(c)	 	-	  	Partnerships
	Schedule 1.1(d)	 	-	  	Other Interests
	Schedule 2.1	 	-	  	Acquired Assets
	Schedule 2.2(b)	 	-	  	Capital Stock
	Schedule 2.2(d)	 	-	  	Excluded Assets
	Schedule 2.4(g)	 	-	  	Excluded Liabilities
	Schedule 2.10(a)	 	-	  	Estimated Net Working Capital
	Schedule 3.2	 	-	  	Capitalization of the Partnerships
	Schedule 3.5	 	-	  	No Conflict or Violation
	Schedule 3.6	 	-	  	Consents and Approvals
	Schedule 3.7(a)	 	-	  	Financial Statements
	Schedule 3.8	 	-	  	Absence of Certain Changes or Events
	Schedule 3.9	 	-	  	No Undisclosed Liabilities
	Schedule 3.10	 	-	  	Litigation
	Schedule 3.11	 	-	  	Governmental Permits
	Schedule 3.12(a)	 	-	  	Contracts
	Schedule 3.12(b)	 	-	  	Contracts not in Full Force and Effect
	Schedule 3.12(c)	 	-	  	Breaches and Defaults
	Schedule 3.13	 	-	  	Material Suppliers
	Schedule 3.14	 	-	  	Title to Acquired Assets
	Schedule 3.15(f)	 	-	  	Environmental Matters
	Schedule 3.16(a)	 	-	  	Intellectual Property
	Schedule 3.16(c)	 	-	  	Intellectual Property Violations
	Schedule 3.19(a)	 	-	  	Business Employees
	Schedule 3.19(b)	 	-	  	Employee Benefit Plans
	Schedule 3.19(h)	 	-	  	Foreign Benefit Plans
	Schedule 3.20	 	-	  	Contracts with Affiliates
	Schedule 3.22	 	-	  	Insurance
	Schedule 3.23	 	-	  	Fixed Assets
	Schedule 3.24	 	-	  	Equity Interests
	Schedule 3.25	 	-	  	Sufficiency of Assets
	Schedule 3.26	 	-	  	Limited Partners
	Schedule 3.27	 	-	  	Certain Regulatory Matters

  

 iii 

					
	Schedule 5.4(a)	 	-	 	Transferred Employees
	Schedule 5.13(a)	 	-	 	754 Elections
	Schedule 6.2	 	-	 	Certain Patents
	Schedule X	 	-	 	Transferred Assets

  

 iv 

 PURCHASE AGREEMENT 
  
 THIS PURCHASE AGREEMENT (this “Agreement”), dated as of August 1, 2005, is entered into by and between
HEALTHTRONICS, INC., a Georgia corporation (“Seller”), and SANUWAVE, INC., a Delaware corporation (“Buyer”). 
  
 WITNESSETH 
  
 WHEREAS, Seller is the direct holder of all of the outstanding limited liability company interests of HT Orthotripsy Management Company, LLC
(“HTO”), which acts as the general partner of certain operating subsidiaries of Seller; 
  
 WHEREAS, Seller desires to sell to Buyer, and Buyer desires to purchase from Seller, all of the outstanding limited liability company interests of HTO and
certain other assets comprising or related to the business of non-invasive surgical solutions for Orthopedic Conditions in animals and humans that is currently conducted or as anticipated to be conducted based on current research and development
efforts and strategic plans by Seller through the Partnerships (as defined below) and through certain non-acquired entities (the “Business”), all on the terms and subject to the conditions set forth in this Agreement. 
  
 NOW, THEREFORE, in consideration of the premises and the representations,
warranties, covenants and agreements contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is acknowledged, the parties agree as follows: 
  
 ARTICLE I 
 DEFINITIONS 
  
 1.1 Definitions. In addition to the other words and terms defined elsewhere in this Agreement, as used in this Agreement, the following words and terms shall have the meanings specified or referred to below:

  
 “1060 Forms” has the meaning specified in
Section 2.11. 
  
 “Accountants” has the meaning
specified in Section 2.10(c). 
  
 “Accounts
Receivable” means the gross amounts of accounts and notes receivable attributable to the Business. 
  
 “Affiliate” means, with respect to any Person, any other Person who directly or indirectly controls, is controlled by or is under common
control with such Person. 
  
 “Agreement” has the
meaning specified in the preamble of this Agreement. 
  
 “Allocation” has the meaning specified in Section 2.11. 
  
 “Applicable Rate” has the meaning specified in Section 2.10(d). 
  

 1 

 “Base Working Capital” has the meaning specified in Section 2.10(a). 
  
 “Business” has the meaning specified in the Recitals.

  
 “Business Employees” means all of the
employees of the Business who are engaged in the conduct of the Business as of the date hereof. 
  
 “Buyer” has the meaning specified in the preamble of this Agreement. 
  
 “Buyer Indemnified Party” has the meaning specified in Section 6.2(a). 
  
 “Buyer Shares” has the meaning specified in Section 2.9.

  
 “Claim” means any claim, demand, cause of
action, chose in action, right of recovery or right of set-off of whatever kind or description against any Person. 
  
 “Claim Notice” has the meaning specified in Section 6.4. 
  
 “Closing” has the meaning specified in Section 2.7. 
  
 “Closing Balance Sheet” has the meaning specified in Section
2.10(b). 
  
 “Closing Date” means the date
hereof. 
  
 “Closing Net Working Capital” has the
meaning specified in Section 2.10(b). 
  
 “Code”
means the Internal Revenue Code of 1986, as amended. 
  
 “Common Stock” has the meaning specified in Section 2.9. 
  
 “Common Stock Equivalents” means securities of any kind (including “phantom” securities) issued by Buyer convertible into or exchangeable for Common Stock or options, warrants or other
rights to purchase or subscribe for Common Stock or securities convertible into or exchangeable for Common Stock. 
  
 “Competing Business” has the meaning specified in Section 5.7(c). 
  
 “Confidentiality Agreement” means that certain confidentiality agreement, dated as of January 21, 2005, by
and between Seller and Prides Capital Partners, LLC. 
  
 “Contract” means, with respect to any Person, any oral or written agreement, contract, understanding, arrangement, indenture, loan, note, mortgage, instruments, license, sales order, purchase order, commitment or lease of
any kind or character to which such Person is a party. 
  
 “Control” (including its correlative meanings “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the
management or policies of a Person, whether through the ownership of securities or partnership or other interests, by contract or otherwise. 
  

 2 

 “Current Assets” means with respect to HTO and the Partnerships, (i) cash, (ii) accounts
receivable net of contractual allowance reserves, reserves for bad debt, and additional reserves, (iii) vendor deposits and (iv) prepaid assets, in each case determined in accordance with GAAP and in a manner consistent with the determination of the
corresponding amounts reflected on the Statement of Net Assets, after elimination of related party receivables. 
  
 “Current Liabilities” means with respect to HTO and the Partnerships, (i) accounts payable, (ii) customer deposits, (iii) accrued
expenses and (iv) accrued facilities fees, in each case determined in accordance with GAAP and in a manner consistent with the determination of the corresponding amounts reflected on the Statement of Net Assets, after elimination of related party
payables. 
  
 “Deficit Amount” has the meaning
specified in Section 2.10(d). 
  
 “Determination
Date” has the meaning specified in Section 2.10(c). 
  
 “Disclosure Schedule” has the meaning specified in Article III. 
  
 “Encumbrance” means any lien (statutory or otherwise), mortgage, deed of trust, pledge, hypothecation, assignment, charge, security interest, option to purchase, easement, restrictive covenant, right
of first refusal, preemptive right, encroachment or conditional sale, or other title retention agreement, or any other restriction or third party right (including licenses), including restrictions on the right to vote equity interests whether
voluntarily incurred or arising by operation of law. 
  
 “Environmental Law” means any statute, law, rule, regulation, ordinance, code, policy, rule of common law or other legally enforceable requirement of any Governmental Authority, and any judicial or administrative
interpretation thereof, including any judicial or administrative order, consent decree or judgment, regulating, relating to or imposing liability or standards of conduct concerning (i) protection of the environment or of human health, including
employee health and safety or (ii) Hazardous Materials, including without limitation, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, 42 U.S.C. § 9601 et seq., the Resource
Conservation and Recovery Act, as amended, 42 U.S.C. § 6901 et seq.; the Federal Water Pollution Control Act, as amended, 33 U.S.C. § 1251 et seq.; the Toxic Substances Control Act, 15 U.S.C. § 2601
et seq.; the Clean Air Act, 42 U.S.C. § 7401 et seq.; and the Safe Drinking Water Act, 42 U.S.C. § 3908 et seq.] 
  
 “Environmental Permits” means any and all Governmental Permits pursuant to or required under any Environmental Law. 
  
 “Environmental Report” means any report, study, assessment,
audit or other similar document that addresses any issue of actual or potential noncompliance with, actual or potential liability under or cost arising out of, or actual or potential impact on business in connection with, any Environmental Law or
any proposed or anticipated change in addition to Environmental Law, that may affect HTO or any Partnership. 
  
 “Equipment Item” has the meaning specified in Section 5.14. 
  

 3 

 “Estimated Net Working Capital” has the meaning specified in Section 2.10(a).

  
 “Excluded Contracts” means those Contracts
listed on Schedule 1.1(a). 
  
 “Excluded
Liabilities” has the meaning specified in Section 2.4. 
  
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated thereunder. 
  
 “Fair Market Value” means as determined in good faith by the board of directors of Buyer. 
  
 “FDA” has the meaning specified in Section 3.27(a).

  
 “Final Purchase Price” has the meaning
specified in Section 2.9. 
  
 “Financial
Statements” has the meaning specified in Section 3.7. 
  
 “First Note” has the meaning specified in Section 2.9. 
  
 “GAAP” means United States generally accepted accounting principles. 
  
 “Governmental Authority” means any court, department, commission, board, bureau, agency, official or other regulatory, administrative or
similar authority of any federal, state, local, foreign or multinational government. 
  
 “Governmental Order” means any order, writ, injunction, decree, award, judgment or ruling entered by or with any Governmental Authority. 
  
 “Governmental Permits” has the meaning specified in Section 3.11. 
  
 “Hazardous Material” means (i) any gasoline or petroleum
(including crude oil or any fraction thereof) or petroleum products, radioactive materials, molds, asbestos in any form, urea formaldehyde foam insulation, polychlorinated biphenyls, transformers or other equipment that contain polychlorinated
biphenyls, and radon gas and (ii) any chemicals, materials or substances defined as “hazardous materials,” “extremely hazardous wastes,” “restricted hazardous wastes,” “toxic substances,” “toxic
pollutants,” or words of similar import or any other substance the presence of or exposure to which could result in liability, under any applicable Environmental Law. 
  
 “Health Care Law” means any statute, law, rule, regulation, ordinance, code, policy, manual provision,
administrative guidance, rule of common law or other legally enforceable requirement of any Governmental Authority, and any judicial or administrative interpretation thereof, including any judicial or administrative order, consent decree or
judgment, regulating, relating to or imposing liability or standards of conduct relating to the regulation of products of the Business, including, without limitation, their design, development, manufacture, labeling, storage, transport, marketing,
sale, reporting, and recordkeeping in all jurisdictions in which such acts or any of them occur or are reasonably likely to occur or such products or any of 
  

 4 

 them are likely to be sold or used, including without limitation, the United States Food, Drug and Cosmetic Act (21
U.S.C. §§ 301 et seq.), Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), Stark Law (42 U.S.C. § 1395nn), Civil False Claims Act (31 U.S.C. §§ 3729 et seq.), Administrative False Claims Act (42
U.S.C. § 1320a-7b(a)), Health Insurance Portability and Accountability Act (42 U.S.C. § 1320d et seq.), Exclusion Laws (42 U.S.C. 1320a-7) and, for each of the foregoing, all comparable state legal requirements and the rules and
regulations promulgated thereunder by Governmental Authorities. 
  
 “Health Care Permits” means any and all Governmental Permits pursuant to or required under any Health Care Law. 
  
 “HHS” has the meaning specified in Section 3.27(a). 
  
 “HMT” means HMT High Medical Technologies AG. 
  
 “HTO Interests” means all of the outstanding limited liability company interests of HTO. 
  
 “Increase Amount” has the meaning specified in Section
2.10(d). 
  
 “Indemnified Party” has the meaning
specified in Section 6.4. 
  
 “Indemnifying
Party” has the meaning specified in Section 6.4. 
  
 “Indemnity Claim” has the meaning specified in Section 6.4. 
  
 “Initial Public Offering” means any public offering of equity securities of Buyer pursuant to an effective registration statement under the Securities Act (other than pursuant to a registration
statement on Form S-8 or comparable form for a private issuer or otherwise relating to equity securities issuable under any employee benefit plan) of the Common Stock. 
  
 “Initial Purchase Price” has the meaning specified in Section 2.9. 
  
 “Intellectual Property” means all intellectual property,
whether registered or unregistered, anywhere in the world, used in the Business as presently conducted including, without limitation: (i) inventions, discoveries, processes, designs, techniques, developments, technology, and related improvements,
whether or not patentable; (ii) patents and applications therefor and all divisionals, reissues, renewals, registrations, confirmations, re-examinations, certificates of inventorship, extensions, continuations and continuations-in-part thereof
(“Patents”); (iii) trademarks, trade dress, service marks, service names, trade names, brand names, logo, business symbols, or other source indicators whether registered or unregistered, and applications to register the foregoing,
including all extensions and renewals thereof and all goodwill associated therewith and all common law rights, relating thereto (“Trademarks”); (iv) copyrights and works of authorship in any media, including writings, designs,
software, marketing materials, Internet site content, proprietary or copyrightable elements of works of authorship, whether registered or unregistered, and applications to register the same (“Copyrights’); (v) know-how, trade
secrets, confidential or proprietary information, data, methods, processes, practices, formulas and techniques, computer software programs and 

  

 5 

 
software systems, including all databases, customer information or any aggregation thereof , and all related documentation and materials (“Trade
Secrets”); (vi) universal resource locators and Internet domain names (“Domain Names”), and (vii) any and all similar rights in intellectual property or proprietary information, including rights provided by treaties,
conventions and common law. 
  
 “Intercompany
Agreement” has the meaning specified in Section 3.20. 
  
 “Interests” means the HTO Interests, the Other Interests and the Partnership Interests, collectively. 
  
 “IP Transferring Parties” has the meaning specified in Section 3.16(a). 
  
 “Knowledge” means the actual knowledge, without independent investigation, of such Person. 
  
 “Losses” means, in respect of any obligation of any party to
this Agreement to indemnify any Person pursuant to the terms of this Agreement, any and all sustained or incurred losses, liabilities, obligations, damages, awards, judgments, settlement payments, fines, complaints, claims, demands, assessments and
deficiencies and other reasonable out-of-pocket costs, expenses and charges, including interest, penalties, reasonable attorneys’ fees and other amounts incurred in proceedings relating to Losses or in enforcing an Indemnified Party’s
right of indemnification against any Indemnifying Party or with respect to any appeal, but all of which Losses shall be reduced by any insurance proceeds (net of the reasonable expenses of the recovery thereof) actually received by the Indemnified
Party with respect to the events or transactions giving rise to such Losses. 
  
 “Material Adverse Effect” means any change or effect that is material and adverse to the business, prospects, assets, liabilities, financial condition or results of operations of the Business or HTO,
taken as a whole, provided that any change or effect to the extent resulting from the entering into of this Agreement or the consummation of transactions contemplated by this Agreement or the other Transaction Agreements, or the announcement of any
of the forgoing shall be deemed not to constitute a Material Adverse Effect. 
  
 “Material Supplier” has the meaning specified in Section 3.13. 
  
 “Multi-Product Patent Rights” means the rights in U.S. and foreign patents and patent applications being transferred by Seller to Buyer
which also relate to Seller’s existing litho-related businesses. 
  
 “Net Working Capital” means, Current Assets minus Current Liabilities as of June 30, 2005. 
  
 “Net Working Capital Adjustment Amount” has the meaning specified in Section 2.10(d). 
  
 “Ordinary Course of Business” shall mean the ordinary course
of business of HTO consistent with past practice. 
  

 6 

 “Organizational Documents” means the charter, articles, memorandum or certificate of
incorporation or association, partnership agreement, certificate of limited partnership, operating agreement, limited liability company agreement, certificate of formation, bylaws, stockholder or shareholder agreements and/or similar formation or
governance documents and agreements of any Person, whether or not filed with any Governmental Authority, including any amendments thereto. 
  
 “Orthopedic Conditions” means all uses of shock wave technology for treatment of bone, tendonopathy, skin wound, diabetic ulcers,
cardiac, dental and neural medical conditions in humans and all uses of shock wave technology for treatment of any condition in animals. 
  
 “Other Interests” means the partnership interests of each of the Partnerships held by Seller or any of its Affiliates (other than HTO)
set forth on Schedule 1.1(d) hereto. 
  
 “Other
Sellers” has the meaning specified in Section 3.1(b). 
  
 “Partnership Interests” means the partnership interests of each of the Partnerships. 
  
 “Partnerships” means those partnerships listed on Schedule 1.1(c) hereto. 
  
 “Permitted Encumbrance” means, with respect to any Person
and its assets or properties, (a) Encumbrances on any assets or property of such Person that do not or would not reasonably be expected to materially adversely affect such Person’s use of such assets or properties as currently utilized; (b)
deposits or pledges made in the Ordinary Course of Business in connection with worker’s compensation, unemployment insurance, old-age pensions and other social security benefits; (c) Encumbrances securing the performance of bids, tenders,
leases, contracts (other than for the repayment of debt), statutory obligations, surety, customs and appeal bonds and other obligations of like nature, incurred as an incident to and in the Ordinary Course of Business; (d) Encumbrances imposed by
law, such as carriers’, warehousemen’s, mechanics’, materialmen’s, landlords’, laborers’, suppliers’ and vendors’ liens, incurred in the Ordinary Course of Business and securing obligations which are not yet
due or which are being contested in good faith by appropriate proceedings; (e) Permitted Tax Liens; (f) survey exceptions, use, zoning or planning restrictions, easements, irregularities, licenses, rights of way, declarations, reservations,
provisions, covenants, conditions, waivers (and with respect to leasehold interests, Encumbrances and other obligations incurred, created, assumed or permitted to exist and arising by, through or under a landlord or owner of the leased property,
with or without consent of the lessee) which are of record or which do not materially impair the use or value of any parcel of property of such Person as presently conducted; and (g) any extensions, renewals and replacements of any of the foregoing.

  
 “Permitted Tax Liens” means liens for current
Taxes not yet due and payable. 
  
 “Person” means
and includes an individual, a partnership, a corporation, a limited liability company, a trust, a joint venture, an unincorporated organization, an association, a joint stock company and any Governmental Authority (or any department, agency or
political subdivision thereof). 
  

 7 

 “Post-Closing Tax Period” means any Tax Period beginning after the Closing Date and that
portion of any Straddle Period beginning after the Closing Date. 
  
 “Pre-Closing Tax Period” means any Tax Period ending on or before the Closing Date and that portion of any Straddle Period ending on the Closing Date. 
  
 “Registered Intellectual Property” shall mean, collectively, all U.S. or foreign Patents, registered
Copyrights, registered Trademarks and trade names, Domain Names and applications for any of the foregoing. 
  
 “Representative” means, with respect to any Person, any officer, director, employee, principal, attorney, agent or other authorized
representative of such Person. 
  
 “Retained
Business” means any business operations or activities of Seller or its Affiliates (other than HTO or the Partnerships) other than those businesses, operations and activities of Seller constituting the Business as of the Closing Date.

  
 “Scheduled Contracts” means those Contracts
set forth or which are required to be set forth on Schedule 3.12(a) hereto. 
  
 “Second Note” has the meaning specified in Section 2.9. 
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  
 “Seller” has the meaning specified in the preamble of this Agreement. 
  
 “Seller Employees” has the meaning specified in Section
3.20(b). 
  
 “Seller Indemnified Parties” has the
meaning specified in Section 6.3(a). 
  
 “Seller
Plans” has the meaning specified in Section 3.20(b). 
  
 “Seller Tax Group” means the “affiliated group” (as defined in Section 1504(a) of the Code without regard to the limitations contained in Section 1504(b) of the Code) that includes Seller. 
  
 “Statement of Net Assets” has the meaning specified in
Section 3.7(a). 
  
 “Subsidiary” and
“Subsidiaries” means any corporation, limited liability company, partnership, joint venture, trust, association, organization or other entity in which a Person directly or indirectly owns 50% or more of the stock or other interests
the holder of which is generally entitled to vote for the election of the board of directors or other governing body of such corporation or other legal entity. For purposes of Seller, such term does not include HTO, any of the Partnerships, HMT or
any of HMT’s subsidiaries. 
  
 “Tax” or
“Taxes” means, all taxes, assessments, charges, duties, fees, levies, imposts or other governmental charges imposed by any Taxing Authority, including income taxes, transfer, gross receipt, sales, use, transfer, service, occupation,
ad valorem, property, 

  

 8 

 
excise, severance, premium, stamp, documentary, license, registration, payroll, employment, social security, unemployment, disability, environmental
(including taxes under Code Section 59A), add-on, value-added and withholding (whether payable directly or by withholding and whether or not requiring the filing of a Tax Return), together with interest, penalties or additions attributable thereto.

  
 “Tax Period” and “Taxable
Period” means any period prescribed by any Taxing Authority for which a Tax Return is required to be filed or a Tax is required to be paid. 
  
 “Tax Return” means any return, report or similar statement or form required to be filed with respect to any Tax (including any attached
schedules and related or supporting information), including any information return, claim for refund, amended return or declaration of estimated Tax. 
  
 “Taxing Authority” means any United States federal, state or local or any foreign governmental, regulatory or administrative authority,
agency or commission exercising Tax regulatory authority. 
  
 “Third Party Claim” has the meaning specified in Section 6.5. 
  
 “Transaction Agreements” has the meaning specified in Section 2.5(a). 
  
 “Transferred Contracts” means all Contracts between Seller or any of its Subsidiaries, other than any Excluded Contract, that is related
primarily or exclusively to the Business, including without limitation those Contracts listed in Schedule 1.1(b). 
  
 “Transferred Employees” has the meaning specified in Section 5.4(a). 
  
 “Transition Services Agreement” means that certain Transition Services Agreement to be entered into by
Buyer and Seller as of the Closing Date, in a form to be agreed upon by Buyer and Seller. 
  
 “Transferred Intellectual Property” means the Intellectual Property of Seller and its Subsidiaries (other than HTO or the Partnerships), other than Intellectual Property set forth on Schedule 2.2(d).

  
 “Transferred Intellectual Property
Assignments” has the meaning specified in Section 2.5(a). 
  
 1.2 Certain Interpretation Matters. Definitions contained in this Agreement apply to singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such terms. Words in the
singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as the context requires. The terms “hereof,” “herein,” “hereby” and
“herewith” and words of similar import shall, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement. The terms “includes” and the word
“including” and words of similar import shall be deemed to be followed by the words “without limitation.” Each Article, Section, paragraph, Schedule and Exhibit references are to the Articles, Sections, 

  

 9 

 
paragraphs, Schedules and Exhibits to this Agreement unless otherwise specified. The words “either” and “or” shall not be
exclusive. Provisions shall apply, when appropriate, to successive events and transactions. 
  
 ARTICLE II 
 PURCHASE AND SALE OF SHARES AND ASSETS 
  
 2.1 Sale of Acquired Assets. Upon the terms and subject to the
conditions set forth in this Agreement, at the Closing, Seller shall, and shall cause its Subsidiaries to, sell, convey, transfer, assign and deliver to Buyer, and Buyer shall purchase or assume, as the case may be, from Seller or such Subsidiary
all of the assets, rights, properties, claims, contracts and business of Seller and its Subsidiaries that are utilized primarily in the Business, of every kind, nature, character and description, tangible and intangible, real, personal or mixed,
wherever located, including without limitation those assets listed on Schedule 2.1 hereto (collectively, the “Acquired Assets“), other than the Excluded Assets described in Section 2.2 hereof. As of the Closing, risk of loss
as to the Acquired Assets shall pass from Seller to Buyer. 
  
 2.2
Excluded Assets. It is expressly agreed that the Acquired Assets shall not include any of the following (the “Excluded Assets”): 
  
 (a) Non-Acquired Assets. Any assets utilized by Seller or its Subsidiaries primarily in connection with businesses other than the Business;

  
 (b) Capital Stock. Any capital stock or other equity
interests owned by Seller or its Subsidiaries other than the HTO Interests, including those partnership or limited liability company interests listed on Schedule 2.2(b) hereto; 
  
 (c) Cash and Cash Equivalents. Cash and cash equivalents, including, without limitation, bank deposits, investments
in so-called “money market” funds, commercial paper funds, certificates of deposit, Treasury Bills and accrued interest thereon; in each case, other than cash set forth on the Statement of Net Assets; and 
  
 (d) Other Excluded Assets. Such other specific assets used in the
Business as are listed on Schedule 2.2(d) hereto. 
  
 2.3
Assumed Liabilities. Upon the terms and subject to the conditions set forth in this Agreement, at the Closing, Buyer assumes and agrees to pay, perform and discharge when due, the following Liabilities, which shall be the “Assumed
Liabilities”: 
  
 (a) all liabilities of HTO and the
Partnerships to the extent reflected in the June 30, 2005 Balance Sheet included in the Statement of Net Assets and still in existence on the Closing Date; 
  
 (b) all Current Liabilities of HTO and the Partnerships of the nature presented on the Statement of Net Assets, which have arisen after June 30, 2005 in
the Ordinary Course of Business (other than any Liability resulting from, arising out of, relating to, in the nature of, or caused by any breach of Contract, breach of warranty, tort, infringement, violation of Law, or environmental matter,
including those arising under Environmental, health, and safety requirements); and 
  

 10 

 (c) all obligations and liabilities, other than those that are Excluded Liabilities pursuant to Section
2.4(c), required to be performed or accruing after the Closing Date under the Transferred Contracts included in the Acquired Assets. 
  
 2.4 Excluded Liabilities. Notwithstanding anything to the contrary in this Agreement, Buyer shall not and does not assume any liabilities, debts or
obligations of any nature of Seller (or any Affiliate of Seller), whether relating to the Business, the Acquired Assets or otherwise, other than the Assumed Liabilities (all such liabilities, debts or obligations other than the Assumed Liabilities
are collectively referred to herein as the “Excluded Liabilities”). Excluded Liabilities include, without limitation, the following: 
  
 (a) all obligations and liabilities arising out of or relating primarily to the Excluded Assets; 
  
 (b) all debts, liabilities or obligations of Seller or its Subsidiaries
other than as set forth in Section 2.3; 
  
 (c) all obligations
and liabilities arising from or related to any breach of a Transferred Contract prior to the Closing Date other than as set forth in Section 2.3; 
  
 (d) all obligations and liabilities of Seller or its Subsidiaries for Taxes; 
  
 (e) all obligations and liabilities under any bond, note, debenture or similar instrument or any other indebtedness for
borrowed money of Seller or its Subsidiaries outstanding prior to the Closing; 
  
 (f) all obligations and liabilities arising out of the conduct of operations of Seller and its Subsidiaries after the Closing; 
  

(g) all obligations and liabilities arising out of those liabilities specifically set forth on Schedule 2.4(g) hereto; 
  
 (h) all obligations and liabilities (including accrued liabilities) for
Taxes with respect to HTO, the Partnerships, the Business and the Acquired Assets for any Pre-Closing Tax Period; 
  
 (i) all obligations and liabilities relating to workers’ compensation claims with respect to occurrences prior to the Closing Date; 
  
 (j) all liabilities relating to or arising under or in connection with the
matters described or otherwise required to be described in Schedule 3.10 hereto (without regard to the Material Adverse Effect qualification set forth in Section 3.10 or the limitation of such representation to the date hereof); 

 

 11 

 (k) any obligation or liability related to any Intercompany Agreement that is not expressly included on
Schedule 1.1(b); 
  
 (l) any obligation or liability
arising from or related to the dissolution, merger, consolidation, restructuring, sale, transfer or assignment of interests or cessation of operations of any Subsidiary (including any such Subsidiary involved in the operation of the Business) or
Partnership prior to the Closing Date; 
  
 (m) all obligations
and liabilities arising out of or relating to Environmental Laws or Hazardous Materials to the extent arising out of or relating to any event or condition occurring or existing as of or prior to the Closing Date; 
  
 (n) all undisclosed obligations and liabilities under the ADA, ADEA, FMLA,
Title VII, the WARN Act or any equivalent federal, state, local or foreign law with respect to any Seller Employees, but only to the extent and degree that the events giving rise to such obligations and liabilities occurred prior to the Closing
Date; 
  
 (o) all obligations and liabilities arising out of or
relating to Health Care Laws or Health Care Permits to the extent arising out of or relating to any event or condition occurring or existing as of or prior to the Closing Date; 
  
 (p) any liability under or relating to any Seller Plan, whether or not such liability or obligation arises prior to or
after the Closing Date or any other liability relating to the employment or termination of employment of any (x) Person arising from or related to the operation of the Business prior to Closing or the transactions contemplated by this Agreement
(including but not limited to, any severance or stay or incentive bonuses) or (y) Person who is not a Transferred Employee arising on or after the Closing; 
  
 (q) any other obligations and liabilities for which Seller has expressly assumed responsibility pursuant to this Agreement. 
  
 (r) all obligations and liabilities relating to product liability claims
with respect to occurrences prior to the Closing Date; 
  
 (s)
all obligations and liabilities relating to accrued vacation accruing prior to the Closing Date with respect to the Transferred Employees; and 
  
 (t) all obligations and liabilities relating to medical benefits accruing or with respect to occurrences prior to the Closing Date with respect to the
Transferred Employees. 
  
 2.5 Transfer of Acquired Assets and
Assumed Liabilities. 
  
 (a) The Acquired Assets shall be
sold, conveyed, transferred, assigned and delivered, and the Assumed Liabilities shall be assumed, pursuant to transfer and assumption agreements and such other instruments in such form as may be necessary or appropriate to effect a conveyance of
the Acquired Assets and an assumption of the Assumed Liabilities in the jurisdictions in which such transfers are to be made. Such transfer and 

  

 12 

 
assumption agreements shall include: (i) a bill of sale in substantially the form attached hereto as Exhibit A, (ii) an assignment and assumption
agreement in substantially the form attached hereto as Exhibit B, and/or (iii) assignments in substantially the form attached hereto as Exhibit C (the “Transferred Intellectual Property Assignments”), with only such
deviations therefrom as are required by local law or otherwise necessary to effectuate and record such transfer of the Transferred Intellectual Property or the recordation of the assignment of the Registered Intellectual Property therein, and (v)
such other agreements as may be required to effect the purchase and assignment of the Acquired Assets and Assumed Liabilities (collectively, clauses (i)–(v), together with the Transition Services Agreement, the License Agreement, that certain
Stockholders Agreement entered into as of the date hereof among Buyer, Seller, NightWatch Capital Partners, LP, NightWatch Capital Partners II, LP and Prides Capital Fund I, L.P. and any other agreement entered into as of the date hereof between
Buyer and Seller, the “Transaction Agreements”) and shall be executed no later than at or as of the Closing by Seller and/or one or more of its Subsidiaries, as appropriate and Buyer. 
  
 (b) Subject to the terms of this Section 2.5(b), Seller agrees, and agrees
to cause its Subsidiaries, to cooperate with Buyer and provide Buyer all assistance reasonably requested by Buyer in connection with the planning and implementation of the transfer of Acquired Assets or any portion of any of them to such location as
Buyer shall designate. Acquired Assets shall be transported by or on behalf of Buyer, and until all of the Acquired Assets are removed from a Seller’s premises, Seller will, and will cause its Subsidiaries to, permit Buyer and its authorized
agents or representatives, upon prior notice, to have reasonable access to such premises during normal business hours to the extent necessary to disconnect, detach, remove, package and crate the Acquired Assets for transport. Buyer shall be
responsible for disconnecting and detaching all fixtures and equipment that are Acquired Assets from the floor, ceiling and walls of Seller’s premises so as to be freely removed from such premises by Buyer. Buyer shall be responsible for
packaging and loading the Acquired Assets for transporting to and reinstalling the Acquired Assets at such location(s) as Buyer shall determine. All risk of loss as to the Acquired Assets shall be borne by, and shall pass to, Buyer as of the
Closing. 
  
 2.6 Post-Closing Transfer of Acquired Assets.
Notwithstanding anything to the contrary contained in this Agreement, to the extent that the sale, assignment, transfer, conveyance or delivery or attempted sale, assignment, transfer, conveyance or delivery to Buyer of any Acquired Asset is
prohibited by any applicable law or would require any governmental or third-party authorizations, approvals, consents or waivers and such authorizations, approvals, consents or waivers shall not have been obtained prior to the Closing, this
Agreement shall not constitute a sale, assignment, transfer, conveyance or delivery, or any attempted sale, assignment, transfer, conveyance or delivery thereof. Following the Closing, the parties shall use all reasonable best efforts, and cooperate
with each other, to obtain promptly such authorizations, approvals, consents or waivers; provided, however, that neither Seller nor Buyer shall be required to pay any consideration therefor, other than filing, recordation or similar
fees payable to any Governmental Authority; provided further, however, that all such fees payable in connection with obtaining such authorizations, approvals, consents or waivers shall be payable by Seller. Pending such authorization,
approval, consent or waiver, the parties shall cooperate with each other in any reasonable and lawful arrangements at the sole expense of Seller, designed to provide to Buyer the benefits and liabilities of use of such Acquired Asset. Once 

  

 13 

 
such authorization, approval, consent or waiver for the sale, assignment, transfer, conveyance or delivery of an Acquired Asset not sold, assigned,
transferred, conveyed or delivered at the Closing is obtained, Seller shall promptly assign, transfer, convey and delivery, or cause to be assigned, transferred, conveyed and delivered, such Acquired Asset to Buyer for no additional consideration
and all reasonable expenses related thereto shall be payable by Seller. To the extent that any such Acquired Asset cannot be transferred promptly following the Closing or the full benefits and liabilities of use of any such Acquired Asset cannot be
provided to Buyer following the Closing pursuant to this Section 2.6, then Buyer and Seller shall promptly enter into such arrangements (including subleasing or subcontracting if permitted) to provide to Buyer the economic (taking into account tax
costs and benefits) and operational equivalent of obtaining such authorization, approval, consent or waiver and the performance by Buyer of the obligations thereunder, and all reasonable expenses incurred in connection with entering into such
arrangements shall be payable by Seller. 
  
 2.7 Closing.
Subject to the terms and conditions set forth in this Agreement, the consummation of the purchase and sale of the Acquired Assets and the other transactions contemplated by this Agreement (the “Closing”) shall take place on the date
hereof (the “Closing Date”) at 10:00 a.m., Pacific time, at the offices of Simpson Thacher & Bartlett LLP, 3330 Hillview Avenue, Palo Alto, California 94304, unless another time and/or place is agreed to in writing by the
parties to this Agreement. 
  
 2.8 Deliveries at the
Closing. 
  
 At the Closing, subject to the terms and
conditions set forth in this Agreement, (a) Seller shall, or shall cause its Subsidiaries (i) to, as appropriate, deliver to Buyer one or more certificates, conveyance agreements or other instruments, each duly executed and delivered, evidencing
Buyer’s ownership of all of the HTO Interests, (ii) to execute and deliver to Buyer each of the Transaction Agreements and such other documents as counsel for Buyer and Seller mutually agree to be reasonably necessary to consummate the
transactions described herein and (iii) to deliver to Buyer the partnership agreement for each of the Partnerships, and (b) Buyer shall execute and deliver to Seller each of the Transaction Agreements and shall pay to Seller in accordance with this
Agreement the Initial Purchase Price for the Acquired Assets. To the extent that a form of any document, instrument, agreement or certificate to be delivered under this Agreement is not attached as an Exhibit to this Agreement, such document,
instrument, agreement or certificate shall be in form and substance, and shall be executed and delivered in a manner, reasonably satisfactory to the parties to this Agreement. 
  
 2.9 Payment of Purchase Price. The aggregate purchase price in consideration of the transfer of the Acquired Assets
pursuant to this Article II shall be (a) six million four hundred thousand dollars ($6,400,000) in cash; (b) a promissory note made in favor of Seller, in an aggregate original principal amount equal to two million dollars ($2,000,000) and in a form
agreed upon by the parties hereto (the “First Note”); (c) a promissory note made in favor of Seller, in an aggregate original principal amount equal to two million dollars ($2,000,000) and in a form agreed upon by the parties hereto
(the “Second Note”); and (d) stock certificates for shares (the “Buyer Shares”) of common stock, $0.01 par value per share, of Buyer (“Common Stock”), which Buyer Shares shall (i) be issued in the
name of Seller or Seller’s designee, (ii) represent five and four hundred seventy four thousandths percent (5.474%) of the 

  

 14 

 
outstanding shares of Common Stock (on an as-converted, fully diluted basis) immediately following the Closing and (iii) be duly authorized and validly
issued, fully paid and non-assessable (collectively, the “Initial Purchase Price”). Solely for the purpose of clarity, the Buyer Shares represent seven and one-half percent (7.5%) of the outstanding shares of Common Stock (on an
as-converted, fully diluted basis) prior to the reduction of Seller’s percentage ownership of Buyer, as agreed by Buyer and Seller, in connection with certain payments by Buyer to Seller (for services rendered in the future and as part of the
Initial Purchase Price paid hereunder) over and above five million dollars ($5,000,000). The Initial Purchase Price shall be subject to adjustment pursuant to Section 2.10 hereof (as finally adjusted pursuant to such sections, the “Final
Purchase Price”). The Initial Purchase Price and all other cash consideration to be paid by Buyer under this Agreement shall be paid by Buyer by wire transfer of immediately available funds to such account or accounts as shall be designated
in writing by Seller. 
  
 2.10 Working Capital Purchase Price
Adjustment. 
  
 (a) Base Working Capital. For
purposes of this Section 2.10 and any Net Working Capital adjustment to the Initial Purchase Price, the parties hereto agree that the amount set forth on Schedule 2.10(a) hereto (the “Estimated Net Working Capital”)
represents the estimated Net Working Capital of HTO and the Partnerships, on a combined basis, as of June 30, 2005 calculated in accordance with GAAP and using the same accounting principles as used in preparing the balance sheet data in the
Financial Statements. Estimated Working Capital plus $100,000 shall be the “Base Working Capital.” 
  
 (b) Closing Balance Sheet. As soon as reasonably practicable following the Closing Date, and in any event within ninety (90) days thereafter,
Buyer shall prepare and deliver to Seller a calculation of the Net Working Capital as of the Closing Date (the “Closing Net Working Capital”). The Closing Net Working Capital shall be prepared in accordance with GAAP and on a basis
consistent with the preparation of the Estimated Net Working Capital set forth on Schedule 2.10(a) hereto and without regard to any purchase accounting adjustments. 
  
 (c) Disputes. Upon delivery of the Closing Balance Sheet, HTO and Buyer will provide to Seller and Seller’s
accountants at Seller’s expense full access to the books and records of HTO and the Partnerships during reasonable business hours and to the extent required to review the calculation of the Closing Net Working Capital. If Seller disagrees with
the calculation of the Closing Net Working Capital, it shall notify Buyer of such disagreement in writing within thirty (30) days after its receipt of the Closing Net Working Capital. In the event that HTO, the Partnerships and Buyer have provided
full access as aforesaid and Seller does not provide such a notice of disagreement within such thirty (30) day period, Seller shall be deemed to have accepted the calculation of the Closing Net Working Capital delivered by Buyer, which shall be
final, binding and conclusive for all purposes under this Agreement. In the event any such notice of disagreement is timely provided by Seller, Buyer and Seller shall use their reasonable best efforts for a period of ninety (90) days (or such longer
period as they may mutually agree) to resolve any disagreements with respect to the calculation of the Closing Net Working Capital. If, at the end of such period, they are unable to resolve such disagreements, then an independent accounting firm of
recognized national standing mutually selected by Seller and Buyer (the “Accountants”) shall resolve any remaining 

  

 15 

 
disagreements. The Accountants shall act as an expert and not as an arbitrator, and shall resolve the matters still in dispute and adjust and establish any
disputed adjustment amount to reflect such resolution. If issues in dispute are submitted to the Accountants for resolution, (A) each party will furnish to the Accountants such workpapers and other documents and information relating to the disputed
issues as the Accountants may reasonably request and are available to that party (or its independent public accountants), and will be afforded the reasonable opportunity to present to the Accountants any material relating to the determination and to
discuss the determination with the Accountants. The Accountants shall determine as promptly as practicable, but in any event within ninety (90) days of the date on which such dispute is referred to the Accountants, based solely on written
submissions forwarded by Buyer and Seller to the Accountants within thirty (30) days following the Accountants’ selection, whether the Closing Balance Sheet was prepared in accordance with the standards set forth in Section 2.10(b) and (only
with respect to the remaining disagreements submitted to the Accountants) whether and to what extent (if any) the Closing Net Working Capital determination requires adjustment. All fees and expenses relating to the work, if any, to be performed by
the Accountants shall be borne pro rata as between Buyer on the one hand and Seller on the other, in proportion to the allocation of the dollar amount of the amounts remaining in dispute between Buyer and Seller made by such Accountants such that
the prevailing party pays the lesser proportion of fees and expenses. The determination of the Accountants shall be set forth in a written statement delivered to Buyer and Seller and shall be final, conclusive and binding on the parties. The date on
which the Closing Net Working Capital is finally determined in accordance with this Section 2.10(c) is referred as to the “Determination Date.” 
  

(d) Payment. The “Net Working Capital Adjustment Amount,” which may be positive or negative, shall mean (i) the Closing Net
Working Capital minus (ii) the Base Working Capital. If the Net Working Capital Adjustment Amount is greater than zero (such difference, the “Increase Amount”), then within five (5) days after the Determination Date, Buyer
shall pay to Seller (by wire transfer to such account as Seller may designate in writing) an additional amount equal to the Increase Amount, together with interest thereon calculated from the Closing Date to the date of payment at the prime rate of
interest, as announced by Citibank, N.A. in New York on the Closing Date (the “Applicable Rate”). If the Net Working Capital Adjustment Amount is less than zero (such absolute difference, the “Deficit Amount”), then
within five (5) days after the Determination Date, Seller shall pay to Buyer an amount equal to the Deficit Amount, together with interest thereon calculated from the Closing Date to the date of payment at the Applicable Rate. 
  
 2.11 Purchase Price Allocation. Buyer and Seller agree to allocate and
Seller agrees to cause its Subsidiaries, as applicable, to allocate the Final Purchase Price in accordance with the rules under Section 1060 of the Code and the Treasury Regulations promulgated thereunder. Buyer shall, within the later of (i) 120
days after the Closing Date, (ii) 30 days prior to the date by which Seller’s federal income Tax Returns must be filed, or (iii) 10 business days after there has been a final determination of the Purchase Price pursuant to Section 2.10
hereof, prepare and deliver to Seller for its consent (which consent shall not be unreasonably withheld, delayed or conditioned) a schedule allocating the Final Purchase Price (such schedule, the “Allocation”). If Seller raises any
objection to the Allocation, the parties will negotiate in good faith to resolve such objection(s). Buyer and Seller agree to act (and cause Seller’s Subsidiaries, as applicable, to act) in accordance with the computations and allocations
contained in the 

  

 16 

 
Allocation (including any modifications thereto reflecting any Net Working Capital Adjustment) in any relevant Tax returns or filings, including any forms or
reports required to be filed pursuant to Section 1060 of the Code, the Treasury Regulations promulgated thereunder, or any provisions of local, state, and foreign, law (“1060 Forms”), and to cooperate in the preparation of any 1060
Forms and to file such 1060 Forms in the manner required by applicable law. 
  
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES REGARDING SELLER, THE PARTNERSHIPS AND HTO 
  
 Seller represents and warrants to Buyer that the statements contained in this
Article III are correct and complete as of the date hereof, except as set forth in the disclosure schedule delivered by Seller to Buyer prior to the date of the execution of the Agreement (the “Disclosure Schedule”): 
  
 3.1 Organization and Qualification. 
  
 (a) Seller is a corporation duly organized, validly existing and in good
standing under the laws of the State of Georgia. Seller (i) has all requisite corporate power and authority to own, lease and operate the Acquired Assets being transferred hereunder and to carry on the Business as it is presently being conducted and
(ii) is duly qualified to do business as a foreign person in each jurisdiction in which the nature of the Acquired Assets or the conduct of the Business requires it to be so qualified. Complete and correct copies of the Organizational Documents of
Seller have been made available to Buyer. 
  
 (b) Each of HTO,
each of the Partnerships and each of the Affiliates of Seller that is party to the other Transaction Agreements (such Affiliates, collectively, the “Other Sellers”) is a corporation, limited partnership or limited liability company
duly organized, validly existing and in good standing under the laws of its jurisdiction of formation. Each of HTO, each Partnership and each of the Other Sellers (i) has all requisite corporate, partnership or limited liability company power and
authority to own, lease and operate its properties and assets and to carry on its business as it is presently being conducted and (ii) is duly qualified to do business as a foreign person in each jurisdiction in which the nature of the property
owned or leased by it or the conduct of its business requires it to be so qualified. Complete and correct copies of the Organizational Documents of HTO, each Partnership and each Other Seller have been made available to Buyer. 
  
 3.2 Capitalization of HTO and the Partnerships. The equity
capitalization of HTO and the Partnerships (including the identity of each equity holder and the partnership interest held thereby) is set forth in Schedule 3.2 hereto. All of the issued and outstanding HTO Interests and Partnership Interests
are beneficially owned solely by Seller or its Subsidiaries as set forth on Schedule 3.2 hereto. The HTO Interests and each of the Partnership Interests have not been issued in violation of any preemptive rights and are free and clear of any
Encumbrances. At the Closing, Buyer will acquire good and valid title to the HTO Interests, free and clear of all Encumbrances incurred by Buyer or its Affiliates. Other than as set forth in Schedule 3.2 hereto, neither HTO nor any
Partnership owns or holds, directly or indirectly, any equity interest of any kind in any Person. 
  

 17 

 (a) Except for this Agreement and the other Transaction Agreements and the transactions contemplated
hereby and thereby, there are no outstanding (i) agreements, arrangements, warrants, options, puts, calls, rights, subscriptions or other commitments to which HTO or any Partnership is a party relating to the sale, issuance or voting of any
partnership interests of HTO or such Partnership, or (ii) securities or other instruments convertible into, exchangeable for or evidencing the right to purchase any limited liability company or partnership interests, as applicable, of HTO or such
Partnership. 
  
 3.3 Corporate Books and Records. The
minute books of HTO and each Partnership contain accurate records of all meetings and accurately reflect all other actions taken by the members or partners of HTO or of such Partnership. Complete and accurate copies of all such minute books and of
the record of limited liability company or partnership interests, as applicable, of HTO and each Partnership have been provided by Seller to Buyer. 
  
 3.4 Authorization; Enforceability. Seller and each Other Seller (as the case may be) has all requisite corporate, partnership or limited liability
company power and authority, and has taken all corporate or other similar action necessary, in order to execute and deliver this Agreement, the other Transaction Agreements and the other instruments contemplated hereby and thereby, to perform its
obligations under this Agreement and the other Transaction Agreements and, subject to the conditions set forth in this Agreement and the other Transaction Agreements, to consummate the transactions contemplated hereby and thereby. The execution,
delivery and performance of this Agreement and the other Transaction Agreements by Seller and each Other Seller have been duly authorized by all requisite corporate or other similar action on behalf of Seller and each Other Seller, as applicable.
This Agreement has been, and the other Transaction Agreements will be upon execution and delivery by Seller and each Other Seller, duly executed and delivered by Seller and each Other Seller and, assuming the due authorization, execution and
delivery of this Agreement and the other Transaction Agreements to which Buyer is a party, constitute or will constitute the legal, valid and binding obligations of Seller and each Other Seller, enforceable against Seller and each Other Seller in
accordance with their terms subject to (a) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights and remedies generally, and (b) the effect of general
equitable principles, regardless of whether asserted in a proceeding in equity or at law. 
  
 3.5 No Conflict or Violation. The execution, delivery and performance by Seller and each Other Seller of this Agreement and the other Transaction Agreements and the consummation by Seller and each Other Seller
of the transactions contemplated hereby and thereby, and compliance by Seller and each Other Seller with, or fulfillment by Seller and each Other Seller of, the terms, conditions and provisions of this Agreement and of the other Transaction
Agreements, do not and will not: (a) violate, conflict with or result in the breach of any provision of the Organizational Documents of Seller, any Other Seller, HTO or any Partnership; (b) except as set forth on Schedule 3.5 hereto, violate,
conflict with or constitute or result in (or with notice, lapse of time or both become) a default or a breach under, require any consent under or result in the acceleration, termination, amendment, suspension, revocation or cancellation of (or
entitle any Person or give any Person the right to accelerate, terminate, amend, suspend, revoke or cancel), or result in the creation of any Encumbrance on the Interests or on any of the assets or properties of HTO or any Partnership pursuant to,
any Contract to 

  

 18 

 
which Seller, HTO or any Partnership is a party or by which any of the Interests or any of such assets or properties is bound, except, in the case of clause
(b) above, for any such matters or consequences that would not reasonably be expected, individually or in the aggregate, to materially adversely affect, restrict or delay the ability of Seller or any Other Seller to consummate the transactions
contemplated by this Agreement and the other Transaction Agreements. 
  
 3.6 Consents and Approvals. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or to materially adversely affect, restrict or delay the ability of Seller or any Other
Seller to consummate the transactions contemplated by this Agreement and the other Transaction Agreements, and except as set forth on Schedule 3.6 hereto, the execution, delivery and performance by Seller and each Other Seller of this
Agreement and the other Transaction Agreements, and the consummation by Seller and each Other Seller of the transactions contemplated hereby and thereby, do not and will not require the approval, consent, authorization or other order of, or action
by, or the making by Seller, HTO, any Other Seller or any Partnership or any other Person of any declaration, filing or registration with, or notification to, any Governmental Authority. 
  
 3.7 Financial Statements. 
  

(a) True and complete copies of (i) the unaudited balance sheet of HTO and each Partnership as of December 31, 2003 and 2004 and as of March 31, 2003,
2004 and 2005, June 30, 2003, 2004 and 2005, and September 30, 2003 and 2004, and (ii) the related unaudited income statement for each of the fiscal quarters ended March 31, 2003, 2004 and 2005, June 30, 2003, 2004 and 2005, September 30, 2003 and
2004 and December 31, 2003 and 2004, and (iii) the statement of net assets of each of the Partnerships and HTO (on a combined basis) as of June 30, 2005 (the “Statement of Net Assets”), (collectively, the “Financial
Statements”), are attached hereto as Schedule 3.7(a) to this Agreement. The Financial Statements have been prepared in accordance with GAAP, applied on a consistent basis throughout the periods covered by such Financial Statements. The
Financial Statements fairly present in accordance with GAAP, in all material respects, the financial condition of HTO and each of the Partnerships and the results of their operations, in each case, as of the dates of such Financial Statements for
the periods referred to in such Financial Statements. 
  
 (b) All
accounts receivable of HTO and each of the Partnerships reflected in the June 30, 2005 Statement of Net Assets included in the Financial Statements or arising since June 30, 2005 have arisen in the Ordinary Course of Business of HTO and the
Partnerships from bona fide transactions and represent valid obligations due to the operations of HTO and the Partnerships in accordance with their terms and are not subject to discount except for immaterial trade discounts consistent with past
practice and contractual allowances and reserves reflected on the Financial Statements. The values at which the accounts receivable are carried on the Financial Statements reflect the accounts receivable consistent with GAAP. 
  
 3.8 Absence of Certain Changes or Events. Since December 31, 2004,
except as set forth in Schedule 3.8 hereto or as disclosed in any of the Financial Statements, (a) HTO and the Partnerships have operated only in the Ordinary Course of Business, and (b) there have not been any changes in the Business or
results of operations of HTO or the 

  

 19 

 
Partnerships or any other events, conditions or circumstances that have, or would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. In addition, since December 31, 2004 and through the date hereof (a) neither HTO nor any Partnership has sold, assigned, transferred, leased, licensed or disposed of any of its material assets or properties and neither
Seller nor any of its Subsidiaries has taken any such action with respect to the Acquired Assets other than the sale of inventory and obsolete or worn-out equipment, in each case in the Ordinary Course of Business; (b) neither HTO nor any
Partnership has made any acquisition of any Person or other business organization or division thereof; (c) neither HTO nor any Partnership has subjected any of its assets to any Encumbrance and neither Seller nor any of its Subsidiaries has taken
any such action with respect to the Acquired Assets, except for Permitted Encumbrances; (d) neither HTO nor any Partnership has amended or authorized any amendment to its Organizational Documents; (e) neither HTO nor any Partnership has materially
changed or modified the commission or sales quota applicable to or the compensation payable to any employee; (f) there has not been any (i) increase in the compensation or fringe benefits of any Transferred Employee, other than increases in salary
in the Ordinary Course of Business and reflected in Schedule 3.19(a) (ii) grant of any severance or termination pay to any Transferred Employee, (iii) loan or advance of money or other property to any present or former employee of HTO or a
Partnership, other than expense advances in the Ordinary Course of Business, (iv) establishment, adoption, entrance into, amendment or termination of any Seller Plan or collective bargaining agreement (other than as may be required by the terms of
an existing Seller Plan or collective bargaining agreement, or as may be required by applicable law or in order to qualify under Sections 401 and 501 of the Code), (v) grants of any equity or equity-based awards to any present or former employee of
HTO or a Partnership; or (g) none of HTO, any Partnership or Seller or any of its Subsidiaries (as applicable) has become obligated in writing or otherwise agreed to take any of the actions specified in subparagraphs (a) through (e) above. Since
December 31, 2004, there has not been (i) any damage, destruction, or loss to any assets or properties that has, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (ii) any change in the
accounting principles or practices used by HTO or the Partnerships. 
  
 3.9 No Undisclosed Liabilities. Except as set forth in Schedule 3.9 hereto, there are no outstanding liabilities or indebtedness of HTO or the Partnerships that would be required to be reflected on a consolidated balance sheet
prepared in conformity with GAAP, except for liabilities or indebtedness (i) disclosed or reflected in the Statement of Net Assets, (ii) incurred in the Ordinary Course of Business since June 30, 2005 that are of the nature required to be reflected
on a consolidated balance sheet prepared in conformity with GAAP, or (iii) that do not have, or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. None of HTO nor any of the Partnerships is a party
to, or has any commitment to become a party to, any contract or other arrangement associated with off balance sheet financing, including without limitation any arrangements for the sale of receivables. 
  
 3.10 Litigation. As of the date of this Agreement, except as set forth
in Schedule 3.10 hereto (which, with respect to each proceeding disclosed therein, sets forth: the parties, nature of the proceeding, date and method commenced, amount of damages or other relief sought and, if applicable, paid or granted),
(a) there are no civil, criminal, judicial, administrative or arbitral lawsuits, actions, audits, hearings, litigation, claims, investigations or other proceedings, public or private, or governmental investigations pending by or against, or, to

  

 20 

 
the knowledge of Seller, threatened against Seller, any of its Subsidiaries, HTO or any Partnership that have, or would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect or that could, individually or in the aggregate, affect the legality, validity or enforceability of this Agreement or the other Transaction Agreements or the consummation of transactions
contemplated hereby or thereby or materially adversely affect, restrict or delay the ability of Seller to consummate such transactions and (b) none of Seller, any of its Subsidiaries, HTO or any Partnership is a party to or in default under any
outstanding Governmental Order (nor, to the knowledge of Seller, are there any such Governmental Orders threatened to be imposed by any Governmental Authority) that have, or would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. 
  
 3.11 Compliance with Laws;
Permits. Seller, its Subsidiaries, HTO and each of the Partnerships are in compliance, and have been in compliance at all times during the past five (5) years, in all material respects with all applicable laws, statutes, regulations and
Governmental Orders relating to the operation of the Business (other than Environmental Laws, which are addressed in Section 3.15(a)). Except as set forth on Schedule 3.11 hereto, Seller, its Subsidiaries, HTO and each of the Partnerships are
in compliance in all material respects with all licenses, permits, approvals, registrations, authorizations, notifications, exemptions, consents, franchises and concessions from any Governmental Authority issued or granted to Seller, its
Subsidiaries, HTO or the Partnerships in connection with the operation of the Business (collectively, “Governmental Permits”) other than Environmental Permits, which are addressed in Section 3.15(f). Seller, its Subsidiaries, HTO
and each of the Partnerships are in compliance, and have been incompliance at all times during the past five (5) years, with the Foreign Corrupt Practices Act of 1977. 
  
 3.12 Contracts 
  
 (a) Except as set forth in Schedule 3.12(a) hereto, neither HTO nor any Partnership is a party to, or bound by, any of the following: 

 
 (i) any Contract relating to or requiring capital
expenditures in excess of either $10,000 in any one fiscal year or $20,000 in the aggregate; 
  
 (ii) any Contract representing an aggregate future liability of HTO or such Partnership or representing the future right of HTO or such
Partnership to receive, in each case, an amount in excess of either $10,000 in any one fiscal year or $20,000 over the term of such Contract (including all potential extensions thereof); 
  
 (iii) any Contract with respect to the purchase of goods or services with a value, or involving payments by
HTO or such Partnership or Seller or its Subsidiaries, of more than $10,000 in any twelve (12) month period that is not subject to cancellation or termination on not more than 30 days’ notice by HTO or such Partnership or Seller or its
Subsidiaries without penalty or further payment, except purchase orders made or letters of credit obtained in its Ordinary Course of Business; 
  

 21 

 (iv) any agreement providing for a commitment of employment or consultation services for
a specified or unspecified term or otherwise relating to employment or the termination of employment and requiring payments in excess of $10,000; 
  
 (v) any note, mortgage, indenture or other obligation or agreement or other instrument for or relating to indebtedness for money borrowed
(including capital lease obligations) by HTO or such Partnership or Seller or its Subsidiaries, or any guarantee, assumption or endorsement by HTO or such Partnership of third-party obligations, of $10,000 or more or letters of credit obtained in
its Ordinary Course of Business; 
  
 (vi) any
collective bargaining agreement with any labor union or association representing employees of HTO or such Partnership or Seller or its Subsidiaries; 
  
 (vii) any lease of personal property with an annual base rental obligation of more than $20,000; 
  
 (viii) any franchise agreement; or 
  
 (ix) any joint venture, partnership, joint marketing or
limited liability company agreement; 
  
 (x) any
contract or agreement with any Governmental Authority that represents an aggregate liability of HTO or such Partnership or Seller or its Subsidiaries in excess of $10,000; 
  
 (xi) any contract or agreement that limits or purports to limit HTO’s or such Partnership’s or
Seller’s or its Subsidiaries’ ability to compete in any line of business or with any Person or in any geographic area or during any period of time or which grants exclusive sales rights in any territory or region or “most favored
nations” or similar from of pricing protection; 
  
 (xii) any contract concerning Intellectual Property, including (a) every contract pursuant to which any Intellectual Property used in the conduct of the Business is licensed from any third party, and (b) every contract pursuant to which any
Intellectual Property used in the conduct of the Business is licensed to any third party; or 
  
 (xiii) any other contract or agreement whether or not made in the Ordinary Course of Business, which is material to the Business.

  
 (b) Except as disclosed in Schedule 3.12(b) hereto,
each Scheduled Contract: (i) is valid and binding on the respective parties thereto and is in full force and effect and (ii) upon consummation of the transactions contemplated by this Agreement and the other Transaction Agreements, except to the
extent that any consents set forth in Schedule 3.5 hereto are not obtained, shall continue in full force and effect without penalty or other adverse consequence. 
  

 22 

 (c) Except as set forth in Schedule 3.12(c) hereto, with respect to each Scheduled Contract,
neither HTO nor any Partnership or, to the knowledge of Seller, any other Person which is a party to any Scheduled Contract, is in breach of or default in any material respect under, and no event has occurred which with notice or lapse of time, or
both, would become a breach of or default in any material respect under such Scheduled Contract. Complete and correct copies of the Scheduled Contracts have been made available to Buyer. 
  
 3.13 Suppliers. Schedule 3.13 hereto lists each of the 25 largest suppliers of supplies, merchandise and other
goods for the Business based on amounts invoiced by such supplier over the 12-month period ended June 30, 2005 (each a “Material Supplier”). To the knowledge of Seller, except as occurring in the Ordinary Course of Business and
except for HMT and its Subsidiaries, since December 31, 2004 and through the date of this Agreement, no Material Supplier has terminated or materially reduced its business relationship with HTO, the Partnerships or Seller or its Subsidiaries, as
applicable, or materially changed the terms on which it does business with HTO, the Partnerships or Seller or its Subsidiaries, as applicable, or communicated its intention to do any of the foregoing. Seller is not aware of any intention of any
Material Supplier to terminate, materially reduce its business relationship with or increase prices charged to HTO, the Partnerships or Seller or its Subsidiaries, as applicable, following the Closing. 
  
 3.14 Title to Acquired Assets. Except as set forth in Schedule
3.14 hereto, Seller, its Subsidiaries, HTO and the Partnerships have good title to, or a valid leasehold interest in or right to use, the respective properties, rights and assets necessary to conduct the Business free and clear of all
Encumbrances other than Permitted Encumbrances, except for items which were disposed of in the Ordinary Course of Business since December 31, 2004, the properties, rights and assets of HMT and its Subsidiaries. Except as set forth in Schedule
3.14, all equipment and tangible personal property related to the Business and held by Seller, its Subsidiaries, HTO and the Partnerships is in good condition or repair, ordinary wear and tear excepted. 
  
 3.15 Environmental Matters. 
  
 (a) Each of HTO and the Partnerships and Seller’s, HTO’s and the
Partnerships’ operation of the Business have been and are in material compliance with all applicable Environmental Laws, and there are no conditions or circumstances arising out of or related to Seller’s, HTO’s or any
Partnership’s past or present operation of the Business that have given or could reasonably be expected to give rise to any material liabilities or claims against Seller, HTO or any Partnership under any Environmental Laws. 
  
 (b) Without limitation to Section 3.15(a), Seller, its Subsidiaries, HTO and
the Partnerships hold, and are in material compliance with, all Environmental Permits required for the ownership and operation of the Acquired Assets and the Business, and the consummation of the transactions contemplated under this Agreement do not
require any transfer, amendment or modification of such Environmental Permits or any consent of, or notice to, any third Person. 
  

 23 

 (c) None of HTO, the Partnerships, and in connection with the Business or the Acquired Assets, none of
Seller nor its Subsidiaries, has received any material Environmental Claim, and Seller has no knowledge of any threatened material Environmental Claim. 
  
 (d) Hazardous Materials are not present at or about any of the Acquired Assets, or any facility currently or formerly owned, leased, operated or used by
HTO or any of the Partnerships, in amount or condition that could reasonably be expected to give rise to any material liabilities or claims against Seller, any of its Subsidiaries, HTO or any Partnership under any Environmental Laws. 
  
 (e) Neither Seller, HTO nor any of its Subsidiaries in connection with the
Business, nor HTO nor any of the Partnerships, has assumed any material liability or obligation under or relating to any Environmental Law. 
  
 (f) Seller has provided to Buyer true and complete copies of all Environmental Reports containing material information that are in the possession or
control of Seller, HTO or any of the Partnerships, each of which is identified on Schedule 3.15(f) hereto. 
  
 3.16 Intellectual Property. 
  
 (a) Schedule 3.16(a) hereto lists (i) all Registered Intellectual Property owned by Seller, its Subsidiaries, HTO or the Partnerships
(collectively, the “IP Transferring Parties”), including in each case the jurisdiction in which each asset is registered or filed, and the corresponding application or registration number and (ii) all other Intellectual Property material
to the Business. 
  
 (b) With respect to each asset set forth in
Schedule 3.16(a) of the Disclosure Schedule, (i) such asset is valid and enforceable, (ii) the IP Transferring Parties own, or possess all right title and interest in and to the asset, (iii) the IP Transferring Parties’ ownership or
interest in such asset is free and clear of any Encumbrance, (iv) the asset is not subject to any outstanding injunction, judgment, order, decree, ruling, or charge, and (iv) no action, suit, proceeding, hearing, investigation, charge, complaint,
Claim or demand is pending, or to the knowledge of Seller, HTO or any Partnership, is threatened, which challenges the legality, validity or enforceability of the asset or the use or ownership of the asset by HTO or the Partnerships. 
  
 (c) Except as set forth in Schedule 3.16(c) of the Disclosure
Schedule, (i) the conduct of the Business does not infringe upon, misappropriate or otherwise violate any Intellectual Property of any third party, (ii) none of the IP Transferring Parties has received any written or oral notice that it is
infringing upon, misappropriating, or otherwise violating any Intellectual Property of any third party, nor is there any action, suit or proceeding pending or, to the knowledge of Seller, threatened, against the IP Transferring Parties claiming that
such Person is infringing upon, misappropriating, or otherwise violating any Intellectual Property of any third party, and Seller knows of no reasonable basis for any such claim, and (iii) no third party is infringing upon, misappropriating, or
otherwise violating any Intellectual Property of the IP Transferring Parties. 
  

 24 

 (d) Each of the IP Transferring Parties have taken reasonably appropriate measures to maintain and
protect their rights in, and the confidentiality and proprietary nature (where appropriate) of, all Intellectual Property assets that they own or use in the conduct of the Business. 
  
 (e) The conduct of the Business by the IP Transferring Parties does not use or incorporate any source, object or other
software code subject to an “open-source’, “copyleft” or other similar license terms (including, without limitation, any GNU General Public License, Library General Public License, Lesser General Public License, Mozilla License,
Berkely Software Distribution License, Open Source Initiative License, MIT, Apache or public domain licenses, and the like). 
  
 (f) None of the IP Transferring Parties has deposited, is obligated to deposit, or reasonably expects that it will be obligated to deposit, the source
code of any of the software products of the used by any of the IP Transferring Parties pursuant to a source code escrow agreement for the benefit of any Person, nor have any of them made the source code of any software product available to any
Person. 
  
 (g) All software, databases, systems, networks and
Internet sites included within the Acquired Assets are free from any material defect, bug, “Trojan Horse”, malware, spyware or other virus or programming design or documentation error or corruptant. The IP Transferring Parties have taken
all reasonably necessary actions to protect the confidentiality, integrity and security of their software, databases, systems, networks and Internet sites and all information stored or contained therein or transmitted thereby from any unauthorized
use, access, interruption or modification by third parties. The IP Transferring Parties fully comply with all relevant laws and regulations and with their own respective policies with respect to the privacy of all users and customers and any of
their personally identifiable information, and no claims have been asserted or threatened in writing against any of the IP Transferring Parties alleging a violation of any of the foregoing. 
  
 3.17 Labor Relations. Seller, its Subsidiaries, HTO and the
Partnerships have not agreed to recognize, and is not a party to any contract with, any labor union, collective bargaining representative, works council, or other form of employee representative. To the knowledge of Seller, no union organizing
campaign or representation petition is currently pending with respect to any of the Business Employees. There is no pending or, to the knowledge of Seller threatened, labor dispute, strike or work stoppage against Seller with respect to the
Business. To the knowledge of Seller, all Business Employees are lawfully authorized to work in their present location under the laws of the jurisdiction in which they work. To the knowledge of Seller, no Business Employee and no independent
contractor or consultant is in violation of any term of any employment, services or other contract, non-disclosure agreement, non-competition agreement, or any restrictive covenant to a former employer relating to (i) the right of any such person to
be employed or retained by Seller or their Affiliates, or (ii) the use by or for the benefit of Seller or an Affiliate of Seller of the trade secrets, intellectual property, or confidential or proprietary information of others. 
  

 25 

 3.18 Taxes. 
  
 (a) All Tax Returns required to be filed by, or with respect to, HTO, the Partnerships, the Acquired Assets and the
Business on or prior to the Closing Date have been or will be duly filed with the appropriate Taxing Authorities on or prior to the Closing Date, and all such Tax Returns are or will be complete and correct in all material respects; 
  
 (b) all liabilities for Taxes with respect to HTO, the Partnerships, the
Acquired Assets or the Business have been timely paid in full (or will be paid in full on or prior to the Closing Date); 
  
 (c) none of Seller, HTO nor any Partnership has received any written notice of deficiency or assessment from any Taxing Authority with respect to any
liability for Taxes with respect to HTO or such Partnership or the Acquired Assets or the Business which has not been fully paid or finally settled; 
  
 (d) as of the Closing Date, there will be no tax sharing, indemnity, allocation or similar agreements in effect to which HTO or any Partnership is a
party or has continuing liability thereunder; 
  
 (e) there are
no liens for Taxes (other than Permitted Tax Liens) upon any assets or properties of HTO, the Partnerships or the Acquired Assets or the Business; 
  
 (f) no audit or other proceeding by any court, governmental or regulatory authority, or similar person has formally commenced and no notification has
been given that such an audit or other proceeding is pending or threatened with respect to any Taxes due from or with respect to HTO, the Partnerships, the Acquired Assets or the Business or any Tax Return filed by or with respect to HTO, the
Partnerships, the Acquired Assets or the Business; 
  
 (g) there
are no outstanding agreements, waivers or arrangements extending the statutory period of limitation applicable to any claim for, or the period for the collection or assessment of, Taxes due from or with respect to HTO, any of the Partnerships, the
Acquired Assets or the Business for any Taxable Period; 
  
 (h)
no closing agreement pursuant to Section 7121 of the Code (or any predecessor provision) or any similar provision of any state, local, or foreign law has been entered into by or with respect to HTO, the Partnerships, the Acquired Assets or the
Business; 
  
 (i) Seller, HTO and the Partnerships have duly and
timely withheld and paid over to the appropriate taxing authorities all amounts required to be withheld and paid over for all periods under all applicable laws and regulations with respect to HTO, the Partnerships, the Acquired Assets and the
Business; 
  
 (j) HTO and each of the Partnerships has at times
since its formation been treated as a partnership for U.S. federal income tax purposes; and 
  

 26 

 (k) none of HTO nor the Partnerships have participated in any “reportable transaction” as
defined in Section 1.6011-4(b) of the Treasury Regulations or any “listed transaction” as defined in Section 301.6111-2(b)(2) of the Treasury Regulations and Seller has not participated in any such transaction with respect to the Acquired
Assets or the Business. 
  
 3.19 Employee Matters and Seller
Plans. 
  
 (a) Schedule 3.19(a) contains (A) a
complete and accurate list of all Transferred Employees, showing for each Transferred Employee (including employees on leave of absence), the location and name of such Transferred Employee, position held, current annual compensation (annual base
salary and base wages, excluding bonus and commissions, if any), (B) the Transferred Employees located within the United States whose position will require action to obtain work authorization (e.g., visa), and (C) information related to whether any
such Transferred Employee is on a leave of absence, including but not limited to leaves for disability, workers compensation, pregnancy, or family medical leave, and if any such Transferred Employee is on a leave of absence, the initial date and
expected duration of such leave, and the pay status of the individual during such leave. 
  
 (b) Schedule 3.19(b) contains a true and complete list of each “employee benefit plan” (within the meaning of Section 3(3) of ERISA, including, without limitation, multiemployer plans within
the meaning of Section 3(37) of ERISA), and all stock purchase, stock option, severance, employment, change-in-control, fringe benefit, collective bargaining, bonus, incentive, deferred compensation, employee loan and all other employee benefit
plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA (including any funding mechanism therefor now in effect or required in the future as a result of the transaction contemplated by this Agreement or
otherwise), whether formal or informal, oral or written, legally binding or not, under which (i) any current or former employee, director or consultant of Seller, its Subsidiaries, HTO or the Partnerships (the “Seller Employees”)
has any present or future right to benefits and which are contributed to, sponsored by or maintained by Seller, any of its Subsidiaries, HTO or any of the Partnerships (ii) Seller, any of its Subsidiaries, HTO or any of the Partnerships has had or
has any present or future liability. All such plans, agreements, programs, policies and arrangements shall be collectively referred to as the “Seller Plans”. 
  
 (c) With respect to each Seller Plan, Seller has provided to Buyer a current, accurate and complete copy (or, to the extent
no such copy exists, an accurate description) thereof and, to the extent applicable: (i) any related trust agreement or other funding instrument; (ii) the most recent determination letter, if applicable; (iii) any summary plan description and other
written communications (or a description of any oral communications) by Seller or its Subsidiaries to Seller Employees concerning the extent of the benefits provided under a Seller Plan; (iv) a summary of any proposed amendments or changes
anticipated to be made to Seller Plans at any time within the twelve months immediately following the date hereof, and (v) for the three most recent years (A) the Form 5500 and attached schedules, (B) audited financial statements and (C) actuarial
valuation reports. 
  

 27 

 (d) Each Seller Plan has been established and administered in accordance with its terms, and in
compliance with the applicable provisions of ERISA, the Code and other applicable laws, rules and regulations; (ii) each Seller Plan which is intended to be qualified within the meaning of Section 401(a) of the Code is so qualified and has received
a favorable determination letter as to its qualification, and nothing has occurred, whether by action or failure to act, that could reasonably be expected to cause the loss of such qualification; (iii) no event has occurred and no condition exists
that would subject Seller or its Subsidiaries, either directly or by reason of their affiliation with any member of their “Controlled Group” (defined as any organization which is a member of a controlled group of organizations within the
meaning of Sections 414(b), (c), (m) or (o) of the Code), to any tax, fine, lien, penalty or other liability imposed by ERISA, the Code or other applicable laws, rules and regulations; (iv) no “reportable event” (as such term is defined in
Section 4043 of the Code) that could reasonably be expected to result in liability, no nonexempt “prohibited transaction” (as such term is defined in Section 406 of ERISA and Section 4975 of the Code) or “accumulated funding
deficiency” (as such term is defined in Section 302 of ERISA and Section 412 of the Code (whether or not waived)) has occurred with respect to any Seller Plan; (v) there is no present intention that any Seller Plan be materially amended,
suspended or terminated, or otherwise modified to adversely change benefits (or the levels thereof) under any Seller Plan at any time within the twelve months immediately following the date hereof. 
  
 (e) No Seller Plan is a “multiemployer plan” (as defined in
Section 4001(a)(3) of ERISA) and neither Seller, its Subsidiaries nor any of their Affiliates has at any time sponsored or contributed to, or has or had any liability or obligation in respect of, any multiemployer plan. 
  
 (f) With respect to any Seller Plan, (i) no actions, suits or claims (other
than routine claims for benefits in the ordinary course) are pending or threatened, (ii) no facts or circumstances exist that could give rise to any such actions, suits or claims, (iii) no written or oral communication has been received from the
Pension Benefit Guaranty Corporation (the “PBGC”) in respect of any Seller Plan subject to Title IV of ERISA concerning the funded status of any such plan or any transfer of assets and liabilities from any such plan in connection
with the transactions contemplated herein, and (iv) no administrative investigation, audit or other administrative proceeding by the Department of Labor, the PBGC, the Internal Revenue Service or other governmental agencies are pending, threatened
or in progress (including, without limitation, any routine requests for information from the PBGC).  
  
 (g) No Seller Plan exists that, as a result of the execution of this Agreement, shareholder approval of this Agreement, or the transactions
contemplated by this Agreement (whether alone or in connection with any subsequent event(s)), (i) could entitle any Seller Employee to severance pay or any increase in severance pay upon any termination of employment after the date of this
Agreement, (ii) could accelerate the time of payment or vesting or result in any payment or funding (through a grantor trust or otherwise) of compensation or benefits under, increase the amount payable or result in any other material obligation
pursuant to, any of the Seller Plans, (iii) could limit or restrict the right of Seller to merge, amend or terminate any of the Seller Plans, (iv) could cause Seller to record additional compensation expense on its income statement with respect to
any outstanding stock option or other equity-based award, or (v) could result in payments under any of the Seller Plans which would not be deductible under Section 280G of the Code. 
  

 28 

 (h) Except as set forth in Schedule 3.19(h) hereto, no Seller Plan is maintained outside the
jurisdiction of the United States, or covers any employee residing or working outside the United States (any such Seller Plan set forth in Schedule 3.19(h), “Foreign Benefit Plans”). With respect to any Foreign Benefit Plans,
(i) all Foreign Benefit Plans have been established, maintained and administered in compliance with their terms and all applicable statutes, laws, ordinances, rules, orders, decrees, judgments, writs, and regulations of any controlling governmental
authority or instrumentality; (ii) all Foreign Benefit Plans that are required to be funded are fully funded, and with respect to all other Foreign Benefit Plans, adequate reserves therefore have been established on the accounting statements of the
applicable Seller, Subsidiary, HTO or Partnership entity; and (iii) no material liability or obligation of Seller, its Subsidiaries, HTO or the Partnerships exists with respect to such Foreign Benefit Plans that has not been disclosed on Schedule
3.19(h). 
  
 3.20 Contracts with Affiliates. Except as
set forth in Schedule 3.20 hereto, (i) on the Closing Date none of Seller or any of its Affiliates has outstanding any loan to, or is party to any other transaction outside of a general employment relationship with, any director, officer or
employee of the Business other than Seller’s executive officers who serve as officers of HTO but are not included in the Transferred Employees and (ii) there are no contracts, agreements or obligations of HTO or any Partnership that are
guaranteed by Seller or any of its Affiliates. Except as set forth in Schedule 3.20 hereto, there is no Contract between the Business and any other business or division of Seller or any Affiliate of Seller (an “Intercompany
Agreement”). On the Closing Date, none of HTO or any of the Partnerships has outstanding any guarantee of any note, mortgage, credit agreement, indenture or other obligation or agreement or other instrument for or relating to indebtedness
for money borrowed of Seller or any of its Subsidiaries. 
  
 3.21
No Brokers, Finders, etc. None of Seller, any of its Subsidiaries, HTO nor any Partnership has paid or will become obligated to pay any fee or commission to any broker, finder or other intermediary for or on account of the transactions
contemplated by this Agreement. 
  
 3.22 Insurance.
Schedule 3.22 hereto lists (a) all insurance policies of Seller, HTO, the Partnerships or any other Affiliate of Seller covering the assets, business, products, services or employees of HTO, the Partnerships or the Business as of the date
hereof, (b) the amount of the annual premiums thereon paid by, or otherwise allocated to, such Person, and (c) any claims made thereunder during the past three years with respect to the assets, business, products, services or employees of HTO, the
Partnerships or the Business. All such policies are in full force and effect, all premiums due thereon have been paid, and Seller, HTO, the Partnerships or any other Affiliate of Seller providing insurance benefits to HTO or any Partnership have
complied in all material respects with the provisions of such policies and have not received any notice from any of their insurance brokers or carriers that such broker or carrier will not be willing or able to renew their existing coverage.

  

 29 

 3.23 Fixed Assets. Except as set forth in Schedule 3.23 hereto, the fixed assets shown on
the Financial Statements or thereafter acquired by HTO or the Partnerships consisted of items of a quantity and quality usable or salable in the Ordinary Course of Business and the fixed assets set forth on Schedule 2.1 hereto that are comprised of
or primarily related to OssaTrons are in good working order. 
  
 3.24 Equity Interests. Schedule 3.24 hereto sets forth the capital stock of or other equity interests in any corporation, partnership or other entity that are included in the Acquired Assets (directly or indirectly). At
the time of the Closing, Seller will have good and marketable title to all such capital stock or other equity interests described in Schedule 3.24 hereto, free and clear of all Encumbrances except Permitted Encumbrances. Prior to the date
hereof, HTO has taken all actions necessary and appropriate to transfer, sell, assign and deliver any and all of the equity interests held by it (directly or indirectly), other than such capital stock or other equity interests set forth on
Schedule 3.24; for the avoidance of doubt, any liabilities or obligations arising therefrom shall be an Excluded Liability pursuant to Section 2.4(l). 
  
 3.25 Sufficiency of Assets. The transfer of the Acquired Assets, and the other rights, licenses, services and benefits to be provided pursuant to
this Agreement and the other Transaction Agreements, constitute the assets, properties and rights, including without limitation all rights in Intellectual Property, necessary to conduct the Business in all material respects as currently conducted,
in each case other than (A) the Excluded Assets described in Schedule 2.2(d) hereto, (B) the assets, properties and rights used to perform the services that are the subject of the Transition Services Agreement and (C) as set forth in
Schedule 3.25 hereto. 
  
 3.26 Limited Partners. To
the knowledge of Seller, except as occurring in the Ordinary Course of Business, since December 31, 2004 and through the date of this Agreement, no limited partner of any of the Partnerships has terminated or materially altered its business
relationship (which business relationship does not include a limited partner’s use of the Partnership’s equipment to perform procedures) with HTO, such Partnership or Seller or its Subsidiaries, as applicable, materially changed the terms
on which it does business with HTO, such Partnership or Seller or its Subsidiaries, as applicable, assigned its limited partnership interest to a third party or communicated its intention to do any of the foregoing. Except as disclosed in
Schedule 3.26 hereto, Seller is not aware of any material dispute with any limited partner of any of the Partnerships or the intention of any such limited partner to terminate, materially alter its business relationship with HTO, such
Partnership or Seller or its Subsidiaries, as applicable, or to assign its limited partnership interest to any third party following the Closing. 
  
 3.27 Certain Regulatory Matters. 
  
 (a) HTO and the Partnerships have established and administer a compliance program (including a written compliance policy) applicable to the Business (i)
to assist HTO and the Partnerships, and their respective directors, officers and employees in complying with applicable Health Care Laws (including, without limitation, those administered by the United States Food and Drug Administration
(“FDA”) and the United States Department of Health and Human Services “HHS”) applicable to the Business and (ii) to provide compliance policies relating to Health Care Laws governing the conduct of medical device
companies (including, without limitation, pre-clinical and clinical testing, product design and development, 

  

 30 

 
product testing, product manufacturing, product labeling, product storage, pre-market clearance and approval, marketing, advertising and promotion, product
sales and distribution, reimbursement, fraud and abuse, medical device recall and reporting regulations, and record keeping). 
  
 (b) HTO and the Partnerships are and at all times during the past five (5) years have been in compliance in all material respects with the provisions of
all Health Care Permits and Health Care Laws. All applications, submissions, information, claims, reports and statistics and other data and conclusions derived therefrom, utilized as the basis for or submitted in connection with any and all requests
for authorizations, approvals, certificates, waivers, certifications, clearances, exemptions, notifications, consents, orders, registrations, licenses or permits of the FDA, HHS or comparable Governmental Authorities relating to HTO and the
Partnerships, the Business and its products, when submitted to the FDA, HHS or other Governmental Authority were true, complete and correct in all material respects and in conformance with Health Care Laws as of the date of submission and any
updates, changes, corrections or modification to such applications, submissions, information and data which were or are necessary or required to be filed, maintained, or furnished to the FDA, HHS or other Governmental Authorities have been timely
filed, maintained, or furnished to the FDA, HHS and other Governmental Authorities and were true, complete and correct in all material respects and in conformance with legal requirements as of the date of submission. 
  
 (c) Neither HTO nor any Partnership is subject to any obligation arising
under any consent decree, consent agreement, or warning letter issued by or entered into with the FDA or any other Governmental Authority or other notice, response or commitment made to the FDA or any other Governmental Authority. Seller has
delivered to Buyer true, correct and complete copies of all customer complaints relating to the products of the Business and all MDRs, as that term is defined in 21 C.F.R. Part 803, filed with the FDA within the last five (5) years. Seller has
delivered to Buyer true, complete and correct copies of all warning letters, untitled letters, notices of inspectional observations (Form FDA-483s), or similar notices, or other correspondence relating to products of the Business and HTO’s and
the Partnerships’ compliance with Health Care Laws from the FDA and any other Governmental Authority and all of their respective responses thereto within the last five (5) years. 
  
 (d) No premarket approval or 510(k) applications for the products of the Business has been subjected to reevaluation or
suspension of sale by the FDA and no products manufactured, marketed or sold by Seller or its Affiliates in connection with Business have been recalled or subject to a field notification, field correction or safety alert (whether voluntarily or
otherwise) and no proceedings have occurred (whether completed or pending) seeking to recall, reclassify, re-label, suspend, or seize any product sold or proposed to be sold by Seller or its Affiliates in connection with the Business. There are no
facts which are reasonably likely to cause: (A) the recall, suspension, field notification, field correction, reclassification, re-labeling or safety alert of any product sold or intended to be sold by Seller or its Affiliates relating to the
Business; (B) a change in the marketing classification or a material change in labeling of any such products; or (C) a termination or suspension of marketing of any such products. 
  

 31 

 (e) Except as set forth in Schedule 3.27, there are no nonclinical, pre-clinical or clinical
trials or studies relating to the Business being conducted by or on behalf of Seller or its Affiliates. All pre-clinical trials and clinical trials relating to the Business conducted by or on behalf of Seller or its Affiliates have been, and are
being conducted in material compliance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all applicable Health Care Laws relating thereto, including the Food, Drug and Cosmetic Act and
its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56 and 812. 
  
 (f) None of HTO, any of the Partnerships nor, to Seller’s knowledge, any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that is prohibited under
federal or state criminal or civil laws (including without limitation the Federal Anti-Kickback statute, Stark law, Civil False Claims Act, Administrative False Claims Act, and any state laws prohibiting kickbacks or certain referrals), or the
regulations promulgated pursuant to such laws, or that could result in a material debarment or exclusion (i) under 21 U.S.C. Section 335a, (ii) under any similar state law or regulation, or (iii) from participation in Medicare, Medicaid or any other
state or federal health care program 
  
 (g) There are no
investigations, audits, actions or other proceedings pending or threatened with respect to a violation by Seller or its Affiliates related to the Business of any Health Care Law or any other legislation or regulation promulgated by any other
Governmental Authority that reasonably would be expected to result in administrative, civil, or criminal liability, debarment or exclusion. 
  
 3.28 Transferred Accounts Receivable. All accounts receivable included on Schedule X hereto have arisen in the Ordinary Course of Business of the
Partnerships from bona fide transactions and represent valid obligations due to the operations of the Partnerships in accordance with their terms and are not subject to discount. The respective values of the accounts receivable reflected in Schedule
X reflect the carrying value of such accounts receivable consistent with GAAP. 
  
 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES OF BUYER 
  
 Buyer represents and warrants to Seller that the statements contained in this
Article IV are correct and complete as of the date hereof: 
  
 4.1 Organization. Buyer is duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation and has all requisite corporate power and authority to own, lease and operate its properties and
assets and to carry on its business as it is now being conducted. Copies of the Organizational Documents of Buyer have been made available to Seller and such copies are complete and correct, except where the failure to have such power or authority
or to be duly qualified to do business does not and would not reasonably be expected to materially adversely affect, restrict or delay the ability of Buyer to consummate the transactions contemplated by this Agreement and the other Transaction
Agreements. Copies of the Organizational Documents have been provided to Seller and such copies are complete and correct. 
  

 32 

 4.2 Authorization; Enforceability. Buyer has all requisite corporate power and authority to
execute and deliver this Agreement and the other Transaction Agreements, to perform its obligations hereunder and thereunder and, subject to the conditions set forth herein and therein, to consummate the transactions contemplated hereby and thereby.
The execution, delivery and performance of this Agreement and the other Transaction Agreements by Buyer have been duly authorized by all requisite corporate action on behalf of Buyer. This Agreement has been and the other Transaction Agreements will
be duly executed and delivered by Buyer and, assuming the due authorization, execution and delivery of this Agreement and the other Transaction Agreements by Seller or its Subsidiaries, constitute or will constitute valid and binding obligations of
Buyer, enforceable against Buyer in accordance with their terms subject to (a) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium and similar laws relating to or affecting creditors’ rights and remedies generally
and (b) the effect of general equitable principles, regardless of whether asserted in a proceeding in equity or at law. 
  
 4.3 No Conflict or Violation. The execution, delivery and performance by Buyer of this Agreement and the other Transaction Agreements and the
consummation by Buyer of the transactions contemplated hereby and thereby, and compliance by Buyer with, or fulfillment by Buyer of, the terms, conditions and provisions hereof and thereof, do not and will not: (a) violate any provision of the
Organizational Documents of Buyer; (b) violate, conflict with or constitute or result in (or with notice, lapse of time or both become) a default or a breach under or result in the acceleration, termination or cancellation of (or entitle any Person
or give any Person the right to accelerate, terminate or cancel) any obligation under any Contract to which Buyer is a party or by which any of the assets or property of Buyer is bound, except for any of such matters or consequences which would not
reasonably be expected, individually or in the aggregate, to materially adversely affect Buyer or to materially adversely affect, restrict or delay the ability of Buyer to consummate the transactions contemplated by this Agreement or the other
Transaction Agreements; or (c) contravene or violate any law, statute, rule or regulation applicable to Buyer or any of its assets or properties, or any Governmental Order to which Buyer is a party or by which Buyer or any of its assets or
properties is bound, except for any of such matters or consequences which do not and would not reasonably be expected, individually or in the aggregate, to materially adversely affect Buyer or materially adversely affect, restrict or delay the
ability of Buyer to consummate the transactions contemplated by this Agreement or other Transaction Agreements. 
  
 4.4 Consents and Approvals. Except for the notification and waiting period requirements of the HSR Act, the execution, delivery and performance by
Buyer of this Agreement or any of the other Transaction Agreements, the consummation by Buyer of the transactions contemplated hereby and thereby and compliance by Buyer with, or fulfillment by Buyer of, the terms, conditions and provisions hereof
and thereof do not and will not require the approval, consent, authorization or act of, or the making by Buyer of any declaration, filing or registration with, any Person or Governmental Authority except for any of such approvals, consents,
authorizations, declarations, filings or registrations that do not and would not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect or materially adversely affect, restrict or delay the ability of Buyer
to consummate the transactions contemplated by this Agreement. 
  

 33 

 4.5 No Brokers, Finders, etc. Buyer has not paid nor will Buyer become obligated to pay any fee or
commission to any broker, finder or other intermediary for or on account of the transactions contemplated by this Agreement. 
  
 4.6 Investment Intent. Buyer has such knowledge and experience in financial matters that it is capable of evaluating the merits and risks of its
purchase of the HTO Interests. Buyer confirms that Seller, HTO and the Partnerships have made available to Buyer the opportunity to ask questions of the officers and management employees of HTO and the Partnerships and to acquire additional
information about the business and financial condition of HTO and the Partnerships. Buyer is acquiring the HTO Interests for investment and not with a view toward, or for sale in connection with, any distribution thereof, or with any present
intention of distributing or selling the HTO Interests. Buyer acknowledges that the HTO Interests have not been registered under the Securities Act, or the securities or “blue sky” laws of any state, and agrees that the HTO Interests may
not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of without registration under the Securities Act, except pursuant to an exemption from such registration available under the Securities Act, and without
compliance with state and foreign securities laws in each case, to the extent applicable. 
  
 4.7 No Outside Reliance. Buyer has performed its own analyses and investigation of the Business, HTO and the Partnerships and their financial condition, assets and liabilities. Buyer acknowledges that Seller is
not making any representation or warranty, express or implied, except those representations and warranties set forth in this Agreement. 
  
 ARTICLE V 
 COVENANTS 
  
 The parties to this Agreement covenant and agree to take, and, to the extent
applicable pursuant to this Article V, with respect to Buyer, to cause HTO from and after the Closing to take, the following actions: 
  
 5.1 Access; Investigation 
  
 (a) Seller agrees, and agrees to cause its Affiliates and representatives, to keep confidential, not disclose to third parties and not use for its own
business benefit all nonpublic information in their possession regarding HTO or any Partnership; provided, however that Seller and its Affiliates and representatives will not be required to maintain as confidential any information that
(i) becomes generally available to the public other than as a result of disclosure (A) by Seller and its Affiliates and representatives or (B) to the knowledge of Seller, by any other Person in violation of a duty of confidentiality between such
Person and HTO or any Partnership, or (ii) is required to be disclosed pursuant to the terms of a valid subpoena or other requirement of Law and prior to such required disclosure, the disclosing party provides reasonable advance notice to HTO and
reasonable assistance in obtaining confidential treatment of such information to the extent possible. 
  

 34 

 (b) At the Closing, Seller shall assign to Buyer, to the extent assignable, its rights under any
confidentiality agreements between Seller and Persons other than Buyer that were entered into in connection with, or relating to, a possible sale of the Business, including without limitation, to the extent assignable, the right to enforce all terms
of such confidentiality agreements; provided, however that to the extent such confidentiality agreements are not assignable, Seller agrees to take such action as may be reasonably necessary to enforce its rights thereunder for the
benefit of HTO and the Partnerships, at Seller’s cost and expense. At the Closing, Seller shall deliver to Buyer executed copies of all such confidentiality agreements to the extent available and permitted under such agreements. In addition,
Seller will immediately request the return or destruction of all nonpublic information provided by Seller, HTO or the Partnerships or their respective representatives that is subject to such confidentiality agreements. 
  
 (c) On and after the Closing Date, all original books and records of HTO and
the Partnerships shall remain with HTO and the Partnerships, respectively. If such books and records are prior to the Closing Date located in the offices of Seller or its Affiliates (other than HTO or the Partnerships), such books and records shall
be delivered to by such party to HTO on or prior to the Closing Date. Except as otherwise provided in Section 7.2 with respect to Tax materials, Buyer and Seller agree from and after the Closing, to hold all of the books and records of HTO that
relate to the period prior to the Closing Date, and not to destroy or dispose of any such books or records, for a period of seven (7) years from the Closing Date, and thereafter, if either party desires to destroy or dispose of such books and
records, to offer first in writing at least sixty (60) days prior to such destruction or disposal to the other party (or to such party’s successors, assigns or other designees) the right to inspect and/or copy such books and records at such
party’s expense. 
  
 5.2 Further Actions. 

 
 (a) Subject to the terms and conditions of this Agreement, each of the
parties hereto agrees to use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable to consummate and make effective the transactions contemplated by this
Agreement, including using its reasonable best efforts: (i) to obtain any licenses, permits, consents, approvals, authorizations, qualifications and orders of Governmental Authorities and parties to contracts with HTO or Seller or any of its
Subsidiaries as are required in connection with the consummation of the transactions contemplated hereby; (ii) to effect all necessary registrations and filings; (iii) to defend any lawsuits or other legal proceedings, whether judicial or
administrative, whether brought derivatively or on behalf of third parties (including Governmental Authorities or officials), challenging this Agreement or the consummation of the transactions contemplated hereby; and (iv) to furnish to each other
such information and assistance and to consult with respect to the terms of any registration, filing, application or undertaking as reasonably may be requested in connection with the foregoing. 
  
 (b) If, after the Closing Date, Seller or Buyer identifies any books,
records or other assets owned by Seller or its Affiliates that were in HTO’s or any Partnership’s possession as of the Closing (which are not Acquired Assets) or that were inadvertently transferred by Seller to Buyer, then Buyer agrees to
cause such asset to be transferred promptly to Seller for no additional consideration. If, after the Closing Date, Seller or Buyer identifies any 

  

 35 

 
books, records or other assets in Seller’s or its Subsidiaries’ possession that are owned by HTO or any Partnership or that Seller or its
Subsidiaries failed to transfer to Buyer at the Closing, Seller shall cause such assets to be promptly transferred to Buyer for no additional consideration. 
  
 (c) Seller shall, or shall cause its Subsidiaries (as applicable) to, promptly remit to Buyer any amounts received by it or them following the Closing in
payment of any account receivable included in the Acquired Assets. 
  
 5.3 Joint Public Announcement. Without limiting the terms of the Confidentiality Agreement, except as required by applicable law or any stock exchange on which the capital stock of Seller or Buyer or any of their Affiliates is listed
and provided that the disclosing party shall provide a copy of such release, statement or announcement as far in advance of its public disclosure as is reasonably practicable such that Buyer may provide comments thereto, no party to this Agreement
or the other Transaction Agreements shall issue any press release, make any public announcement or statement or respond in writing to any press inquiry with respect to this Agreement or the other Transaction Agreements or the transactions
contemplated hereby or thereby without the prior approval of the other parties. Notwithstanding the foregoing, the parties shall issue appropriate joint press releases, which shall be reasonably acceptable to Seller and Buyer, with respect to the
transactions contemplated by this Agreement and the other Transaction Agreements following the execution and delivery of this Agreement and the other Transaction Agreements and the consummation of the transactions contemplated hereby and thereby.

  
 5.4 Employee Matters. 
  
 (a) Buyer shall have no obligation to hire any of the Business Employees.
Each of the Business Employees whom Buyer or its Subsidiaries intend to hire are listed on Schedule 5.4(a) hereto and shall be offered employment by the Buyer or any of its Subsidiaries within an administratively reasonable period following
the Closing Date, to be effective as of the Closing, which offers may be conditioned upon the active employment of such Business Employee by the Business as of the Closing Date. Those employees who accept the offer of employment from the Company or
one of its Subsidiaries and commence active employment with the Company or one of its Subsidiaries shall be referred to herein as “Transferred Employees”. 
  
 (b) Seller shall not engage in any activity intended to discourage any Business Employee from accepting an offer of
employment from the Buyer or one of its Subsidiaries. 
  
 (c)
Seller shall provide continuation health care coverage as required under COBRA to all individuals who are M&A qualified beneficiaries (within the meaning assigned to such term under Q&A-4 of Treasury regulation Section 54.4980B-9) with
respect to the sale of the Business for the duration of the period to which such individuals are entitled to such coverage. Seller shall comply with the provisions of WARN and similar laws and regulations, if applicable, and shall be solely
responsible for any and all liabilities, penalties, fines or other sanctions that may be assessed or otherwise due under such applicable laws and regulations on account of the dismissal or termination of any of the Business Employees as a result of,
or in connection with, the sale of the Business hereunder. 
  

 36 

 The parties hereto acknowledge and agree that all provisions contained in this Section 5.4 with respect
to employees are included for the sole benefit of the respective parties hereto and shall not create any right (i) in any other Person, including, without litigation, any employees, former employees, any participant in any Seller Plan or any
beneficiary thereof or (ii) to continued employment with Seller or Buyer. 
  
 5.5 Non-Disparagement. Both Buyer and Seller agree not to, and to cause their respective Affiliates not to, at any time, on or after the Closing disparage any other party hereto or their respective Affiliates
or any business or operations conducted by Buyer, HTO or the Partnerships prior to, or after the Closing. 
  
 5.6 Insurance. Following the Closing, Buyer and Seller shall cooperate, and cause their Affiliates to cooperate with each other in submitting any
claims on behalf of Seller, Buyer, HTO or any of the Partnerships under any insurance policies maintained by Seller, Buyer, HTO or the Partnerships with respect to any loss, liability, damage, claim or expense relating to the Business occurring, or
arising from events occurring, prior to the Closing. 
  
 5.7
Non-Competition. 
  
 (a) In order that Buyer and its
Affiliates may have and enjoy the full benefit of the Business, Seller and its Affiliates agree that for a period of five (5) years commencing on the Closing Date, neither Seller nor any of its Affiliates will, without the express written approval
of Buyer, directly or indirectly engage in, manage, own, operate, invest in, acquire or loan money to, any business which is a Competing Business. Notwithstanding the foregoing, the provisions of this Section 5.7(a) shall not restrict Seller or any
of its Affiliates from acquiring and operating any Competing Business so long as Seller or such Affiliate divests all or a portion of the Competing Business conducted by such Person within six months of such transaction such that an acquisition by
Seller or such Affiliate of the retained portion of the Competing Business would be permissible under the terms of this Section 5.7(a); provided that Seller or such Affiliate shall, at least thirty (30) days prior to such divestiture, deliver an
offer notice to Buyer containing the price and terms of such divestiture. Such offer notice shall be deemed to be an offer of the Competing Business to Buyer on the same terms and conditions as proposed by such third party. Buyer shall first have
the right, but not the obligation, to purchase all or a portion of the Competing Business specified in the offer notice at the price and on the terms specified therein by delivering written notice of such election to Seller or such Affiliate within
thirty (30) days after the delivery of the offer notice. 
  
 (b)
If Buyer (or a transferee of Buyer) transfers, directly or indirectly, by sale of stock, merger, sale of assets or otherwise, any part of the Business to one or more third parties, Seller’s agreements in this Section 5.7 shall continue with
respect to such third party transferees and each transferee shall have the same rights as Buyer hereunder. The parties agree that the remedy at law for any breach of any obligation under this Section 5.7 will be inadequate and that in addition to
any other rights and remedies to which they may be entitled hereunder, at law or in equity, Buyer and its transferees shall be entitled to injunctive relief and 

  

 37 

 
reimbursement for all reasonable attorney’s fees and other expenses incurred in connection with the enforcement hereof. In the event this Section 5.7 is
held to be in any respect an unreasonable restriction upon Seller or any of its Affiliates by any court having competent jurisdiction, the court so holding may reduce the territory to which this Section 5.7 pertains and/or the period of time for
which it operates, or effect any other change to the extent necessary to render this Section 5.7 enforceable by such court. As so modified this Section 5.7 will continue in full force and effect. Such decision by a court of competent jurisdiction
shall not invalidate this Agreement, but this Agreement shall be interpreted, construed and enforced as not containing such invalidated provision. 
  
 (c) For purposes of this Section 5.7, “Competing Business” means any Person engaged in the business of developing, marketing, providing
treatments and selling non-invasive surgical solutions by shock wave technology for treatment of (i) skin wounds in humans and animals or (ii) any condition in animals. 
  
 5.8 Transition Services Agreement. On the Closing Date, Seller and Buyer shall execute and deliver a transition
services agreement (the “Transition Services Agreement”), pursuant to which Seller and Buyer shall each agree to provide certain transition services and information sharing and transfer services. 
  
 5.9 License Agreement. On the Closing Date, Seller and Buyer shall
execute and deliver a license agreement (the “License Agreement”), pursuant to which Buyer shall provide a limited license to Seller under the Multi-Product Patent Rights. 
  
 5.10 Anti-Dilution. Prior to an Initial Public Offering, if Buyer
shall (other than in connection with the issuance of Common Stock or Common Stock Equivalents to employees, officers, directors, consultants or agents of Buyer or any of its direct or indirect Subsidiaries with respect to any employee benefit plan,
incentive award program or other compensation arrangement) (A) issue any Common Stock at a price per share less than Fair Market Value for such Common Stock, (B) issue any Common Stock Equivalents at a price per share less than Fair Market Value for
such Common Stock or (C) enter into any contracts, commitments, agreements, understandings or arrangements of any kind relating to the issuance of any Common Stock or Common Stock Equivalents at a price per share less than Fair Market Value, prior
to taking any such action described in the foregoing clause (A), (B) or (C), Buyer shall deliver a notice to Seller stating the number of shares of Common Stock or Common Stock Equivalents proposed to be issued and the price and other material terms
on which it proposes to issue such Common Stock or Common Stock Equivalents. Within ten (10) days after receipt of such notice, Seller may elect to purchase that number of shares of Common Stock (or Buyer Share Equivalents, as the case may be) at
the same purchase price as the price for the additional Common Stock (or Buyer Share Equivalents) to be issued so that, after the issuance, all of such Common Stock (or Buyer Share Equivalents), together with all Common Stock (or Buyer Share
Equivalents) to be issued pursuant to this Section 5.10 in connection therewith, Seller would, in the aggregate, hold the same proportional interest of the outstanding Common Stock (assuming, in the case of an issuance of Buyer Share Equivalents,
the conversion, exercise or exchange thereof) as was held by Seller prior to the issuance of such additional Common Stock (or Buyer Share Equivalents). 
  

 38 

 5.11 Use of Name. 
  
 (a) Seller agrees for itself and its Affiliates that they shall cease all use of the name and mark “OssaTron,”
“ReflecTron,” “EquiTron,” “EvoTron” and “VersaTron” and/or any names or marks confusingly similar thereto after the Closing. 
  
 (b) Until the date that is eighteen (18) months from the date hereof, Seller and its Affiliates hereby grant to Buyer a
worldwide, nontransferable, paid-up, irrevocable license and right to use “a former HealthTronics company.” 
  
 5.12 Permits; Certain Regulatory Matters. 
  
 (a) Seller agrees, and shall cause its Subsidiaries, to cooperate with Buyer and to take all actions reasonably necessary, at Seller’s reasonable
expense, to bring into compliance any Governmental Permits listed on Schedule 3.11 hereto as promptly as practicable following the Closing. 
  
 (b) Seller agrees, and shall cause its Subsidiaries, to cooperate with Buyer and to take all actions reasonably necessary, to bring into compliance any
items described on Schedule 3.27 pursuant to Section 3.27(b) hereto as promptly as practicable following the Closing. Seller agrees to share equally any expenses (including with respect to consultants and advisors) relating thereto with Buyer;
provided, however, that Buyer and Seller mutually agree with respect to the choice of any consultant and advisor, such agreement not to be unreasonably withheld. 
  
 5.13 Tax Matters. 
  
 (a) Section 754 Election. Set forth on Schedule 5.13(a) is a list indicating whether each of HTO and the Partnerships has in effect, as of the
Closing Date, a valid election under Section 754 of the Code. Seller has provided a copy of each such election to Buyer. 
  
 (b) FIRPTA Certificate. On or prior to the Closing Date, Buyer shall have received from Seller a certificate in compliance with Treasury
Regulation Section 1.1445-2(b), certifying that Seller is not a “foreign person” under Section 1445 of the Code. 
  
 5.14 ELC 114. Seller agrees that it will promptly following the Closing conduct a joint inspection, with one or more of Buyer’s
representatives present, of each item of machinery, each tool and each item of other equipment that is used or can be used in the production and refurbishment of ELC 114 electrodes (an “Equipment Item”). Seller agrees that in the
event that it is discovered that Seller or its Affiliates own more than one of the same Equipment Item that fulfills the same purpose, Seller will assign to Buyer, at no additional consideration, one of those Equipment Items, such that Seller
retains at least one entire set of Equipment Items in good working order and repair. Furthermore, subject to the terms of the License Agreement, Seller will upon request by Buyer provide advice and consultation to assist Buyer in developing the
manufacturing capabilities for the ELC 114. 
  

 39 

 5.15 Certain Additional Assets. Seller and Buyer agree that, promptly following the Closing Seller
will sell to Buyer, and Buyer will purchase from Seller, those Versatrons, Versatrodes and Evotrodes included on Schedule 2.2(d) under “Other Excluded Assets,” at the invoice price charged to Seller and as agreed upon by Buyer and Seller.

  
 ARTICLE VI 
 INDEMNIFICATION 
  
 6.1 Survival of Representations, Etc. All of the representations, warranties, covenants and indemnities set forth in this Agreement or in any
certificate, document or other instrument delivered at the Closing in connection with this Agreement or contemplated by this Agreement shall survive the Closing indefinitely, except that (a) except as otherwise expressly set forth in this Section
6.1, the representations and warranties of Seller set forth in this Agreement shall survive until the date 24 months after the Closing Date; (b) the representations and warranties of Seller set forth in Section 3.15 (Environmental) and 3.16
(Intellectual Property) shall survive the 
  
 Closing for a period
of five (5) years; (c) the representations and warranties of Seller set forth in Sections 3.1 (Organization), 3.2 (Capitalization), 3.4 (Authorization; Enforceability), 3.20 (Contracts with Affiliates) 3.21 (Brokers), 4.1 (Organization), 4.2
(Authorization) and 4.5 (Brokers) shall survive the Closing indefinitely and (d) the representations and warranties set forth in Sections 3.18 (Taxes) and 3.19 (Employee Benefits) shall survive the Closing until sixty (60) days after the expiration
of the applicable statute of limitations, giving effect to any extension (whether automatic or permissive) of such period. The expiration of any representation or warranty as provided in this Section 6.1 shall preclude any indemnity with respect
thereof under this Article VI from and after the time such representation, warranty or covenant shall have expired; provided, however, that the expiration of any such representation or warranty shall not affect the rights of any party
in respect of any such indemnity claim therefor as to which valid notice thereof has been given under this Article VI prior to the expiration of the applicable survival period provided in this Section 6.1. 
  
 6.2 Indemnification by Seller 
  
 (a) From and after the Closing, Seller shall indemnify, defend, save and
hold harmless Buyer, its Affiliates (including without limitation, HTO and the Partnerships) and the successors of the foregoing and their respective Representatives (collectively, the “Buyer Indemnified Parties”), from and against
any and all Losses sustained or incurred by any Buyer Indemnified Party and arising out of in connection with or relating to (i) any misrepresentation or breach of warranty given or made by Seller in this Agreement; (ii) any breach of or failure to
perform any covenant or agreement made by Seller in this Agreement or in the other Transaction Agreements; (iii) any liabilities, other than Assumed Liabilities, arising out of or pertaining to actions or omissions prior to the Closing, insofar as
they relate to the Business, including, without limitation, any Losses arising out of or related to any of the patents described on Schedule 6.2 hereto or the dissolution, merger, consolidation, restructuring or cessation of operations of any
Subsidiary (including any such Subsidiary involved in the operation of the Business) or Partnership prior to the Closing Date; (iv) the Excluded Liabilities (including any liability of Seller or its Affiliates that becomes a liability of Buyer under
any bulk transfer law of 

  

 40 

 
any jurisdiction, under any common law doctrine of de factor merger or successor liability, or otherwise by operation of law); and (v) the ownership or
operation of any Excluded Assets. Solely for purposes of determining the amount of any Losses arising out of, relating to or resulting from any breach of any representation or warranty, the representations and warranties of Seller or Buyer, as the
case may be, shall be considered without giving effect to any limitation or qualifications as to “knowledge,” “materiality,” “Material Adverse Effect” or any other derivation of the word “material”.

  
 (b) Notwithstanding anything to the contrary contained in
this Agreement, (i) (except a claim for Losses related to Sections 3.1 (Organization), 3.2 (Capitalization), 3.18 (Taxes), each of which shall not be subject to this Section 6.2(b)), no indemnification under Section 6.2(a)(i) shall be made by
Seller, and Seller shall not have any liability therefor, unless and until the aggregate amount of Losses subject to indemnification by Seller pursuant thereto shall exceed $125,000, and once such threshold amount is exceeded Seller shall indemnify
the Buyer Indemnified Parties, and shall be liable, only for the amount of any such Losses in excess of such threshold amount, (ii) the aggregate amount required to be paid by Seller pursuant to Section 6.2(a)(i) shall not exceed $7,000,000 plus the
amounts actually received by Seller under the First Note and the Second Note, and Seller shall not indemnify the Buyer Indemnified Parties pursuant to Section 6.2(a)(i) and shall not have any liability to any Buyer Indemnified Party for, and the
Buyer Indemnified Parties shall have no right to recover from Seller pursuant to Section 6.2(a)(i), any amount of Losses which exceeds (and from and after the time Losses exceed) such amount. For the avoidance of doubt, the limitations on
indemnification set forth in this Section 6.2(b) shall not apply to Losses sustained or incurred by any Buyer Indemnified Party pursuant to subsections (ii), (iii), (iv) or (v) of Section 6.2(a). 
  
 6.3 Indemnification by Buyer. 
  
 (a) From and after the Closing, Buyer shall indemnify, defend, save and
hold harmless Seller, its Affiliates and their respective Representatives (collectively, the “Seller Indemnified Parties”) from and against any and all Losses incurred by any Seller Indemnified Party and arising out of or resulting
from (i) any misrepresentation or breach of warranty given or made by Buyer in this Agreement or the other Transaction Agreements; (ii) any breach of or failure to perform any covenant or agreement made by Buyer in this Agreement or the other
Transaction Agreements; and (iii) the ownership or operation after the Closing of the Business, except, with respect to this Section 6.3, to the extent to which any Buyer Indemnified Party is entitled to indemnification by Seller as to such Losses
pursuant to Section 6.2, or would be entitled to such indemnification but for the limits on survival set forth in Section 6.1. Any payments pursuant to Section 6.2 or this Section 6.3 shall be treated as an adjustment to the Final Purchase Price for
Tax purposes. 
  
 (b) Notwithstanding anything to the contrary
contained in this Agreement (except a claim for Losses related to Sections 4.1, 4.2 and 4.5, each of which shall not be subject to this Section 6.3(b)), (i) no indemnification under Section 6.3(a)(i) shall be made by Buyer, and Buyer shall not have
any liability therefor, unless and until the aggregate amount of Losses subject to indemnification by Buyer pursuant thereto shall exceed $125,000, and once such threshold amount is exceeded Buyer shall indemnify the Seller Indemnified Parties, and
shall be liable, only for the amount of any such Losses in excess of such threshold amount, (ii) 

  

 41 

 
the aggregate amount required to be paid by Buyer pursuant to Section 6.3(a)(i) shall not exceed $7,000,000, plus the amounts actually received by Seller
under the First Note and the Second Note, and Buyer shall not indemnify the Seller Indemnified Parties pursuant to Section 6.3(a)(i) and shall not have any liability to any Seller Indemnified Party for, and the Seller Indemnified Parties shall have
no right to recover from Buyer pursuant to Section 6.3(a)(i), any amount of Losses which exceeds (and from and after the time Losses exceed) such amount. For the avoidance of doubt, the limitations on indemnification set forth in this Section 6.3(b)
shall not apply to Losses sustained or incurred by any Seller Indemnified Party pursuant to subsections (ii) or (iii) of Section 6.3(a). 
  
 6.4 Notice of Indemnity Claims. If any Buyer Indemnified Party or Seller Indemnified Party entitled to or seeking indemnification hereunder (an
“Indemnified Party”) (a) determines that any event, occurrence, fact, condition or Claim has given or could give rise to Losses for which such Indemnified Party is or may be entitled to, or may seek, indemnification under this
Agreement, (b) otherwise identifies an event, occurrence, fact, condition or Claim giving rise (or which may give rise) to a right of indemnification hereunder in favor of such Indemnified Party, or (c) with respect to any Third Party Claim, becomes
aware of the assertion of any Claim or of the commencement of any action, suit or proceeding at law or in equity (any of the foregoing, an “Indemnity Claim”), such Indemnified Party shall promptly notify the party obligated to
provide indemnification or from whom indemnification is being or will be sought (the “Indemnifying Party”) in writing of such Indemnity Claim (a “Claim Notice”) describing in reasonable detail the facts giving rise
to the claim for indemnification under this Agreement and shall include in such Claim Notice (if then known) the amount or the method of computation of the amount of such claim, and a reference to the provision of this Agreement or any other
agreement, document or instrument executed hereunder or in connection with this Agreement upon which such claim is based; provided, however, that the failure of any Indemnified Party to give timely notice thereof shall not affect any
of its rights to indemnification hereunder nor relieve the Indemnifying Party from any of its indemnification obligations hereunder, except to the extent the Indemnifying Party is materially prejudiced by such failure. Any Claim Notice not relating
to a Third Party Claim shall specify the nature of the Loss and the estimated amount thereof. After the giving of any Claim Notice pursuant to this Agreement, the amount of indemnification to which an Indemnified Party shall be entitled under this
Article VI shall be determined: (a) by the written agreement between the Indemnified Party and the Indemnifying Party; (b) by a final judgment or decree of any court of competent jurisdiction; or (c) by any other means to which the Indemnified Party
and the Indemnifying Party shall agree. The judgment or decree of a court shall be deemed final when the time for appeal, if any, shall have expired and no appeal shall have been taken or when all appeals taken shall have been finally determined.

  
 6.5 Indemnification Procedures. Any obligation to
provide indemnification hereunder with respect to any action, suit or proceeding at law or in equity by or against any third party, including any Governmental Authority (a “Third Party Claim”), shall be subject to the following
terms and conditions: 
  
 (a) Upon receipt of a Claim Notice in
respect of any such Third Party Claim, the Indemnifying Party shall be entitled, at its option and its sole cost and expense and upon written notice to the Indemnified Party within fifteen (15) days of its receipt of such 

  

 42 

 
Claim Notice, to assume and control the defense, compromise, settlement and investigation of such Indemnity Claim, including the management of any proceeding
relating thereto, and to employ and engage counsel reasonably acceptable to the Indemnified Party; provided, however, that if there exists a conflict of interest (other than one of a monetary nature) or if the Indemnified Party has
been advised by counsel that there may be one or more legal or equitable defenses available to it that are different from or additional to those available to the Indemnifying Party, which, in either case, would make it inappropriate for the same
counsel to represent both the Indemnifying Party and the Indemnified Party, then the Indemnified Party shall be entitled to retain its own counsel at the reasonable cost and expense of the Indemnifying Party (except that the Indemnifying Party shall
not be obligated to pay the fees and expenses of more than one separate counsel for all Indemnified Parties, taken together). 
  
 (b) In the event the Indemnifying Party (i) exercises the right to undertake the defense and investigation of any such Indemnity Claim as provided in
Section 6.5(a), (A) the Indemnified Party may, at its sole cost and expense (subject to Section 6.5(a)), participate in the defense of such Indemnity Claim, (B) the Indemnified Party agrees to cooperate with the Indemnifying Party in such efforts
and make available to the Indemnifying Party all witnesses, records, materials and information in the Indemnified Party’s possession, under its control or to which it may have access as may be reasonably required by the Indemnifying Party, and
(C) the Indemnifying Party will keep the Indemnified Party reasonably informed of the progress of the defense of any such Indemnity Claim, or (ii) fails to so assume the defense and investigation of any such Indemnity Claim as provided in Section
6.5(a), (A) the Indemnified Party against which such Indemnity Claim has been asserted shall have the right to undertake the defense, compromise, settlement and investigation of such Indemnity Claim on behalf of, and at the cost and expense of and
for the account and risk of the Indemnifying Party, (B) the Indemnifying Party agrees to cooperate with the Indemnified Party in such efforts and make available to the Indemnifying Party all witnesses, records, materials and information in the
Indemnified Party’s possession, under its control or to which it may have access as may be reasonably required by the Indemnifying Party, and (C) the Indemnified Party will keep the Indemnifying Party reasonably informed of the progress of the
defense of any such Indemnity Claim. 
  
 (c) Notwithstanding the
foregoing, an Indemnified Party shall have the right to jointly control the defense of any claim or demand against such Indemnified Party in the event the potential Losses with respect to such Indemnity Claim, when aggregated with all other
satisfied or pending Losses subject to indemnification pursuant to Section 6.2 or 6.3 hereof exceed the limits set forth in Section 6.2(b), in the case of any Seller or in Section 6.3, in the case of Buyer. 
  
 6.6 Settlement of Indemnity Claims. The Indemnifying Party shall not,
without the prior written consent of the Indemnified Party, (a) settle or compromise any Indemnity Claim or consent to the entry of any final judgment which does not include as an unconditional term thereof the delivery by the claimant or plaintiff
of a written release or releases from all liability in respect of such Indemnity Claim of all Indemnified Parties affected by such Indemnity Claim, or (b) settle or compromise any Indemnity Claim if the settlement imposes equitable remedies,
material obligations on the Indemnified Party other than financial obligations for which such Indemnified Party will be indemnified hereunder, or in any way 

  

 43 

 
restricts or adversely affects the future conduct or activity of the Indemnified Party or any Affiliate thereof. No Indemnity Claim shall be settled or
compromised by the Indemnified Party without the prior written consent of the Indemnifying Party which consent shall not be unreasonably withheld, conditioned or delayed. 
  
 6.7 Exclusivity of Indemnification Remedy. Except for any equitable relief, including injunctive relief or specific
performance, to which any party to this Agreement may be entitled, the indemnification provided in this Article VI shall be the sole and exclusive remedy of any party with respect to this Agreement or the transactions contemplated by this Agreement,
except with respect to any Losses incurred by any party as a result of fraud on the part of the other party. 
  
 ARTICLE VII 
 TAX MATTERS 
  
 7.1 Liability and Indemnification for Taxes 
  
 (a) To the extent permitted by law, Seller (or the appropriate member of
the Seller Tax Group) shall claim all Tax deductions arising by reason of exercises of options to acquire Seller’s stock held by employees of the Business. If all or any part of a tax deduction claimed pursuant to this Section 7.1(a) is
disallowed to Seller (or any member of the Seller Tax Group), to the extent permitted by law, Buyer shall claim such Tax deduction. Seller shall withhold applicable Taxes and satisfy applicable Tax reporting obligations with respect to exercises of
options to acquire Seller’s stock held by employees of the Business. If Buyer (or any Affiliate of Buyer) actually realizes any Tax benefit (assuming such Tax benefit is realized after the use of all other losses, deductions, credits or items
of Buyer or such Affiliate of Buyer) in any Taxable Period as a result of any deduction claimed by Buyer pursuant to this Section 7.1(a), Buyer shall pay the amount of such Tax benefit in such Taxable Period to Seller; provided that Seller does not
otherwise realize a related Tax benefit (such as an adjustment to the amount of gain or loss recognized by Seller upon the sale of the HTO Interests to Buyer) in connection with such exercises of options. 
  
 (b) All transfer and other similar Taxes (including, without limitation,
real and personal property transfer taxes) incurred in connection with the transactions contemplated by this Agreement shall be borne by Seller. 
  
 7.2 Assistance and Cooperation. After the Closing Date, Seller and Buyer shall (and shall cause their respective Affiliates to): 
  
 (a) timely assist the other party in preparing any Tax Returns of HTO or
the Partnerships or with respect to the Acquired Assets and the Business; 
  
 (b) timely cooperate fully in preparing for any audits of, or disputes with Taxing Authorities regarding, any Tax Returns of HTO or the Partnerships or with respect to the Acquired Assets and the Business, including
making employees available on a mutually convenient basis to testify at any proceeding; 
  

 44 

 (c) make available to the other party and to any Taxing Authority in a timely manner as reasonably
requested all information, records, databases and documents relating to Taxes of HTO or the Partnerships or with respect to the Acquired Assets and the Business; 
  
 (d) within thirty (30) days of the receipt of a written request therefor, furnish the other with copies of all
correspondence received from any Taxing Authority in connection with any Tax audit or information request with respect to any Taxable Period for which the other may have a liability; 
  
 (e) timely sign and deliver such certificates or forms as may be necessary or appropriate to establish an exemption from
(or otherwise reduce), or file Tax Returns or other reports with respect to, Taxes; and 
  
 (f) use reasonable best efforts to properly retain and maintain accounting and Tax records and information, in a timely manner consistent with Taxing Authority guidelines, to the extent such records and information
relate to HTO, the Partnerships or the Acquired Assets or the Business until ninety (90) days following the expiration of the applicable statute of limitations period, and promptly notify the other prior to the destruction of any such Tax records or
information and provide the other party a reasonable opportunity to make and retain copies of any such Tax records or information. 
  
 7.3 Confidentiality of Tax Information. Unless otherwise required by law, stock exchange regulation or legal proceedings, each party shall, and
shall cause its Representatives to, keep confidential any non-public Tax information, records and documents disclosed by the other party, or to which such party has received or been granted access, pursuant to this Article VII and will not use such
Tax information for any purpose other than making the determinations and taking such other actions contemplated by this Article VII. 
  
 7.4 Termination of Tax Sharing Agreements. Any Tax sharing agreement or arrangement to which HTO or any of the Partnerships is a party shall be
terminated or amended as of or prior to the Closing Date and, from and after the Closing Date, none of HTO nor the Partnerships shall be bound thereby or have any liability thereunder. 
  
 ARTICLE VIII 
 GENERAL PROVISIONS 
  
 8.1 Expenses. Except
as otherwise provided in this Agreement or the other Transaction Agreements, each party to this Agreement shall pay all of its own costs and expenses incident to its negotiation and preparation of this Agreement and to its performance and compliance
with all terms, agreements, covenants and conditions contained in this Agreement and the other Transaction Agreements on its part to be performed or complied with, including the fees, expenses and disbursements of its counsel and accountants.
Notwithstanding the foregoing, (a) Seller will be solely responsible for all the fees and expenses incurred by HTO or the Partnerships prior to Closing in connection with the negotiation, execution, delivery and performance of this Agreement and the
other Transaction Agreements and (b) Buyer and Seller shall share equally any and all consulting expenses and travel expenses incurred in connection with the transactions contemplated hereby and relating to compliance by Buyer with FDA regulations.

  

 45 

 8.2 Notices. All notices and other communications given or made pursuant to this Agreement shall
be in writing and shall be deemed to have been duly given or made (i) five business days after being sent by registered or certified mail, return receipt requested, (ii) upon delivery, if hand delivered, (iii) one business day after being sent by
prepaid overnight courier with guaranteed delivery, with a record of receipt, or (iv) upon transmission with confirmed delivery if sent by cable, telegram, facsimile or telecopy, to the parties at the following addresses (or at such other addresses
as shall be specified by the parties by like notice); provided that each party shall be required to transmit such notice by facsimile: 
  
 (a) if to Buyer: 
  
 SanuWave, Inc. 
 44 Montgomery Street, Suite
860 
 San Francisco, California 94104 
 Attention: Chris Puscasiu 
 Facsimile No.: (617) 507-0438 
  
         with a copy to: 
  
 Simpson Thacher & Bartlett LLP 
 3330 Hillview Avenue 
 Palo Alto, California
94304 
 Attention: Michael J. Nooney 
 Facsimile No.: (650) 251-5002 
  
 (b) if to Seller:

  
 HealthTronics, Inc. 
 1301 S. Capital of Texas Hwy., Suite B-200 
 Austin, Texas 78746 
 Attention: James Whittenburg 
 Facsimile No.: (512) 314-4305 
  
 8.3 Severability. Wherever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but in case any one or more of the provisions contained in this Agreement
shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed as if such invalid,
illegal or unenforceable provision or provisions had never been contained in this Agreement unless the deletion of such provisions or provisions would result in such a material change as to cause completion of the transactions contemplated by this
Agreement to be unreasonable. 
  

 46 

 8.4 Counterparts. This Agreement may be executed in one or more counterparts, each of which shall
be considered an original instrument, but all of which shall be considered one and the same agreement, and shall become binding when one or more counterparts have been executed and delivered by each of the parties. Such execution and delivery may be
evidenced by an exchange of facsimile or telegraphic communications or any other rapid transmission device designed to produce a written record of communications transmitted. 
  
 8.5 Assignment; Successors and Assigns. Neither this Agreement nor any of the rights, interest or obligations
hereunder shall be assigned by either party to this Agreement without the prior written consent of the other party; provided, however, Buyer may assign any or all if its rights and obligations under this Agreement to any affiliate of Buyer,
or to a lender of Buyer as collateral for indebtedness, or in connection with a merger, consolidation, conversion or sale of assets of Buyer (provided that no such assignment shall release Buyer from any obligation under this Agreement). Any
purported assignment not in compliance with this Section 8.5 shall be null and void. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties to this Agreement and their respective successors or assigns,
heirs, legatees, distributees, executors, administrators and guardians. 
  
 8.6 No Third Party Beneficiaries. Except as provided in Section 5.5 and Article VI, nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any rights, benefits or remedies of any nature
whatsoever under or by reason of this Agreement. 
  
 8.7
Descriptive Headings. Titles and headings to Articles and Sections in this Agreement are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. 

 
 8.8 Schedules and Exhibits; Construction of Certain Provisions. The
Schedules and Exhibits referred to in this Agreement shall be construed with and as an integral part of this Agreement to the same extent as if the same had been set forth in their entirety in this Agreement. Each disclosure in the Disclosure
Schedule shall be deemed to qualify all representations and warranties of Seller, notwithstanding the lack of a specific cross-reference, except to the extent that its applicability to a particular representation, warranty, agreement or condition is
not reasonably apparent from the disclosure thereof. Buyer acknowledges that the disclosure or inclusion of any specific agreement, document, instrument, report, item, fact or event by Seller in the Disclosure Schedule shall not create any
implication or constitute any admission by Seller or its Affiliates or their respective Representatives that such agreement, document, instrument, report, item, fact or event is material to the Business, HTO or to the Partnerships or their
respective financial condition, businesses, operations, liabilities, assets or properties or would constitute a Material Adverse Effect. Buyer further acknowledges that the specification of any dollar amount in the representations and warranties
contained in this Agreement or in the Disclosure Schedule is not intended to imply that such amount or higher or lower amounts are or are not material. Buyer shall not use the fact of any disclosure or inclusion of any such agreement, document,
instrument, report, item, fact or event in the Disclosure Schedule or the setting of such amounts in any dispute or controversy between the parties as to whether any obligation, item or matter not described in this Agreement or included in the
Disclosure Schedule is or is not material for purposes of this Agreement. 
  

 47 

 8.9 No Implied Representation. Except as expressly set forth in Article III or any other provision
of this Agreement, Seller makes no representation or warranty whatsoever, express or implied, in respect of Seller, HTO or the Partnerships. 
  
 8.10 Waivers. Any term or provision of this Agreement may be waived, or the time for its performance may be extended, by the party or parties
entitled to the benefit thereof. Except as provided in Section 6.1, the failure of any party to this Agreement to enforce at any time any provision of this Agreement shall not be construed to be a waiver of such provision, nor in any way to affect
the validity of this Agreement or any part of this Agreement or the right of any party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent
breach. 
  
 8.11 Governing Law; Jurisdiction; Waiver of Jury
Trial. 
  
 (a) THIS AGREEMENT SHALL BE GOVERNED AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED ENTIRELY WITHIN THAT STATE. 
  
 (b) Each of the parties to this Agreement irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any
California state court, or Federal court of the United States of America, sitting in the Northern District of California, and any appellate court to any thereof, in any action or proceeding arising out of or relating to this Agreement or the
agreements delivered in connection with this Agreement or the transactions contemplated by this Agreement or by the agreements delivered in connection with this Agreement or for recognition or enforcement of any judgment relating thereto, and each
of the parties irrevocably and unconditionally (i) agrees not to commence any such action or proceeding except in such courts, (ii) agrees that any claim in respect of any such action or proceeding may be heard and determined in such California
state court or, to the extent permitted by law, in such Federal court, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such action or proceeding
in any such California state or Federal court, and (iv) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such California state or Federal court. Each of the
parties to this Agreement agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Each party to this Agreement
irrevocably consents to service of process in the manner provided for notices in Section 8.2. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law. 
  
 (c) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE
UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A 

  

 48 

 
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN
CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY OF THE AGREEMENTS DELIVERED IN CONNECTION WITH THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (ii) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (iii) IT MAKES SUCH WAIVERS
VOLUNTARILY, AND (iv) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8.11. 
  
 8.12 Enforcement. The parties to this Agreement agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specifically enforce the
terms and provisions of this Agreement, in addition to any other remedy to which any party is entitled at law or in equity. 
  
 8.13 Entire Agreement; Amendments; Electronic Signatures. This Agreement, including the Schedules and Exhibits, and the Confidentiality Agreement
contains the entire understanding of the parties to this Agreement with regard to the subject matter contained in this Agreement. This Agreement may only be amended, modified or supplemented by written agreement of the parties. No agreement made
through the use of electronic records or electronic signatures, as those terms are used in the Electronic Signatures in Global and National Commerce Act, 15 U.S.C. Section 7001 et. seq., or the Delaware Uniform Electronic Transactions Act, 6 Del. C.
Section 12A-101 et. seq., shall be enforceable or binding on either party to this Agreement. 
  
 8.14 Construction; Joint Drafting. The parties acknowledge that they have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed consistent with the joint drafting of this Agreement by the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of
the provisions of this Agreement. 
  
 {Signature page follows}

  

 49 

 IN WITNESS WHEREOF, the parties to this Agreement have caused this Agreement to be executed as of the day
and year first above written. 
  

			
	“Seller”
	
	HEALTHTRONICS, INC.
		
	By:	 	 /s/ James Whittenburg

	Name:	 	James Whittenburg
	Title:	 	 Senior Vice President Development,
 General Counsel and
Secretary

	
	“Buyer”
	
	SANUWAVE, INC.
		
	By:	 	 /s/ Christian Puscasiu

	Name:	 	Christian Puscasiu
	Title:	 	President

  
 SIGNATURE PAGE TO
PURCHASE AGREEMENT 
  

 50Registrant's 2000 Equity Incentive Plan

 Exhibit 4.01 
  
 ELECTRONIC ARTS INC. 
  
 2000 EQUITY INCENTIVE PLAN 
  
 As Amended by the Stockholders on July 28, 2005 
  
 1. PURPOSE. The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential
contributions are important to the success of the Company, its Parent and Subsidiaries by offering them an opportunity to participate in the Company’s future performance through awards of Options, Restricted Stock, Restricted Stock Units, and
Stock Appreciation Rights. Capitalized terms not defined in the text are defined in Section 24. 
  
 2. SHARES SUBJECT TO THE PLAN. 
  
 2.1 Number of Shares. Subject to Sections 2.2, 2.3 and 19, the aggregate number of Shares that have been reserved pursuant to this Plan is 67,400,000 Shares. Shares that are: (a) subject to issuance upon
exercise of an Award but cease to be subject to such Award for any reason other than exercise of such Award; (b) subject to an Award granted hereunder but are forfeited; or (c) subject to an Award that otherwise terminates or is settled without
Shares being issued shall revert to and again become available for issuance under the Plan. The following Shares shall not again become available for issuance under the Plan: (x) Shares that are not issued or delivered as a result of the net
settlement of an Option or Stock Appreciation Right; (y) Shares that are used to pay the exercise price or withholding taxes related to an Award; or (z) Shares that are repurchased by the Company with the proceeds of an Option exercise. At all times
the Company shall reserve and keep available a sufficient number of Shares as shall be required to satisfy the requirements of all outstanding Options and Stock Appreciation Rights granted under this Plan and all other outstanding but unvested
Awards granted under this Plan. 
  
 2.2 Limitation on Number of
Shares Subject to Restricted Stock Awards and Restricted Stock Unit Awards. The number of Shares that may be issued under Sections 6 and 7 of this Plan shall not exceed 4,000,000 in the aggregate. 
  
 2.3 Adjustment of Shares. In the event that the number of outstanding
shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company without consideration, then (a) the number of Shares
reserved for issuance under this Plan, (b) the Exercise Prices of and number of Shares subject to outstanding Awards, and (c) the number of Shares associated with other outstanding Awards, will be proportionately adjusted, subject to any required
action by the Board or the stockholders of the Company and compliance with applicable securities laws; provided, however, that fractions of a Share will not be issued but will either be replaced by a cash payment equal to the Fair Market
Value of such fraction of a Share or will be rounded up to the nearest whole Share, as determined by the Committee. 
  
 3. ELIGIBILITY. ISOs (as defined in Section 5 below) may be granted only to employees (including officers and directors who are also employees) of
the Company or of a Parent or Subsidiary of the Company. All other Awards may be granted to employees and directors of the Company or any Parent or Subsidiary of the Company. No person will be eligible to receive Awards covering more than 1,400,000
Shares in any calendar year under this Plan, of which no more than 400,000 Shares shall be covered by Awards of Restricted Stock or Restricted Stock Units, other than new employees of the Company or of a Parent or Subsidiary of the Company
(including new employees who are also officers and directors of the Company or any Parent or Subsidiary of the Company), who are eligible to receive Awards covering up to a maximum of 2,800,000 Shares in the calendar year in which they commence
their employment, of which no more than 800,000 Shares shall be covered by Awards of Restricted Stock or Restricted Stock Units. For purposes of these limits, each Restricted Stock Unit settled in Shares (but not those settled in cash), shall be
deemed to cover one Share. A person may be granted more than one Award under this Plan. 
  
 4. ADMINISTRATION. 
  
 4.1
Committee Authority. This Plan will be administered by the Committee or by the Board acting as the Committee. Except for automatic grants to Outside Directors pursuant to Section 10 hereof, and subject to the general purposes, terms and
conditions of this Plan, and to the direction of the Board, the Committee will have full power to implement and carry out this Plan. Except for automatic grants to Outside Directors pursuant to Section 10 hereof, the Committee will have the
authority to: 
  

	 	(a)	construe and interpret this Plan, any Award Agreement and any other agreement or document executed pursuant to this Plan; 

	 	(b)	prescribe, amend and rescind rules and regulations relating to this Plan or any Award; 

  

	 	(c)	select persons to receive Awards; 

  

	 	(d)	determine the form and terms of Awards; 

  

	 	(e)	determine the number of Shares or other consideration subject to Awards; 

  

	 	(f)	determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other Awards under this Plan or any other incentive
or compensation plan of the Company or any Parent or Subsidiary of the Company; 

  

	 	(g)	grant waivers of Plan or Award conditions; 

  

	 	(h)	determine the vesting, exercisability and payment of Awards; 

  

	 	(i)	correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement; 

  

	 	(j)	determine whether an Award has been earned; and 

  

	 	(k)	make all other determinations necessary or advisable for the administration of this Plan. 

  
 4.2 Committee Discretion. Except for automatic grants to Outside Directors pursuant to Section 10 hereof, any
determination made by the Committee with respect to any Award will be made in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of this Plan or Award, at any later time, and such determination will
be final and binding on the Company and on all persons having an interest in any Award under this Plan. The Committee may delegate to one or more officers of the Company the authority to grant an Award under this Plan to Participants who are not
Insiders of the Company. 
  
 4.3 Section 162(m). To the
extent that Awards are granted hereunder as “performance-based compensation” within the meaning of Section 162(m) of the Code, the Plan shall be administered by a committee, which may be the Committee, of two or more “outside
directors” within the meaning of Section 162(m) of the Code. For purposes of qualifying grants of Awards as “performance-based compensation” under Section 162(m) of the Code, the committee, in its discretion, may set restrictions
based upon the achievement of performance goals. The performance goals shall be set by the committee on or before the latest date permissible to enable the Awards to qualify as “performance-based compensation” under Section 162(m) of the
Code. In granting Awards that are intended to qualify under Section 162(m) of the Code, the committee shall follow any procedures determined by it from time to time to be necessary or appropriate to ensure qualification of the Awards under Section
162(m) of the Code (e.g., in determining the performance goals). 
  
 5.
OPTIONS. The Committee may grant Options to eligible persons and will determine whether such Options will be Incentive Stock Options within the meaning of the Code (“ISO”) or Nonqualified Stock Options
(“NQSOs”), the number of Shares subject to the Option, the Exercise Price of the Option, the period during which the Option may be exercised, and all other terms and conditions of the Option, subject to the following:

  
 5.1 Form of Option Grant. Each Option granted under
this Plan will be evidenced by an Award Agreement which will expressly identify the Option as an ISO or an NQSO (“Stock Option Agreement”), and, except as otherwise required by the terms of Section 10 hereof, will be in such
form and contain such provisions (which need not be the same for each Participant) as the Committee may from time to time approve, and which will comply with and be subject to the terms and conditions of this Plan. 
  
 5.2 Date of Grant. The date of grant of an Option will be the date on
which the Committee makes the determination to grant such Option, unless otherwise specified by the Committee. The Stock Option Agreement and a copy of this Plan will be delivered to the Participant within a reasonable time after the granting of the
Option. 
  
 5.3 Exercise Period; Performance Goals.

  
 (a) Options may be exercisable within the times or upon the
events determined by the Committee as set forth in the Stock Option Agreement governing such Option; provided, however, that no Option will be exercisable after the expiration of ten (10) years from the date the Option is granted; and
provided, further, that no ISO granted to a person who directly or by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent or Subsidiary of the Company
(“Ten Percent Stockholder”) will be exercisable after the 

 
expiration of five (5) years from the date the ISO is granted. The Committee also may provide for Options to become exercisable at one time or from time to
time, periodically or otherwise, in such number of Shares or percentage of Shares as the Committee determines. 
  
 (b) Participant’s ability to exercise Options shall be subject to such restrictions, if any, as the Committee may impose. These restrictions may be
based upon completion of a specified number of years of service with the Company or upon completion of the performance goals as set out in advance in the Participant’s individual Stock Option Agreement. Options may vary from Participant to
Participant and between groups of Participants. Should the Committee elect to impose restrictions on an Option, the Committee shall: (a) determine the nature, length and starting date of any Performance Period for the Option; (b) select from among
the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Shares subject to such Option. Prior to such Option becoming exercisable, the Committee shall determine the extent to which such Performance
Factors have been met. Performance Periods may overlap and Participants may participate simultaneously with respect to Options that are subject to different Performance Periods and have different performance goals and other criteria. 
  
 5.4 Exercise Price. The Exercise Price of an Option will be determined
by the Committee when the Option is granted and may be not less than 100% of the Fair Market Value of the Shares on the date of grant; provided that the Exercise Price of any ISO granted to a Ten Percent Stockholder will not be less than 110% of the
Fair Market Value of the Shares on the date of grant. Payment for the Shares purchased may be made in accordance with Section 9 of this Plan. 
  
 5.5 Method of Exercise. Options may be exercised only by delivery to the Company of a written stock option exercise agreement (the
“Exercise Agreement”) in a form approved by the Committee (which need not be the same for each Participant), stating the number of Shares being purchased, the restrictions imposed on the Shares purchased under such Exercise
Agreement, if any, and such representations and agreements regarding Participant’s investment intent and access to information and other matters, if any, as may be required or desirable by the Company to comply with applicable securities laws,
together with payment in full of the Exercise Price for the number of Shares being purchased. 
  
 5.6 Termination. Notwithstanding the exercise periods set forth in the Stock Option Agreement, exercise of an Option will always be subject to the following: 
  

	 	(a)	If the Participant is Terminated for any reason except death or Disability, then the Participant may exercise such Participant’s Options only to the extent that such Options
would have been exercisable upon the Termination Date no later than three (3) months after the Termination Date (or such shorter or longer time period not exceeding five (5) years as may be determined by the Committee, with any exercise beyond three
(3) months after the Termination Date deemed to be an NQSO), but in any event, no later than the expiration date of the Options. 

  

	 	(b)	If the Participant is Terminated because of Participant’s death or Disability (or the Participant dies within three (3) months after a Termination other than for Cause or
because of Participant’s Disability), then Participant’s Options may be exercised only to the extent that such Options would have been exercisable by Participant on the Termination Date and must be exercised by Participant (or
Participant’s legal representative or authorized assignee) no later than twelve (12) months after the Termination Date (or such shorter or longer time period not exceeding five (5) years as may be determined by the Committee, with any such
exercise beyond (a) three (3) months after the Termination Date when the Termination is for any reason other than the Participant’s death or Disability, or (b) twelve (12) months after the Termination Date when the Termination is for
Participant’s death or Disability, deemed to be an NQSO), but in any event no later than the expiration date of the Options. 

  

	 	(c)	Notwithstanding the provisions in paragraph 5.6(a) above, if a Participant is terminated for Cause, neither the Participant, the Participant’s estate nor such other person who
may then hold the Option shall be entitled to exercise any Option with respect to any Shares whatsoever, after termination of service, whether or not after termination of service the Participant may receive payment from the Company or Subsidiary for
vacation pay, for services rendered prior to termination, for services rendered for the day on which termination occurs, for salary in lieu of notice, or for any other benefits. In making such determination, the Board shall give the Participant an
opportunity to present to the Board evidence on his behalf. For the purpose of this paragraph, termination of service shall be deemed to occur on the date when the Company dispatches notice or advice to the Participant that his service is
terminated. 

 5.7 Limitations on Exercise. The Committee may specify a reasonable minimum number of Shares that
may be purchased on any exercise of an Option, provided that such minimum number will not prevent Participant from exercising the Option for the full number of Shares for which it is then exercisable. 
  
 5.8 Limitations on ISO. The aggregate Fair Market Value (determined as
of the date of grant) of Shares with respect to which ISO are exercisable for the first time by a Participant during any calendar year (under this Plan or under any other incentive stock option plan of the Company, Parent or Subsidiary of the
Company) will not exceed $100,000. If the Fair Market Value of Shares on the date of grant with respect to which ISO are exercisable for the first time by a Participant during any calendar year exceeds $100,000, then the Options for the first
$100,000 worth of Shares to become exercisable in such calendar year will be ISO and the Options for the amount in excess of $100,000 that become exercisable in that calendar year will be NQSOs. In the event that the Code or the regulations
promulgated thereunder are amended after the Effective Date of this Plan to provide for a different limit on the Fair Market Value of Shares permitted to be subject to ISO, such different limit will be automatically incorporated herein and will
apply to any Options granted after the effective date of such amendment. 
  
 5.9 Modification, Extension or Renewal. The Committee may modify, extend or renew outstanding Options and authorize the grant of new Options, provided however, that (i) any such action may not, without the
written consent of a Participant, impair any of such Participant’s rights under any Option previously granted and (ii) the Committee may not reduce the Exercise Price of outstanding Options without the approval of the stockholders. Any
outstanding ISO that is modified, extended, renewed or otherwise altered will be treated in accordance with Section 424(h) of the Code. 
  
 5.10 No Disqualification. Notwithstanding any other provision in this Plan, no term of this Plan relating to ISO will be interpreted, amended or
altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section 422 of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.

  
 6. RESTRICTED STOCK. A Restricted Stock Award is an offer
by the Company to grant or to sell to an eligible person Shares that are subject to restrictions. The Committee will determine to whom an offer will be made, the number of Shares the person may purchase, the price to be paid (the
“Purchase Price”), if any, the restrictions to which the Shares will be subject, and all other terms and conditions of the Restricted Stock Award, subject to the following: 
  
 6.1 Form of Restricted Stock Award. All grants or purchases under a
Restricted Stock Award made pursuant to this Plan will be evidenced by an Award Agreement (“Restricted Stock Purchase Agreement”) that will be in such form (which need not be the same for each Participant) as the Committee
will from time to time approve, and will comply with and be subject to the terms and conditions of this Plan. The offer of Restricted Stock will be accepted by the Participant’s execution and delivery of the Restricted Stock Purchase Agreement
and full payment, if any, for the Shares to the Company within thirty (30) days, or such other date as may be set forth in the Restricted Stock Purchase Agreement, from the date the Restricted Stock Purchase Agreement is delivered to the person. If
such person does not execute and deliver the Restricted Stock Purchase Agreement along with full payment, if any, for the Shares to the Company within thirty (30) days, or such other date as may be set forth in the Restricted Stock Purchase
Agreement, then the offer will terminate, unless otherwise determined by the Committee. 
  
 6.2 Purchase Price. The Purchase Price of Shares sold pursuant to a Restricted Stock Award, if any, will be determined by the Committee on the date the Restricted Stock Award is granted. At the Committee’s
discretion, consideration for the Restricted Stock Award may be in the form of continued service to the Company. Payment of the Purchase Price may be made in accordance with Section 9 of this Plan. 
  
 6.3 Terms of Restricted Stock Awards. Restricted Stock Awards shall be
subject to such restrictions as the Committee may impose. These restrictions may be based upon completion of a specified number of years of service with the Company or upon completion of the performance goals as set out in advance in the
Participant’s individual Restricted Stock Purchase Agreement. Restricted Stock Awards may vary from Participant to Participant and between groups of Participants. Prior to the grant of a Restricted Stock Award, the Committee shall: (a)
determine the nature, length and starting date of any Performance Period for the Restricted Stock Award; (b) select from among the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Shares that may
be awarded to the Participant. Prior to the payment of any Restricted Stock Award, the Committee shall determine the extent to which such Restricted Stock Award has been earned. Performance Periods may overlap and Participants may participate
simultaneously with respect to Restricted Stock Awards that are subject to different Performance Periods and having different performance goals and other criteria. 
  
 6.4 Termination During Performance Period. If a Participant is Terminated during a Performance Period for any reason,
then such Participant will be entitled to payment (whether in Shares, cash or otherwise) with respect to the Restricted Stock Award only to the extent earned as of the date of Termination in accordance with the Restricted Stock 

 
Purchase Agreement, unless the Committee determines otherwise in the case of a Participant who is not a “covered employee” for purposes of Section
162(m) of the Code in the year of Termination. 
  
 7. RESTRICTED
STOCK UNITS. Each Restricted Stock Unit shall have a value equal to the Fair Market Value of a share of the Company’s Common Stock. A Restricted Stock Unit does not constitute a share of, nor represent any ownership interest in, the
Company. The Committee will determine the number of Restricted Stock Units granted to any eligible person; whether the Restricted Stock Units will be settled in Shares, in cash, or in a combination of the two; the price to be paid (the
“Purchase Price”), if any, for any Shares issued pursuant to a Restricted Stock Unit; the restrictions to which the Restricted Stock Units will be subject, and all other terms and conditions of the Restricted Stock Units,
subject to the following: 
  
 7.1 Form of Restricted Stock Unit
Award. All Restricted Stock Units granted pursuant to this Plan will be evidenced by an Award Agreement (“Restricted Stock Unit Agreement”) that will be in such form (which need not be the same for each Participant) as
the Committee will from time to time approve, and will comply with and be subject to the terms and conditions of this Plan. The offer of Restricted Stock Units will be accepted by the Participant’s execution and delivery of the Restricted Stock
Unit Agreement within thirty (30) days, or such other date as may be set forth in the Restricted Stock Unit Agreement, from the date the Restricted Stock Unit Agreement is delivered to the person. If such person does not execute and deliver the
Restricted Stock Unit Agreement within thirty (30) days, or such other date as may be set forth in the Restricted Stock Unit Agreement, then the offer will terminate, unless otherwise determined by the Committee. 
  
 7.2 Purchase Price. The Purchase Price of Shares sold pursuant to a
Restricted Stock Unit, if any, will be determined by the Committee on the date the Restricted Stock Unit is granted. At the Committee’s discretion, consideration for the Restricted Stock Unit may be in the form of continued service to the
Company. Payment of the Purchase Price, if any, shall be made in accordance with Section 9 of this Plan when the Shares are issued. 
  
 7.3 Terms of Restricted Stock Units. Restricted Stock Units shall be subject to such restrictions as the Committee may impose. These restrictions
may be based upon completion of a specified number of years of service with the Company or upon completion of the performance goals as set out in advance in the Participant’s individual Restricted Stock Unit Agreement. Restricted Stock Units
may vary from Participant to Participant and between groups of Participants. Prior to the grant of Restricted Stock Units, the Committee shall: (a) determine the nature, length and starting date of any Performance Period for the Restricted Stock
Unit; (b) select from among the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Restricted Stock Units that will be awarded to the Participant. Prior to the payment (whether in Shares, cash or
otherwise) of any Restricted Stock Units, the Committee shall determine the extent to which such Restricted Stock Units have been earned. Performance Periods may overlap and Participants may participate simultaneously with respect to Restricted
Stock Units that are subject to different Performance Periods and have different performance goals and other criteria. 
  
 7.4 Termination During Performance Period. If a Participant is Terminated during a Performance Period for any reason, then such Participant will be
entitled to payment (whether in Shares, cash or otherwise) with respect to the Restricted Stock Units only to the extent earned as of the date of Termination in accordance with the Restricted Stock Unit Agreement, unless the Committee determines
otherwise in the case of a Participant who is not a “covered employee” for purposes of Section 162(m) of the Code in the year of Termination. 
  
 7.5 Payment When Restrictions Lapse. The cash or Shares that a Participant is entitled to receive pursuant to a Restricted Stock Unit shall be paid
or issued to the Participant when all applicable restrictions and other conditions applicable to the Restricted Stock Unit have lapsed or have been satisfied, unless the Restricted Stock Unit Agreement provides for a later settlement date.

  
 8. STOCK APPRECIATION RIGHTS. The Committee may
grant Stock Appreciation Rights or SARs to eligible persons and will determine the number of Shares subject to the SARs, the Exercise Price of the SARs, the period during which the SARs may be exercised, and all other terms and conditions of the
SARs, subject to the following: 
  
 8.1 Form of SAR Grant.
SARs granted under this Plan will be evidenced by an Award Agreement that will expressly identify the SARs as freestanding SARs (SARs granted independent of any other Option), tandem SARs (SARs granted in connection with an Option, or any portion
thereof), or any combination thereof (“SAR Agreement”), and will be in such form and contain such provisions (which need not be the same for each Participant) as the Committee may from time to time approve, and which will
comply with and be subject to the terms and conditions of this Plan. 
  
 8.2 Date of Grant. The date of grant of a SAR will be the date on which the Committee makes the determination to grant such SAR, unless otherwise specified by the Committee. The SAR Agreement and a copy of this Plan will be delivered
to the Participant within a reasonable time after the granting of the SAR. 

 8.3 Exercise Price and Other Terms. 
  
 (a) The Committee, subject to the provisions of the Plan, shall have complete discretion to determine the terms and
conditions of SARs granted under the Plan. However, the Exercise Price for freestanding SARs shall be not less than one hundred percent (100%) of the Fair Market Value of a Share on the grant date. The Exercise Price for tandem SARs shall equal the
Exercise Price of the related Option. 
  
 (b) Participant’s
ability to exercise SARs shall be subject to such restrictions, if any, as the Committee may impose. These restrictions may be based upon completion of a specified number of years of service with the Company or upon completion of the performance
goals as set out in advance in the Participant’s individual SAR Agreement. SARs may vary from Participant to Participant and between groups of Participants. Should the Committee elect to impose restrictions on a SAR, the Committee shall: (a)
determine the nature, length and starting date of any Performance Period for the SAR; (b) select from among the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Shares subject to such SAR. Prior to
such SAR becoming exercisable, the Committee shall determine the extent to which such Performance Factors have been met. Performance Periods may overlap and Participants may participate simultaneously with respect to SAR that are subject to
different Performance Periods and have different performance goals and other criteria. 
  
 8.4 Exercise of Tandem SARs. Tandem SARs may be exercised for all or part of the Shares subject to the related Option upon the surrender of the right to exercise the equivalent portion of the related Option.
Tandem SARs may be exercised only with respect to the Shares for which the related Option is then exercisable. With respect to tandem SARs granted in connection with an Option: (a) the tandem SARs shall expire no later than the expiration of the
underlying Option; (b) the value of the payout with respect to the tandem SARs shall be for no more than one hundred percent (100%) of the difference between the Exercise Price of the underlying Option and the Fair Market Value of the Shares subject
to the underlying Option at the time the tandem SARs are exercised; and (c) the tandem SARs shall be exercisable only when the Fair Market Value of the Shares subject to the underlying Option exceeds the Exercise Price of the Option. 
  
 8.5 Exercise of Freestanding SARs. Freestanding SARs shall be
exercisable on such terms and conditions as the Committee, in its sole discretion, shall determine. 
  
 8.6 Payment of SAR Amount. Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by
multiplying: 
  

	 	(a)	The difference between (i) the Fair Market Value of a Share on the date of exercise (or such other date as may be determined by the Committee and set forth in the Participant’s
SAR Agreement) and (ii) the Exercise Price; times 

  

	 	(b)	The number of Shares with respect to which the SAR is exercised. 

  
 At the discretion of the Committee, the payment upon exercise of the SAR may be in cash, in Shares of equivalent value, or in some
combination thereof. 
  
 8.7 Termination. Notwithstanding
the exercise periods set forth in the SAR Agreement, exercise of a SAR will always be subject to the following: 
  

	 	(a)	If the Participant is Terminated for any reason except death or Disability, then the Participant may exercise such Participant’s SAR only to the extent that such SAR would have
been exercisable upon the Termination Date no later than three (3) months after the Termination Date (or such shorter or longer time period not exceeding five (5) years as may be determined by the Committee), but in any event, no later than the
expiration date of the SAR. 

  

	 	(b)	If the Participant is Terminated because of Participant’s death or Disability (or the Participant dies within three (3) months after a Termination other than for Cause or
because of Participant’s Disability), then Participant’s SAR may be exercised only to the extent that such SAR would have been exercisable by Participant on the Termination Date and must be exercised by Participant (or Participant’s
legal representative or authorized assignee) no later than twelve (12) months after the Termination Date, but in any event no later than the expiration date of the SAR. 

  

	 	(c)	 Notwithstanding the provisions in paragraph 8.7(a) above, if a Participant is terminated for Cause, neither the Participant, the Participant’s estate nor such
other person who may then hold the SAR shall be entitled to exercise any SAR with respect to any Shares whatsoever, after termination of service, whether or not after termination of service the Participant may receive payment from the Company or
Subsidiary for vacation pay, for 

	 	 
services rendered prior to termination, for services rendered for the day on which Termination occurs, for salary in lieu of notice, or for any other
benefits. In making such determination, the Board shall give the Participant an opportunity to present to the Board evidence on his behalf. For the purpose of this paragraph, Termination of service shall be deemed to occur on the date when the
Company dispatches notice or advice to the Participant that his service is terminated. 

  
 9. PAYMENT FOR SHARE PURCHASES. Payment for Shares purchased pursuant to this Plan may be made in cash (by check) or, where expressly approved for the Participant by the Committee and where
permitted by law: 
  

	 	(a)	by cancellation of indebtedness of the Company to the Participant; 

  

	 	(b)	by surrender of shares that either: (1) have been owned by Participant for more than six (6) months and have been paid for within the meaning of SEC Rule 144 (and, if such shares
were purchased from the Company by use of a promissory note, such note has been fully paid with respect to such shares); or (2) were obtained by Participant in the public market; 

  

	 	(c)	by waiver of compensation due or accrued to the Participant for services rendered; 

  

	 	(d)	with respect only to purchases upon exercise of an Option, and provided that a public market for the Company’s stock exists: 

  

	 	(1)	through a “same day sale” commitment from the Participant and a broker-dealer that is a member of the National Association of Securities Dealers (an “NASD
Dealer”) whereby the Participant irrevocably elects to exercise the Option and to sell a portion of the Shares so purchased to pay for the Exercise Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Shares to
forward the Exercise Price directly to the Company; or 

  

	 	(2)	through a “margin” commitment from the Participant and a NASD Dealer whereby the Participant irrevocably elects to exercise the Option and to pledge the Shares so
purchased to the NASD Dealer in a margin account as security for a loan from the NASD Dealer in the amount of the Exercise Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Shares to forward the Exercise Price directly to
the Company; or 

  

	 	(e)	by withholding from the Shares to be issued upon exercise of an Award that number of Shares having a Fair Market Value equal to the minimum amount required to satisfy the Exercise
Price or Purchase Price (the Fair Market Value of the Shares to be withheld shall be determined on the date that the Award is exercised by the Participant); or 

  

	 	(f)	by any combination of the foregoing; or 

  

	 	(g)	such other consideration and method of payment for issuance of Shares to the extent permitted by applicable laws. 

  
 10. AUTOMATIC GRANTS TO OUTSIDE DIRECTORS. 
  
 10.1 Types of Awards and Shares. Awards granted under this Plan and
subject to this Section 10 may, at the discretion of the Committee, be NQSOs or SARs; provided, however, that any payment upon exercise of SARs granted pursuant to this section 10 shall be in Shares of equivalent value. 
  
 10.2 Eligibility. Awards subject to this Section 10 shall be granted
only to Outside Directors. Outside Directors shall also be eligible to receive Awards granted pursuant to sections 5, 6, 7 and 8 hereof at such times and on such conditions as determined by the Committee. 
  
 10.3 Initial Grant. Each Outside Director who first becomes a member
of the Board on or after the Effective Date will automatically be granted an Option or SAR, as determined by the Committee, for 25,000 Shares (an “Initial Grant”) on the date such Outside Director first becomes a member of
the Board. 

 10.4 Succeeding Grants. Upon re-election to the Board at each Annual Meeting of Stockholders, each
Outside Director will automatically be granted an Option or SAR, as determined by the Committee, for 10,000 Shares (a “Succeeding Grant”); provided, however, that any such Outside Director who received an Initial Grant
since the last Annual Meeting of Stockholders will receive a prorated Succeeding Grant to purchase a number of Shares equal to 10,000 multiplied by a fraction whose numerator is the number of calendar months or portions thereof that the Outside
Director has served since the date of the Initial Grant and whose denominator is twelve. 
  
 10.5 Vesting. The date an Outside Director receives an Initial Grant or a Succeeding Grant is referred to in this Plan as the “Start Date” for such Award. Each Initial Grant will vest as
to 2% of the Shares on the Start Date for such Initial Grant, and as to an additional 2% of the Shares on the first day of each calendar month after the Start Date, so long as the Outside Director continuously remains a director of the Company.
Succeeding Grants will vest in accordance with each Stock Option Agreement or SAR Agreement, as the case may be. 
  
 Notwithstanding any provision to the contrary, in the event of a corporate transaction described in Section 19.1, the vesting of all Awards granted to
Outside Directors pursuant to this Section 10 will accelerate and such Awards will become exercisable in full prior to the consummation of such event at such times and on such conditions as the Committee determines, and must be exercised, if at all,
within three months of the consummation of said event. Any Awards not exercised within such three-month period shall expire. 
  
 10.6 Exercise Price. The exercise price of an Award pursuant to an Initial Grant or Succeeding Grant shall be the Fair Market Value of the Shares
at the time that the Award is granted. 
  
 10.7 Deferral of
Cash Compensation. Each Outside Director may elect to reduce all or part of the cash compensation otherwise payable for services to be rendered by him as a director (including the annual retainer and any fees payable for serving on the Board or
a Committee of the Board) and to receive in lieu thereof Shares. Any such election shall be in writing and must be made before the services are rendered giving rise to such compensation, and may not be revoked or changed thereafter during the
Outside Director’s term. On such election, the cash compensation otherwise payable will be increased by 10% for purposes of determining the number of Shares to be credited to such Outside Director. 
  
 If an Outside Director so elects to defer, there shall be credited to such
Outside Director a number of Shares equal to the amount of the deferral (increased by 10% as described in the preceding sentence) divided by the Fair Market Value on the day in which the compensation would have been paid in the absence of a deferral
election. 
  
 11. WITHHOLDING TAXES. 
  
 11.1 Withholding Generally. Whenever Shares are to be issued in
satisfaction of Awards granted under this Plan, the Company may require the Participant to remit to the Company an amount sufficient to satisfy federal, state and local withholding tax requirements prior to the delivery of any certificate or
certificates for such Shares. Whenever, under this Plan, payments in satisfaction of Awards are to be made in cash, such payment will be net of an amount sufficient to satisfy federal, state, and local withholding tax requirements. 
  
 11.2 Stock Withholding. When, under applicable tax laws, a Participant
incurs tax liability in connection with the exercise or vesting of any Award that is subject to tax withholding and the Participant is obligated to pay the Company the amount required to be withheld, the Committee may in its sole discretion allow
the Participant to satisfy the minimum withholding tax obligation by electing to have the Company withhold from the Shares to be issued that number of Shares having a Fair Market Value equal to the minimum amount required to be withheld, determined
on the date that the amount of tax to be withheld is to be determined. All elections by a Participant to have Shares withheld for this purpose will be made in accordance with the requirements established by the Committee and be in writing in a form
acceptable to the Committee. 
  
 12. TRANSFERABILITY.

  
 12.1 Except as otherwise provided in this Section 12, Awards
granted under this Plan, and any interest therein, will not be transferable or assignable by Participant, and may not be made subject to execution, attachment or similar process, otherwise than by will or by the laws of descent and distribution or
as determined by the Committee and set forth in the Award Agreement with respect to Awards that are not ISOs. 
  
 12.2 All Awards other than NQSOs and SARs. All Awards other than NQSOs and SARs shall be exercisable: (i) during the Participant’s lifetime,
only by (A) the Participant, or (B) the Participant’s guardian or legal representative; and (ii) after Participant’s death, by the legal representative of the Participant’s heirs or legatees. 

 12.3 NQSOs and SARs. Unless otherwise restricted by the Committee, a NQSO and SAR shall be
exercisable: (i) during the Participant’s lifetime only by (A) the Participant, (B) the Participant’s guardian or legal representative, (C) a Family Member of the Participant who has acquired the NQSO or SAR by “permitted
transfer;” and (ii) after Participant’s death, by the legal representative of the Participant’s heirs or legatees. “Permitted transfer” means, as authorized by this Plan and the Committee in a Stock Option Agreement or SAR
Agreement, any transfer effected by the Participant during the Participant’s lifetime of an interest in such NQSO and SAR but only such transfers which are by gift or domestic relations order. A permitted transfer does not include any transfer
for value and neither of the following are transfers for value: (a) a transfer under a domestic relations order in settlement of marital property rights or (b) a transfer to an entity in which more than fifty percent of the voting interests are
owned by Family Members or the Participant in exchange for an interest in that entity. 
  
 13. PRIVILEGES OF STOCK OWNERSHIP; RESTRICTIONS ON SHARES. 
  
 13.1 Voting and Dividends. No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued to the Participant. After Shares are issued to the Participant, the
Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid with respect to such Shares; provided, that if
such Shares are Restricted Stock, then any new, additional or different securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split or any other change in the corporate or capital
structure of the Company will be subject to the same restrictions as the Restricted Stock; provided, further, that the Participant will have no right to retain such stock dividends or stock distributions with respect to Shares that are
repurchased at the Participant’s Purchase Price or Exercise Price pursuant to Section 13.2. 
  
 13.2 Restrictions on Shares. At the discretion of the Committee, the Company may reserve to itself and/or its assignee(s) in the Award Agreement a
right to repurchase a portion of or all Unvested Shares held by a Participant following such Participant’s Termination at any time within ninety (90) days after the later of Participant’s Termination Date and the date Participant purchases
Shares under this Plan, for cash and/or cancellation of purchase money indebtedness, at the Participant’s Exercise Price or Purchase Price, as the case may be. 
  
 14. CERTIFICATES. All certificates for Shares or other securities delivered under this Plan will be subject to such
stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC
or any stock exchange or automated quotation system upon which the Shares may be listed or quoted. 
  
 15. ESCROW; PLEDGE OF SHARES. To enforce any restrictions on a Participant’s Shares, the Committee may require the Participant to deposit all certificates representing Shares, together with
stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed or terminated, and the Committee
may cause a legend or legends referencing such restrictions to be placed on the certificates. Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan will be required
to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of Participant’s obligation to the Company under the promissory note; provided, however, that the Committee may require or
accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory note notwithstanding any pledge of the Participant’s
Shares or other collateral. In connection with any pledge of the Shares, Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will from time to time approve. The Shares purchased with the
promissory note may be released from the pledge on a pro rata basis as the promissory note is paid. 
  
 16. EXCHANGE AND BUYOUT OF AWARDS. The Committee may, at any time or from time to time, authorize the Company, with the consent of the respective Participants, to issue new Awards in exchange for
the surrender and cancellation of any or all outstanding Awards; provided, however, that no such exchange program may, without the approval of the Company’s stockholders, allow for the cancellation of an outstanding Option followed by
its immediate replacement with a new Option having a lower Exercise Price. The Committee may, subject to approval by the Company’s stockholders, at any time buy from a Participant an Award previously granted with payment in cash, Shares
(including Restricted Stock) or other consideration, based on such terms and conditions as the Committee and the Participant may agree. 
  
 17. SECURITIES LAW AND OTHER REGULATORY COMPLIANCE. An Award will not be effective unless such Award is in compliance with all applicable federal and
state securities laws, rules and regulations of any governmental body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as they are in effect on the date of grant of the
Award and also on the date of exercise or other issuance. Notwithstanding any other provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to: (a) obtaining any approvals from
governmental agencies that the Company determines are 

 
necessary or advisable; and/or (b) completion of any registration or other qualification of such Shares under any state or federal law or ruling of any
governmental body that the Company determines to be necessary or advisable. The Company will be under no obligation to register the Shares with the SEC or to effect compliance with the registration, qualification or listing requirements of any state
securities laws, stock exchange or automated quotation system, and the Company will have no liability for any inability or failure to do so. 
  
 18. NO OBLIGATION TO EMPLOY. Nothing in this Plan or any Award granted under this Plan will confer or be deemed to confer on any Participant any
right to continue in the employ of, or to continue any other relationship with, the Company or any Parent or Subsidiary of the Company or limit in any way the right of the Company or any Parent or Subsidiary of the Company to terminate
Participant’s employment or other relationship at any time, with or without cause. 
  
 19. CORPORATE TRANSACTIONS. 
  
 19.1
Assumption or Replacement of Awards by Successor. Except for automatic grants to Outside Directors pursuant to Section 10 hereof, in the event of (a) a dissolution or liquidation of the Company, (b) a merger or consolidation in which the
Company is not the surviving corporation (other than a merger or consolidation with a wholly-owned subsidiary, a reincorporation of the Company in a different jurisdiction, or other transaction in which there is no substantial change in the
stockholders of the Company or their relative stock holdings and the Awards granted under this Plan are assumed, converted or replaced by the successor corporation, which assumption will be binding on all Participants), (c) a merger in which the
Company is the surviving corporation but after which the stockholders of the Company immediately prior to such merger (other than any stockholder that merges, or which owns or controls another corporation that merges, with the Company in such
merger) cease to own their shares or other equity interest in the Company, (d) the sale of substantially all of the assets of the Company, or (e) the acquisition, sale, or transfer of more than 50% of the outstanding shares of the Company by tender
offer or similar transaction, any or all outstanding Awards may be assumed, converted or replaced by the successor corporation (if any), which assumption, conversion or replacement will be binding on all Participants. In the alternative, the
successor corporation may substitute equivalent Awards or provide substantially similar consideration to Participants as was provided to stockholders (after taking into account the existing provisions of the Awards). The successor corporation may
also issue, in place of outstanding Shares of the Company held by the Participants, substantially similar shares or other property subject to repurchase restrictions no less favorable to the Participant. In the event such successor corporation (if
any) refuses to assume or substitute Awards, as provided above, pursuant to a transaction described in this Section 19.1, such Awards will accelerate and will become exercisable in full prior to the consummation of such transaction at such time and
on such conditions as the Committee will determine, and if such Awards are not exercised prior to the consummation of the corporate transaction, they shall terminate at such time as determined by the Committee. 
  
 19.2 Other Treatment of Awards. Subject to any greater rights granted
to Participants under the foregoing provisions of this Section 19, in the event of the occurrence of any transaction described in Section 19.1, any outstanding Awards will be treated as provided in the applicable agreement or plan of merger,
consolidation, dissolution, liquidation, or sale of assets. 
  
 19.3 Assumption of Awards by the Company. The Company, from time to time, also may substitute or assume outstanding awards granted by another company, whether in connection with an acquisition of such other company or otherwise, by
either; (a) granting an Award under this Plan in substitution of such other company’s award; or (b) assuming such award as if it had been granted under this Plan if the terms of such assumed award could be applied to an Award granted under this
Plan. Such substitution or assumption will be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the other company had applied the rules of this Plan to such grant. In the
event the Company assumes an award granted by another company, the terms and conditions of such award will remain unchanged (except that the exercise price and the number and nature of Shares issuable upon exercise of any such option will be
adjusted appropriately pursuant to Section 424(a) of the Code). In the event the Company elects to grant a new Option or SAR rather than assuming an existing option, such new Option or SAR may be granted with a similarly adjusted Exercise Price.

  
 20. ADOPTION AND STOCKHOLDER APPROVAL. This Plan will
become effective on the date that it is adopted by the Board (the “Effective Date”). This Plan shall be approved by the stockholders of the Company (excluding Shares issued pursuant to this Plan), consistent with applicable
laws, within twelve (12) months before or after the date this Plan is adopted by the Board. Upon the Effective Date, the Committee may grant Awards pursuant to this Plan; provided, however, that: (a) no Option or SAR may be exercised prior to
initial stockholder approval of this Plan; (b) no Option or SAR granted pursuant to an increase in the number of Shares subject to this Plan approved by the Board will be exercised prior to the time such increase has been approved by the
stockholders of the Company; (c) in the event that initial stockholder approval is not obtained within the time period provided herein, all Awards granted hereunder shall be cancelled, any Shares issued pursuant to any Awards shall be cancelled and
any purchase of Shares issued hereunder shall be rescinded; and (d) in the event that stockholder approval of such increase is not obtained within the time period provided herein, all Awards granted pursuant to 

 
such increase will be cancelled, any Shares issued pursuant to any Award granted pursuant to such increase will be cancelled, and any purchase of Shares
pursuant to such increase will be rescinded. 
  
 21. TERM OF
PLAN/GOVERNING LAW. Unless earlier terminated as provided herein, this Plan will terminate ten (10) years from the date this Plan is adopted by the Board or, if earlier, the date of stockholder approval. This Plan and all agreements
thereunder shall be governed by and construed in accordance with the laws of the State of California. 
  
 22. AMENDMENT OR TERMINATION OF PLAN. The Board may at any time terminate or amend this Plan in any respect, including without limitation amendment of any form of Award Agreement or instrument to
be executed pursuant to this Plan; provided, however, that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder approval. 
  
 23. NONEXCLUSIVITY OF THE PLAN. Neither the adoption of this Plan by the
Board, the submission of this Plan to the stockholders of the Company for approval, nor any provision of this Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may
deem desirable, including, without limitation, the granting of stock options and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases. 
  
 24. DEFINITIONS. As used in this Plan, the following terms
will have the following meanings: 
  
 “Award” means any award under this Plan, including any Option, Restricted Stock, Restricted Stock Unit or Stock Appreciation Right. 
  
 “Award Agreement” means, with respect to each Award, the signed written agreement between the
Company and the Participant setting forth the terms and conditions of the Award. 
  
 “Board” means the Board of Directors of the Company. 
  
 “Cause” means the commission of an act of theft, embezzlement, fraud, dishonesty or a breach of fiduciary duty to the Company or a
Parent or Subsidiary of the Company. 
  
 “Code” means the Internal Revenue Code of 1986, as amended. 
  
 “Committee” means the Compensation Committee of the Board. 
  
 “Company” means Electronic Arts Inc. or any successor corporation. 
  
 “Disability” means a disability, whether temporary or permanent, partial or total, as determined by
the Committee. 
  
 “Exchange Act”
means the Securities Exchange Act of 1934, as amended. 
  
 “Exercise Price” means the price at which a holder of an Option or a SAR, as the case may be, may purchase the Shares issuable upon exercise of such Option or SAR. 
  
 “Fair Market Value” means, as of any date, the value
of a share of the Company’s Common Stock determined as follows: 
  

	 	(a)	if such Common Stock is then quoted on the Nasdaq National Market, its closing price on the Nasdaq National Market on the date of determination as reported in The Wall Street
Journal; 

  

	 	(b)	if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities
exchange on which the Common Stock is listed or admitted to trading as reported in The Wall Street Journal; 

  

	 	(c)	if such Common Stock is publicly traded but is not quoted on the Nasdaq National Market nor listed or admitted to trading on a national securities exchange, the average of the
closing bid and asked prices on the date of determination as reported in The Wall Street Journal; or 

	 	(d)	if none of the foregoing is applicable, by the Committee in good faith. 

  
 “Family Member” includes any of the following: 
  

	 	(a)	child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law of the Participant, including any such person with such relationship to the Participant by adoption; 

  

	 	(b)	any person (other than a tenant or employee) sharing the Participant’s household; 

  

	 	(c)	a trust in which the persons in (a) and (b) have more than fifty percent of the beneficial interest; 

  

	 	(d)	a foundation in which the persons in (a) and (b) or the Participant control the management of assets; or 

  

	 	(e)	any other entity in which the persons in (a) and (b) or the Participant own more than fifty percent of the voting interest. 

  
 “Insider” means an officer or director of the Company
or any other person whose transactions in the Company’s Common Stock are subject to Section 16 of the Exchange Act. 
  
 “Option” means an award of an option to purchase Shares pursuant to Section 5. 
  
 “Outside Director” means a member of the Board who is
not an employee of the Company or any Parent or Subsidiary of the Company. 
  
 “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing
50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
  
 “Participant” means a person who receives an Award under this Plan. 
  
 “Performance Factors” means any of the factors selected by the Committee and specified in an Award
Agreement, from among the following objective measures, either individually, alternatively or in any combination, applied to the Company as a whole or any business unit or Subsidiary, either individually, alternatively, or in any combination, and
measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance goals established by the Committee with respect to applicable Awards have been satisfied: 
  

	 	(a)	Net revenue; 

  

	 	(b)	Earnings before interest, income taxes, depreciation and amortization; 

  

	 	(c)	Operating income; 

  

	 	(d)	Operating margin; 

  

	 	(e)	Net income; 

  

	 	(f)	Earnings per share; 

  

	 	(g)	Total stockholder return; 

  

	 	(h)	The Company’s stock price; 

  

	 	(i)	Growth in stockholder value relative to a pre-determined index; 

  

	 	(j)	Return on equity; 

  

	 	(k)	Return on invested capital; 

	 	(l)	Operating cash flow; 

  

	 	(m)	Free cash flow; 

  

	 	(n)	Economic value added; and 

  

	 	(o)	Individual confidential business objectives. 

  
 The Committee may, in recognition of unusual or non-recurring items such as acquisition-related activities or changes in applicable accounting rules,
provide for one or more equitable adjustments (based on objective standards) to the Performance Factors to preserve the Committee’s original intent regarding the Performance Factors at the time of the initial award grant. It is within the sole
discretion of the Committee to make or not make any such equitable adjustments. 
  
 “Performance Period” means the period of service determined by the Committee, which shall be no less than one calendar quarter nor more than five years (unless tied to a specific and objective
milestone or event), during which time of service or performance is to be measured for Awards. 
  
 “Plan” means this EA 2000 Equity Incentive Plan, as amended from time to time. 
  
 “Restricted Stock Award” means an award of Shares that are subject to restrictions pursuant to Section 6. 
  
 “Restricted Stock Unit” means an award of the right
to receive, in cash or Shares, the value of a share of the Company’s Common Stock pursuant to Section 7. 
  
 “SEC” means the Securities and Exchange Commission. 
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  
 “Shares” means shares of the Company’s Common
Stock reserved for issuance under this Plan, as adjusted pursuant to Sections 2 and 19, and any successor security. 
  
 “Stock Appreciation Right” or “SAR” means an Award, granted alone or in tandem with a related Option that
pursuant to Section 8 is designated as a SAR. 
  
 “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock
possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
  
 “Termination” or “Terminated” means, for purposes of this Plan with respect to a Participant, that the
Participant has for any reason ceased to provide services as an employee, officer, director, consultant, independent contractor, or advisor to the Company or a Parent or Subsidiary of the Company. An employee will not be deemed to have ceased to
provide services in the case of (i) sick leave, (ii) military leave, or (iii) any other leave of absence approved by the Committee, provided, that such leave is for a period of not more than 90 days, unless reemployment upon the expiration of such
leave is guaranteed by contract or statute or unless provided otherwise pursuant to formal policy adopted from time to time by the Company and issued and promulgated to employees in writing. In the case of any employee on an approved leave of
absence, the Committee may make such provisions respecting suspension of vesting of the Award while on leave from the employ of the Company or a Subsidiary as it may deem appropriate, except that in no event may an Option be exercised after the
expiration of the term set forth in the Option agreement. The Committee will have sole discretion to determine whether a Participant has ceased to provide services and the effective date on which the Participant ceased to provide services (the
“Termination Date”). 
  
 “Unvested Shares” means “Unvested Shares” as defined in the Award Agreement. 
  
 “Vested Shares” means “Vested Shares” as defined in the Award Agreement. 

 Emp#:                ; 
 Grant#:
               
 Location:
            
  
 ELECTRONIC ARTS INC. 
 NONQUALIFIED STOCK OPTION GRANT 
 2000 EQUITY INCENTIVE PLAN 
  
 Electronic Arts Inc., a Delaware corporation, (the “Company”) hereby grants to the optionee named below (the “Optionee”), a non-qualified stock option (the “Option”) under the Company’s 2000 Equity
Incentive Plan as amended (the “Plan”), to purchase the total number of shares set forth below of common stock of the Company (the “Option Shares”) at the exercise price per share set forth below (the “Exercise Price”).
The option is subject to all the terms and conditions of the Nonqualified Stock Option Grant including the terms and conditions contained in the attached Appendix A (the “Grant”) and the Plan, the provisions of which are incorporated
herein by reference. The principal features of the option are as follows: 
  

			
	Optionee:	  	_______________________________________
		
	Address:	  	_______________________________________

  

							
	Number of Option Shares:	  	__________	  	Exercise Price per Share:	  	__________
	Date of Grant:	  	__________	  	Expiration Date:	  	__________
	Vest Start Date:	  	__________	  	 	  	 

  
 Subject to the terms
and conditions of the Plan and the Grant, the Option shall vest and become exercisable as to 24%, 12 months from Vest Start Date and will then vest 2% first calendar day of each month thereafter for 38 months. Optionee may then exercise the Option
with respect to vested Option Shares at any time until expiration or termination. 
  
 The Optionee shall be deemed to have worked a calendar month if Optionee has worked any portion of that month. Only vested Options may be exercised. Vesting will continue in accordance with the Grant schedule during a
leave of absence that is protected under local law (which may include, but is not limited to, a maternity, paternity, disability, medical, or military leave), provided that such vesting shall not exceed the maximum vesting period protected by local
law. Vesting shall be suspended during any unpaid personal leave of absence, except as otherwise provided by local law. 
  
 PLEASE READ ALL OF APPENDIX A WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF THE OPTION. 
  

	
	 ELECTRONIC ARTS INC.

	
	  
	Stephen G. Bené
	Sr. Vice President, General Counsel

  
 ACCEPTANCE 
  
 Optionee hereby acknowledges that a copy of the Plan and a copy of the Prospectus as amended
are available upon request from the Stock Administration department and can also be accessed electronically. Optionee represents that Optionee has read and understands the terms and conditions thereof, and accepts the Option subject to all the terms
and conditions of the Plan and the Grant. Optionee acknowledges that there may be adverse tax consequences upon exercise of the Option and that Optionee should consult a tax adviser prior to such exercise. 
  

	
	
	  
	Optionee

 Appendix A 
  

ELECTRONIC ARTS INC. 
 Nonqualified
Stock Option (the “Option”) Terms and Conditions (US) 
 Under the 2000 Equity Incentive Plan 
  
 1. Form of Option Grant. Each Option granted under the Plan shall be evidenced by a
Stock Option Grant (the “Grant”) in such form (which need not be the same for each Optionee) as the Committee shall from time to time approve, which Grant shall comply with and be subject to the terms and conditions of the Plan. Grants may
be evidenced by paper copy or electronic copy. 
  
 2. Date of Grant. The
date of grant of the Option shall be the date on which the Committee makes the determination to grant such Option unless otherwise specified by the committee. The Grant representing the Option will be delivered to Optionee within a reasonable time
after the granting of the Option. Copies of the Plan and Prospectus are available electronically at http://portal.ea.com/home/stockadmin and can also be obtained by contacting the Stock Administration Department. Delivery may be made either by paper
copy or electronically. 
  
 3. Exercise Price. The exercise price of the
Option shall be determined by the Committee on the date the Option is granted. 
  
 4. Exercise Period. Options shall be exercisable within the times or upon the events determined by the Committee as set forth in the Grant; provided, however, that no Option shall be exercisable after the expiration of ten (10) years
from the date the Option is granted. 
  
 5. Restrictions on Exercise.
Exercise of the Option is subject to the following limitations: 
  
 (a) The Option may not be exercised until the Plan has been approved by the stockholders of the Company as set forth in the Plan. 
  
 (b) The Option may not be exercised unless such exercise is in compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as
amended, all applicable state securities laws, and the requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise. 
  
 (c) The Option may be exercised even if there is outstanding, within the
meaning of Section 422A(c)(7) of the Internal Revenue Code of 1954, as amended (the “Code”), any incentive stock option to purchase stock of the Company or its Parent or Subsidiary (as defined in the plan) that was granted to the
Optionee before the grant of the Option. 
  
 6. Cancellation of Option.

  
 (a) Except as provided in this section, the Option shall be
cancelled in whole if Optionee is terminated and may not be exercised to the extent cancelled. If the Optionee is terminated for any reason except by death or disability, the Option, to the extent it is exercisable on the Termination Date, may be
exercised by the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date; 
  
 (b) Except as provided in this subsection, the Option shall be cancelled in part, if Optionee ceases to be a full-time employee, but remains an employee
of the Optionee’s employer, and may not be exercised to the extent cancelled. If the Optionee ceases to be a full-time employee for any reason other than disability, the Option, to the extent it is exercisable on the date on which the Optionee
ceases to be a full-time employee, may be exercised by the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date: 
  
 (i) Unless otherwise required by local law, an Optionee shall be deemed to be a “full-time”
employee if Optionee works not less than 40 hours per week; 
  
 (ii) Except to the extent the Option is cancelled in accordance with subsection (b)(iii) below, the Option shall continue to vest in equal monthly amounts from the Termination Date up to 50 calendar months from the
vest start date set forth in the Grant (the “Vest Start Date”), provided the Optionee is continuously employed during the period; and 
  
 (iii) The number of Option Shares under the Option that shall be cancelled in accordance with this subsection will be determined by
multiplying the total number of Option Shares by the following fraction: 
  
 40 minus [number of hours regularly worked per week] 
 40 
  
 (c) If the Optionee’s employment with the Company is terminated because of the Retirement of the Optionee, as defined
below, the Option, to the extent that it is exercisable on the Termination Date, may be exercised by the Optionee at any time prior to the earlier of (i) expiration of sixty (60) months from the Termination Date, and (ii) the Expiration Date. For
the purposes of this Paragraph 6(c) “Retirement” means voluntary termination of employment with the Company by Optionee if Optionee’s age added to Optionee’s years of Service with the Company equals or exceeds sixty (60) and
Optionee has at least ten (10) years of service with the Company. For the purposes of this Paragraph 6(c), “Service” means employment from date of hire to Termination Date plus any previous employment with the Company where the previous
employment period was at least 12 months (exclusive of any extended non-medical leaves of absence) and exceeded the length of time between Optionee’s previous and current employment with the Company. 
  
 (d) If the Optionee is Terminated because of the death of the Optionee or
disability of the Optionee within the meaning of Section 22(e)(3) of the Code, the Option, to the extent that it is exercisable on the Termination Date, may be exercised by the Optionee (or the Optionee’s legal representative) at any time prior
to the expiration of twelve months after the Termination Date, but in any event no later than the Expiration Date. 
  
 (e) Notwithstanding the provisions in subsection 6(a) above, if the Optionee’s employment is terminated for Cause, the Option may not be exercised to
any extent whatsoever and any and all rights and claims Optionee may have to any Option Shares, or value attributable to any Option Shares upon vesting is hereby revoked. 

 (f) Nothing in the Plan or the Grant shall confer on Optionee any right to continue in the employ of, or
other relationship with, the Company or any Parent, Subsidiary or Affiliate of the Company or limit in any way the right of the Company or any Parent, Subsidiary or Affiliate of the Company to terminate Optionee’s employment or other
relationship at any time, with or without cause. 
  
 7. Manner of Exercise.

  
 (a) The Option shall be exercisable by delivery to the Company
of written notice in the form attached hereto as Exhibit A, or in such other form as may be approved by the Board of Directors of the Company, which shall set forth the Optionee’s election to exercise the Option, the number of Option
Shares being purchased, and such other representations and agreements as to the Optionee’s investment intent and access to information as may be required by the Company to comply with applicable securities laws. 
  
 (b) Such notice shall be accompanied by full payment of the Exercise Price
(i) in cash; (ii) by tender of shares of Common Stock of the Company having a fair market value equal to the Exercise Price; or (iii) a combination of the foregoing, provided that a portion of the exercise price equal to the par value of the Shares,
if any, must be paid in cash or other legal consideration. 
  
 (c)
Prior to the issuance of the Option Shares upon exercise of the Option, the Optionee must pay or make adequate provision for any applicable federal, state, or provincial withholding obligations of the Company. 
  
 (d) Provided that such notice and payment are in form and substance
satisfactory to counsel for the Company, the Company shall issue the Option Shares registered in the name of the Optionee or the Optionee’s legal representative. 
  
 8. Compliance with Laws and Regulations. The issuance and transfer of Option Shares shall be subject to compliance by the Company and
the Optionee with all applicable requirements of federal and state laws and with all applicable requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed at the time of such issuance or
transfer. 
  
 9. Nontransferability of Option. No Option or Stock Purchase
Right may be sold, pledged, hypothecated, transferred or disposed of in any manner other than by will or the laws of descent and distribution or as determined by the Committee and set forth in the written grant with respect to Stock Purchase Rights
and Options that are not Incentive Stock Options. 
  
 10. Tax Consequences.
Set forth below is a brief summary as of the date the form of grant was adopted of some of the federal and California tax consequences of exercise of the Option and disposition of the Shares. Additional information is included in the Prospectus for
the Plan, as amended. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES. 
  
 (a) Exercise. Upon exercise, Optionee will recognize compensation
income (taxable at ordinary income tax rates) equal to the excess, if any, of the fair market value of the Shares on the date of exercise over the Exercise Price. The Company may be required to withhold from Optionee’s compensation or collect
from Optionee and pay to the applicable taxing authorities an amount equal to a percentage of this compensation income at the time of exercise. 
  
 (b) Disposition of the Shares. For federal tax purposes, if the Shares are held for less than twelve (12) months after the date of transfer of the
Shares pursuant to the exercise of a nonqualified stock option, any gain realized on the disposition of the Shares will be treated as a short-term capital gain. If the Shares are held for more than twelve (12) months any such gain will be treated as
long-term capital gain. 
  
 11. Authority of the Board and the Committee.
Any dispute regarding the interpretation of the Grant shall be submitted by Optionee, Optionee’s employer, or the Company, forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting. The resolution of
such a dispute by the Board or Committee shall be final and binding on the Optionee, Optionee’s employer, and/or the Company. 
  
 12. Entire Agreement. The Exercise Notice and Agreement attached as Exhibit A and the Plan available upon request from the Stock Administration department and also
accessible electronically is incorporated herein by reference. The Grant, the Plan and the Exercise Notice and Agreement constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject
matter hereof. 

 ELECTRONIC ARTS INC. 
 STOCK OPTION EXERCISE NOTICE AND AGREEMENT 
  
 Electronic Arts Inc. 
 209 Redwood Shores Parkway 
 Redwood City, CA 94065 
 Attention: Stock Administrator 
  
 1. Exercise of Option. The undersigned (the “Optionee”) hereby elects to exercise the Optionee’s option to purchase shares of
the Common Stock (the “Option Shares”) of Electronic Arts Inc. (the “Company”) pursuant to the following grant (the “Grant”): 
  

			
	 Plan: ____________________________________
	 	Grant No.: ________________________________
	 Date of Grant: _____________________________
	 	 No. of Option Shares to be
 purchased:________________________________

  
 2. Representations
of Optionee. The Optionee hereby acknowledges, represents, and warrants that the Optionee has received, read, and understood the Plan and the Grant; and will abide by and be bound by the respective terms and conditions. 
  
 3. Compliance with Securities Laws. The Optionee understands and
acknowledges that the exercise of any rights to purchase any Option Shares is expressly conditioned upon compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as amended, all applicable state securities laws, and the
requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise. The Optionee agrees to cooperate with the Company to ensure compliance with such
laws. 
  
 4. Stop Transfer Notices. The Optionee
understands and agrees that the Company may issue appropriate “stop transfer” instructions to its transfer agent to ensure compliance with any restrictions on transfer required by applicable laws or regulations. 
  
 5. Tax Consequences. THE OPTIONEE UNDERSTANDS THAT THE OPTIONEE MAY
SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF THE OPTIONEE’S PURCHASE OR DISPOSITION OF THE OPTION SHARES. THE OPTIONEE REPRESENTS THAT THE OPTIONEE HAS CONSULTED WITH ANY TAX CONSULTANT(S) THAT THE OPTIONEE DEEMS NECESSARY IN CONNECTION WITH
THE PURCHASE OR DISPOSITION OF THE OPTION SHARES; AND THAT THE OPTIONEE IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE. 
  
 6. Payment. The Optionee herewith delivers to the Company the aggregate exercise price of the Option Shares that the Optionee has elected to
purchase. In addition to the aggregate exercise price, the Optionee herewith delivers to the Company the amount of, or has made adequate provisions for, the withholding of applicable income tax, social insurance, and other taxes. 
  
 7. Cashless Exercise. If the cashless method of exercise is used,
payment of the aggregate exercise price shall be made through a special sale and remittance procedure pursuant to which the Optionee provides irrevocable instructions to (A) a Company-designated brokerage firm to effect the immediate sale of the
purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable income tax, social insurance, and other
taxes required to be withheld by the Company by reason of such exercise; and (B) the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale. 
  
 8. Entire Agreement. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject matter hereof. 
  
 9. Governing Law. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan shall be governed by, and subject to, the laws of the State of California, United States, except for that body of law pertaining to conflicts of laws. 
  

									
	 OPTIONEE
	 	 	 	 ELECTRONIC ARTS INC.

					
	By:	 	 	 	 	 	By:	 	 
	 Name:
	 	 	 	 	 	 Name:
	 	Steve Bené
	 	 	 	 	 	 	 Title:
	 	Sr. Vice President, General Counsel
	 Date:
	 	 	 	 	 	 Date:
	 	 

 Appendix A 
  

ELECTRONIC ARTS INC. 
 Nonqualified
Stock Option Terms and Conditions (Intl.) 
 Under the 2000 Equity Incentive Plan 
  
 1. Form of Option Grant. The Option granted under the Plan shall be evidenced by a
written Stock Option Grant (the “Grant”) in such form (which need not be the same for each Optionee) as the Committee shall from time to time approve, which Grant shall comply with and be subject to the terms and conditions of the Plan.
Grants may be evidenced by paper copy or electronic copy. 
  
 2. Date of
Grant. The date of grant of the Option will be the date on which the Committee makes the determination to grant such Option, unless otherwise specified by the Committee. The Grant representing the Option will be delivered to Optionee within a
reasonable time after the granting of the Option. Delivery may be made by either paper copy or electronic copy. 
  
 3. Exercise Price. The Committee shall determine the exercise price of the Option on the date the Option is granted. 
  
 4. Exercise Period. Options shall be exercisable within the times or upon the events
determined by the Committee as set forth in the Grant; provided, however, that no Option shall be exercisable after the expiration of ten (10) years from the date the Option is granted (the “Expiration Date”). 
  
 5. Restrictions on Exercise. Exercise of the Option is subject to the following
limitations: 
  
 (a) the Option may not be exercised until the
Plan has been approved by the stockholders of the Company as set forth in the Plan; 
  
 (b) the Option may not be exercised unless such exercise is in compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as amended, all applicable state securities laws, and the requirements
of any stock exchange or national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise; and 
  
 (c) the Option may be exercised even if there is outstanding, within the meaning of Section 422A(c)(7) of the Code, any incentive stock option to purchase
stock of the Company or its Parent or Subsidiary (as defined in the Plan) that was granted to the Optionee before the grant of the Option. 
  
 6. Acknowledgments and Waiver. The Optionee agrees and acknowledges that: 
  

(a) the Plan is discretionary and the Company can amend or cancel it at any time; 
  
 (b) participation in the Plan is voluntary and does not create any contractual or other right to receive future rights to
purchase shares; 
  
 (c) the right to purchase shares under the
Plan is not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any termination, severance, resignation, redundancy, bonuses, pension or retirement benefits or similar payments; 

 
 (d) the future value of the shares purchased under the Plan is unknown and
cannot be predicted with certainty; 
  
 (e) no claim or
entitlement to compensation or damages arises from the termination of the right to purchase shares or diminution in value of the shares purchased under the Plan and the Optionee irrevocably releases the Company and the Optionee’s employer from
any such claim that may arise; and 
  
 (f) the Optionee’s
participation in the Plan shall not create a right to further employment with the Optionee’s employer and shall not interfere with the ability of the Optionee’s employer to terminate the employment relationship at any time. 
  
 7. Cancellation of Option. 
  
 (a) Except as provided in this section, the Option shall be cancelled in
whole if Optionee is terminated and may not be exercised to the extent cancelled. If the Optionee is terminated for any reason except by death or disability, the Option, to the extent it is exercisable on the Termination Date, may be exercised by
the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date; 
  
 (b) Except as provided in this subsection, the Option shall be cancelled in part, if Optionee ceases to be a full-time employee, but remains an employee
of the Optionee’s employer, and may not be exercised to the extent cancelled. If the Optionee ceases to be a full-time employee for any reason other than disability, the Option, to the extent it is exercisable on the date on which the Optionee
ceases to be a full-time employee, may be exercised by the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date: 
  
 (i) Unless otherwise required by local law, an Optionee shall be deemed to be a “full-time”
employee if Optionee works not less than 40 hours per week; 
  
 (ii) Except to the extent the Option is cancelled in accordance with subsection (b)(iii) below, the Option shall continue to vest in equal monthly amounts from the Termination Date up to 50 calendar months from the
vest start date set forth in the Grant (the “Vest Start Date”), provided the Optionee is continuously employed during the period; and 
  
 (iii) The number of Option Shares under the Option that shall be cancelled in accordance with this subsection will be determined by
multiplying the total number of Option Shares by the following fraction: 
  
 40 minus [number of hours regularly worked per week] 
 40 

 (c) If the Optionee’s employment with the Company is terminated because of the Retirement of the
Optionee, as defined below, the Option, to the extent that it is exercisable on the Termination Date, may be exercised by the Optionee at any time prior to the earlier of (i) expiration of sixty (60) months from the Termination Date, and (ii) the
Expiration Date. For the purposes of this Paragraph 7(c) “Retirement” means voluntary termination of employment with the Company by Optionee if Optionee’s age added to Optionee’s years of Service with the Company equals or
exceeds sixty (60) and Optionee has at least ten (10) years of service with the Company. For the purposes of this Paragraph 7(c), “Service” means employment from date of hire to Termination Date plus any previous employment with the
Company where the previous employment period was at least 12 months (exclusive of any extended non-medical leaves of absence) and exceeded the length of time between Optionee’s previous and current employment with the Company. 
  
 (d) If the Optionee is Terminated because of the death of the Optionee or
disability of the Optionee within the meaning of Section 22(e)(3) of the Code, the Option, to the extent that it is exercisable on the Termination Date, may be exercised by the Optionee (or the Optionee’s legal representative) at any time prior
to the expiration of twelve months after the Termination Date, but in any event no later than the Expiration Date. 
  
 (e) Notwithstanding the provisions in subsection 7(a) above, if the Optionee’s employment is terminated for Cause, the Option may not be exercised to
any extent whatsoever and any and all rights and claims Optionee may have to any Option Shares, or value attributable to any Option Shares upon vesting is hereby revoked. 
  
 (f) Notwithstanding the provisions in subsection 7(a) above, if (i) the Optionee’s employment with the Company is
terminated other than for Cause, (ii) the Optionee was subject to the Company’s “trading window” (as described in the Company’s Policy on Securities Trades by Electronic Arts Personnel) at the time his or her employment was
terminated, and (iii) the “trading window” was closed at the time the Optionee’s employment was terminated and remained closed during the entire Post-Termination Exercise Period (thereby preventing the immediate resale of Shares
acquired upon exercise of the Option), then the Option, to the extent it is exercisable on the Termination Date, shall remain exercisable until [ten (10)] days after the date the Optionee is notified by the Company that the “trading
window” has been opened; provided, however, that no Option will be exercisable later than the Expiration Date. 
  
 8. Manner of Exercise. 
  
 (a) The Option shall be exercisable by delivering to the Company a written notice in the form attached hereto as Exhibit A or in such other form as
may be approved by the Board, which shall set forth the Optionee’s election to exercise the Option, the number of Option Shares being purchased, and such other representations and agreements as to the Optionee’s investment intent and
access to information as may be required by the Company to comply with applicable securities laws. 
  
 (b) Such notice shall be accompanied by full payment of the Exercise Price (i) in cash; (ii) by tender of shares of Common Stock of the Company having a
fair market value equal to the Exercise Price; or (iii) a combination of the foregoing, provided that a portion of the exercise price equal to the par value of the Shares, if any, must be paid in cash or other legal consideration. 
  
 (c) Provided that such notice and payment are in form and substance
satisfactory to counsel for the Company, the Company shall issue the Option Shares registered in the name of the Optionee or the Optionee’s legal representative. 
  
 9. Governing Law. The Grant as well as the terms and conditions set forth in the Plan shall be governed by, and subject to, the law
of the State of California, United States. 
  
 10 Translation. If the
Optionee has received this or any other document related to the Plan that is translated into a language other than English and if the translated version is different from the English version, the English version will take precedence. 
  
 11 Tax Withholding. 
  
 (a) The Company will assess its requirements regarding tax, social insurance, and other applicable taxes (“Tax
Items”) in connection with the Option. These requirements may change from time to time as laws or interpretations change. Regardless of the Company’s actions in this regard, the Optionee hereby acknowledges and agrees that the ultimate
liability for Tax Items is the responsibility of the Optionee and that the Company and/or the Optionee’s employer: 
  
 (i) make no representations or undertakings regarding the treatment of any Tax Items in connection with any aspect of the Grant, including
the grant or exercise of the purchase rights and the subsequent sale of shares acquired under the Plan; and 
  
 (ii) do not commit to structure the terms of the Grant or any aspect of the Option to reduce or eliminate the Optionee’s liability
for Tax Items. 
  
 (b) Prior to the issuance of the Option Shares
upon exercise of the Option, the Optionee must pay or make adequate provisions for the withholding of Tax Items. The Optionee authorizes the Company and/or the Optionee’s employer to withhold all applicable Tax Items legally payable by the
Optionee from the compensation paid to the Optionee by the Company and/or the Optionee’s employer or from proceeds of sale. Alternatively, or in addition, if permissible under local law, the Company may sell or arrange for the sale of shares
that the Optionee is due to acquire to meet the minimum withholding obligation for Tax Items. The Company or the Optionee’s employer will repay to the Optionee any estimated withholding which is not required in satisfaction of any Tax Items.
The Optionee shall pay to the Company or the Optionee’s employer any amount of any Tax Items that the Company or the Optionee’s employer may be required to withhold as a result of the Optionee’s participation in the Plan or the
Optionee’s purchase of shares that cannot be satisfied by the means previously described. 
  
 12. Data Privacy. As a condition of participating in the Plan, the Optionee: 
  
 (a) consents to the collection, use, processing, and transfer, in electronic or other form, of personal data described in this section by, as applicable,
the employer of the Optionee, and the Company and any of its Subsidiaries or affiliates for the exclusive purpose of administering the Optionee’s participation in the Plan; 

 (b) understands that the Company, the Optionee’s employer and any of its Subsidiaries or affiliates
may hold certain personal information about the Optionee, including the Optionee’s name, home address and telephone number, date of birth, social security number or other identification number, nature and amount of compensation, nationality,
job title, any shares or directorships held in the Company, details of all purchase rights or any other entitlement to shares awarded, canceled, purchased, or outstanding in the Optionee’s favor, for the purpose of administering the Plan
(“Data”); 
  
 (c) understands that Data may be
transferred to any third parties assisting the Company in the administration of the Plan; 
  
 (d) understands that the recipients of Data may be located in the Optionee’s country of residence, or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the
Optionee’s country of residence; 
  
 (e) authorizes the
recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of administering the Optionee’s participation in the Plan, including any requisite transfer of such Data as may be required for the
administration of the Plan and/or the subsequent holding of shares on the Optionee’s behalf to a broker or other third party with whom the Optionee may elect to deposit any shares acquired pursuant to the Plan; 
  
 (f) understands that Data will be held only as long as necessary to
administer the Optionee’s participation in the Plan; 
  
 (g)
understands that the Optionee may, at any time, review Data, require any necessary amendments to Data or withdraw the consents herein in writing by contacting the Company; and 
  
 (h) understands that withdrawing the Optionee’s consent may affect the Optionee’s ability to participate in the
Plan. 
  
 13. Nontransferability of Option. No Option may be sold, pledged,
hypothecated, transferred, or disposed of in any manner other than by will or the laws of descent and distribution or as determined by the Committee and set forth in the Grant. 
  
 14. Exclusion of Option From Notice Period. The period of continuous employment for the purposes of the Grant shall be the period
commencing on the Vest Start Date and ending on the Termination Date, or if earlier, the date on which the Optionee’s employer gives notice of Termination (the “Vest End Date”). In no event shall vesting of the Option extend beyond
the Vest End Date, nor shall any potential value of the Option after the Vest End Date be considered in determining any notice or compensation in lieu of notice that may be required or given upon Termination. Optionee agrees that this provision is a
condition to the Grant and hereby waives any and all rights and claims Optionee may have to any Option Shares, or value attributable to any Option Shares, which would have under any circumstances vested after the Vest End Date. 
  
 15. Authority of the Board and the Committee. Any dispute regarding the interpretation
of the Grant shall be submitted by Optionee, Optionee’s employer, or the Company, forthwith to the Board or the Committee, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Board or Committee
shall be final and binding on the Optionee, Optionee’s employer, and/or the Company. 
  
 16. Entire Agreement. The Grant, the Plan and the written notice and agreement attached as Exhibit A constitute the entire agreement of the parties and supersede all prior undertakings and agreements with
respect to the subject matter hereof. 
  
 17. Notice. Copies of the Plan
and prospectus are available electronically at http://portal.ea.com/home/stockadmin. The Company’s most recent annual report and published financial statements are available electronically as soon as practicable after their publication by
clicking the “Financial Reports” link at http://investor.ea.com. The Plan, prospectus, the Company’s annual report, and the Company’s financial statements are also available at no charge by submitting a request to the
Company’s Stock Administration Department at stockadministration@ea.com. 

 ELECTRONIC ARTS INC. 
 STOCK OPTION EXERCISE NOTICE AND AGREEMENT 
  
 Electronic Arts Inc. 
 209 Redwood Shores Parkway 
 Redwood City, CA 94065 
 Attention: Stock Administrator 
  
 1. Exercise of Option. The undersigned (the “Optionee”) hereby elects to exercise the Optionee’s option to purchase shares of
the Common Stock (the “Option Shares”) of Electronic Arts Inc. (the “Company”) pursuant to the following grant (the “Grant”): 
  

			
	 Plan: ____________________________________
	 	Grant No.: __________________________________
	 Date of Grant: _____________________________
	 	No. of Option Shares to be purchased:____________

  
 2. Representations
of Optionee. The Optionee hereby acknowledges, represents, and warrants that the Optionee has received, read, and understood the Plan and the Grant; and will abide by and be bound by the respective terms and conditions. 
  
 3. Compliance with Securities Laws. The Optionee understands and
acknowledges that the exercise of any rights to purchase any Option Shares is expressly conditioned upon compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as amended, all applicable state securities laws, and the
requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise. The Optionee agrees to cooperate with the Company to ensure compliance with such
laws. 
  
 4. Stop Transfer Notices. The Optionee
understands and agrees that the Company may issue appropriate “stop transfer” instructions to its transfer agent to ensure compliance with any restrictions on transfer required by applicable laws or regulations. 
  
 5. Tax Consequences. THE OPTIONEE UNDERSTANDS THAT THE OPTIONEE MAY
SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF THE OPTIONEE’S PURCHASE OR DISPOSITION OF THE OPTION SHARES. THE OPTIONEE REPRESENTS THAT THE OPTIONEE HAS CONSULTED WITH ANY TAX CONSULTANT(S) THAT THE OPTIONEE DEEMS NECESSARY IN CONNECTION WITH
THE PURCHASE OR DISPOSITION OF THE OPTION SHARES; AND THAT THE OPTIONEE IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE. 
  
 6. Payment. The Optionee herewith delivers to the Company the aggregate exercise price of the Option Shares that the Optionee has elected to
purchase. In addition to the aggregate exercise price, the Optionee herewith delivers to the Company the amount of, or has made adequate provisions for, the withholding of applicable income tax, social insurance, and other taxes. 
  
 7. Cashless Exercise. If the cashless method of exercise is used,
payment of the aggregate exercise price shall be made through a special sale and remittance procedure pursuant to which the Optionee provides irrevocable instructions to (A) a Company-designated brokerage firm to effect the immediate sale of the
purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable income tax, social insurance, and other
taxes required to be withheld by the Company by reason of such exercise; and (B) the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale. 
  
 8. Entire Agreement. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject matter hereof. 
  
 9. Governing Law. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan shall be governed by, and subject to, the laws of the State of California, United States, except for that body of law pertaining to conflicts of laws. 
  

									
	 OPTIONEE
	 	 	 	 ELECTRONIC ARTS INC.

					
	By:	 	 	 	 	 	By:	 	 
	 Name:
	 	 	 	 	 	 Name:
	 	Stephen G. Bené
	 	 	 	 	 	 	 Title:
	 	Senior Vice President, General Counsel
	 Date:
	 	 	 	 	 	 Date:
	 	 

 ELECTRONIC ARTS INC. 
 NONQUALIFIED STOCK OPTION GRANT 
 2000 EQUITY INCENTIVE PLAN 
  

			
	Employee: Name	 	Employee #:
		
	Address:	 	Grant #:
		
	 	 	Class:
		
	 	 	Location:

  
 Electronic Arts Inc.,
a Delaware corporation, (the “Company”) hereby grants to the individual named above (the “Optionee”), a non-qualified stock option grant (the “Option”) under the Company’s 2000 Equity Incentive Plan (the
“Plan”), to purchase the total number of shares set forth below of common stock of the Company (the “Option Shares”) at the exercise price set forth below (the “Exercise Price”). The Option is subject to all the terms
and conditions of the Nonqualified Stock Option Grant including the terms and conditions in the attached Appendix A (the “Grant”) and the Plan, the provisions of which are incorporated herein by reference. All capitalized terms used in
this Grant that are not defined herein have the meanings defind in the Plan. The principal features of the Option are as follows: 
  

			
	Number of Option Shares:	 	Exercise Price:
		
	Date of Grant:	 	Expiration Date:
		
	Vest Start Date:	 	 

  
 Subject to the terms
and conditions of the Plan and the Grant, these Options will first vest and become exercisable as to 24%, 12 months from Vest Start Date and will then vest 2% on the first calendar day of each month thereafter for 38 months. The Optionee may then
exercise the option to the extent it has become vested, at any time until expiration or cancellation. 
  
 The Optionee shall be deemed to have worked a calendar month if Optionee has worked any portion of that month. Only vested Options may be exercised.
Vesting will continue in accordance with the Grant schedule during a leave of absence that is protected under local law (which may include, but is not limited to, a maternity, paternity, disability, medical, or military leave), provided that such
vesting shall not exceed the maximum vesting period protected by local law. Vesting shall be suspended during any unpaid personal leave of absence, except as otherwise provided by local law. 
  
 Election to Transfer Employer’s National Insurance Contributions
Liability to Optionee (the “Election”). 
  
 Optionee
acknowledges that he or she will pay the employee’s primary Class 1 National Insurance Contributions (“the Primary Contributions”) due on the exercise or assignment or release of the Option, pursuant to section 4(4)(a) of the Social
Security Contributions and Benefits Act 1992. The Primary Contributions will be payable (i) on the gain arising on exercise or (ii) in the case of assignment or release of the Option, in respect of the difference between the amount of the
consideration (if any) given for such assignment or release and the amount of the consideration (if any) given for the Option. 
  
 In addition, Optionee and Electronic Arts Limited (“the Employer”) hereby elect that the entire liability of the Employer to pay secondary Class
1 National Insurance Contributions due on the exercise or assignment or release of the Option (“the Secondary Contributions”) is hereby transferred to Optionee. The Secondary Contributions will also be payable (i) on the gain arising on
exercise or (ii) in the case of assignment or release of the Option, in respect of the difference between the amount of the consideration (if any) given for such assignment or release and the amount of the consideration (if any) given for the
Option. The purpose of this Election is to transfer the Employer’s liability for the Secondary Contributions to the Optionee. 
  
 Optionee hereby authorizes the Employer to collect the Secondary Contributions from the Optionee within 30 days after the exercise or assignment or
release of the Option or, if earlier, within 14 days after the end of the tax month during which such exercise or assignment or release takes place: 
  
 (i) by deduction from salary or any other payment which is payable to the Optionee at any time on or after the date of exercise or assignment or release
of the Option, or 
  
 (ii) directly from the Optionee by payment
in cleared funds, or 
  
 (iii) by arranging for the sale of some
of the shares that the Optionee is entitled to receive on the exercise of the Option. 

 The Company has reserved the right under the Plan to withhold the transfer of any shares unless payment
is received within the requisite period. 
  
 Optionee and the
Employer agree to be bound by the terms of this Election. Optionee and the Employer agree that the terms of this Election will apply regardless of whether the Optionee is abroad or not employed on the date on which the liability to Secondary
Contributions becomes due. 
  
 This Election will continue in
effect until such time (if ever) as both the Optionee and the Employer agree that it should cease to have effect or, if earlier, until the date the Inland Revenue may withdraw approval of this Election. This Election will cease to have effect after
due payment of the Secondary Contributions in respect of the exercise or assignment or release or cancellation of the Options. 
  
 The Employer agrees to pay the Secondary Contributions to the Inland Revenue on behalf of the Optionee within 14 days after the end of the tax month
during which the exercise or assignment or release of the Option takes place. 
  
 PLEASE READ ALL OF APPENDIX A WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF THE OPTION. 
  

	
	ELECTRONIC ARTS INC.
	
	  
	Stephen G. Bené
	Senior Vice President, General Counsel

  
 ACCEPTANCE: 
  
 Optionee hereby acknowledges that a copy of the Plan, the Rules and a copy of the Prospectus
as amended are available upon request from the Stock Administration department and can also be accessed electronically. Optionee represents that Optionee has read and understands the terms and provisions thereof, and accepts the Option subject to
all the terms and provisions of the Plan, the Rules and the Grant. Optionee acknowledges that there may be adverse tax consequences upon exercise of the Option and that Optionee should consult a tax adviser prior to such exercise. 

 

	
	
	  
	 Optionee Name

 ELECTRONIC ARTS INC. 
 APPROVED UK STOCK OPTION GRANT 
 2000 EQUITY INCENTIVE PLAN 
  

			
	Employee: Name	 	Address:
		
	Employee #:	 	 
		
	Grant #:	 	Class:
		
	 	 	Location:

  
 Electronic Arts Inc.,
a Delaware corporation, (the “Company”) hereby grants to the individual named above (the “Optionee”), a non-qualified stock option (the “Option”) to purchase the total number of shares set forth below of common stock of
the Company (the “Option Shares”) at the exercise price per share set forth below (the “Exercise Price”). The Option is subject to all the terms and conditions of the UK Sub-Plan of the Electronic Arts Inc. 2000 Equity Incentive
Plan (the “Plan”) including the terms and conditions contained in the attached Appendix A (the “Grant”) and the Addendum to the Company’s 2000 Equity Incentive Plan entitled “Rules Applicable to United Kingdom
Employees” as amended to date (the “Rules”), the provisions of which are incorporated herein by this reference. The principal features of the option are as follows: 
  

			
	Number of Option Shares:	 	Exercise Price:
		
	Date of Grant:	 	Expiration Date:
		
	Vest Start Date:	 	 

  
 Subject to the terms
and conditions of the Plan and the Grant, these Options will first vest and become exercisable as to 24%, 12 months from Vest Start Date and will then vest 2% on the first calendar day of each month thereafter for 38 months. Optionee may then
exercise the option with respect to vested Option Shares at any time until expiration or termination. 
  
 The Optionee shall be deemed to have worked a calendar month if Optionee has worked any portion of that month. Only vested Options may be exercised.
Vesting will continue in accordance with the Grant schedule during a leave of absence that is protected under local law (which may include, but is not limited to, a maternity, paternity, disability, medical, or military leave), provided that such
vesting shall not exceed the maximum vesting period protected by local law. Vesting shall be suspended during any unpaid personal leave of absence, except as otherwise provided by local law. 
  
 Election to Transfer Employer’s National Insurance Contributions
Liability to Optionee (the “Election”). 
  
 Under
the terms of the Plan, the Optionee is eligible to receive preferential tax treatment on the “gain arising on exercise.” The gain is equal to the difference between the fair market value of the Option Shares at a time of exercise and the
Option exercise price. If Optionee does not exercise the Option under tax-approved circumstances (for example, Optionee exercises the Option within three years of the Date of Grant), Optionee will be subject to UK income tax and National Insurance
Contributions on the gain. 
  
 Optionee acknowledges that he or
she will pay the employee’s primary Class 1 National Insurance Contributions (“the Primary Contributions”) due on the exercise or assignment or release of the Option, pursuant to section 4(4)(a) of the Social Security Contributions
and Benefits Act 1992. The Primary Contributions will be payable (i) on the gain arising on exercise or (ii) in the case of assignment or release of the Option, in respect of the difference between the amount of the consideration (if any) given for
such assignment or release and the amount of the consideration (if any) given for the Option. 
  
 In addition, Optionee and Electronic Arts Limited (“the Employer”) hereby elect that the entire liability of the Employer to pay secondary Class 1 National Insurance Contributions due on the exercise or
assignment or release of the Option (“the Secondary Contributions”) is hereby transferred to Optionee. The Secondary Contributions will also be payable (i) on the gain arising on exercise or (ii) in the case of assignment or release of the
Option, in respect of the difference between the amount of the consideration (if any) given for such assignment or release and the amount of the consideration (if any) given for the Option. The purpose of this Election is to transfer the
Employer’s liability for the Secondary Contributions to the Optionee. 
  
 Optionee hereby authorizes the Employer to collect the Secondary Contributions from the Optionee within 30 days after the exercise or assignment or release of the Option or, if earlier, within 14 days after the end of
the tax month during which such exercise or assignment or release takes place: 
  
 (i) by deduction from salary or any other payment which is payable to the Optionee at any time on or after the date of exercise or assignment or release of the Option, or 
  
 (ii) directly from the Optionee by payment in cleared funds, or 

 
 (iii) by arranging for the sale of some of the shares that the Optionee is
entitled to receive on the exercise of the Option. 

 The Company has reserved the right under the Plan to withhold the transfer of any shares unless payment
is received within the requisite period. 
  
 Optionee and the
Employer agree to be bound by the terms of this Election. Optionee and the Employer agree that the terms of this Election will apply regardless of whether the Optionee is abroad or not employed on the date on which the liability to Secondary
Contributions becomes due. 
  
 This Election will continue in
effect until such time (if ever) as both the Optionee and the Employer agree that it should cease to have effect or, if earlier, until the date the Inland Revenue may withdraw approval of this Election. This Election will cease to have effect after
due payment of the Secondary Contributions in respect of the exercise or assignment or release or cancellation of the Options. 
  
 The Employer agrees to pay the Secondary Contributions to the Inland Revenue on behalf of the Optionee within 14 days after the end of the tax month
during which the exercise or assignment or release of the Option takes place. 
  
 PLEASE READ ALL OF APPENDIX A WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF THE OPTION. 
  

	
	ELECTRONIC ARTS INC.
	
	  
	Stephen G. Bené
	Senior Vice President, General Counsel

  
 ACCEPTANCE: 
  
 Optionee hereby acknowledges that a copy of the Plan, the Rules and a copy of the Prospectus
as amended are available upon request from the Stock Administration department and can also be accessed electronically. Optionee represents that Optionee has read and understands the terms and provisions thereof, and accepts the Option subject to
all the terms and provisions of the Plan, the Rules and the Grant. Optionee acknowledges that there may be adverse tax consequences upon exercise of the Option and that Optionee should consult a tax adviser prior to such exercise. 

 

	
	
	  
	 Optionee Name

 Appendix A 
  
 ELECTRONIC ARTS INC. 
 UK Stock Option Terms and Conditions 
 Under the 2000 Equity Incentive Plan and Rules of
the UK Sub-Plan 
  
 1. Form of Option Grant. The Option granted
under the UK Sub-Plan shall be evidenced by an approved Stock Option Grant (the “Grant”), which Grant shall comply with and be subject to the terms and conditions of the UK Sub-Plan. 
  
 2. Date of Grant. The date of grant of the Option will be the date on which the
Committee makes the determination to grant such Option, unless otherwise specified by the Committee. The Grant representing the Option will be delivered to the Optionee within a reasonable time after the granting of the Option. Copies of the Plan
and Prospectus are available electronically at http://portal.ea.com/home/stockadmin and can also be obtained by contacting the Stock Administration Department. Delivery may be made either by paper copy or electronically. 
  
 3. Exercise Price. The Committee shall determine the exercise price of the Option on
the date the Option is granted. 
  
 4. Exercise Period of Option. The
Option shall be exercisable within the times or upon the events determined by the Committee as set forth in the Grant; provided, however, that no Option shall be exercisable after the expiration of ten (10) years from the date the Option is granted
(the “Expiration Date”). 
  
 5. Restrictions on Exercise.
Exercise of the Option is subject to the following limitations: 
  
 (a) the Option may not be exercised unless such exercise is in compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as amended, all applicable state securities laws, and the requirements of any stock exchange or
national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise; and 
  
 (b) the Option may be exercised even if there is outstanding, within the meaning of Section 422A(c)(7) of the United States Internal Revenue Code of 1954,
as amended (the “Code”), any incentive stock option to purchase stock of the Company or its Parent or Subsidiary (as defined in the UK Sub-Plan) that was granted to the Optionee before the grant of the Option. 
  
 6. Acknowledgments and Waiver. The Optionee agrees and acknowledges that: 

 
 (a) the UK Sub-Plan is discretionary and the Company can amend or cancel
the UK Sub-Plan at any time; 
  
 (b) participation in the UK
Sub-Plan is voluntary and does not create any contractual or other right to receive future rights to purchase shares; 
  
 (c) the right to purchase shares under the UK Sub-Plan is not part of normal or expected compensation or salary for any purposes, including, but not
limited to, calculating any termination, severance, resignation, redundancy, bonuses, pension or retirement benefits or similar payments; 
  
 (d) the future value of the Option Shares purchased under the UK Sub-Plan is unknown and cannot be predicted with certainty; 
  
 (e) no claim or entitlement to compensation or damages arises from the
termination of the right to purchase shares or diminution in value of the shares purchased under the UK Sub-Plan and the Optionee irrevocably releases the Company and the Optionee’s employer from any such claim that may arise; and 

 
 (f) the Optionee’s participation in the UK Sub-Plan shall not create
a right to further employment with the Optionee’s employer and shall not interfere with the ability of the Optionee’s employer to Terminate the employment relationship at any time. 
  
 7. Cancellation of Option. 
  
 (a) Except as provided in this section, the Option shall be cancelled in
whole if the Optionee Terminates and may not be exercised to the extent cancelled. If the Optionee Terminates for any reason except by death, disability, or retirement, the Option, to the extent it is exercisable on the date on the Termination Date,
may be exercised by the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date. 
  
 (b) Except as provided in this subsection, the Option shall be cancelled in part, if the Optionee ceases to be a full-time employee, but remains an
employee of the Optionee’s employer, and may not be exercised to the extent cancelled. If the Optionee ceases to be a full-time employee for any reason other than disability, the Option, to the extent it is exercisable on the date on which the
Optionee ceases to be a full-time employee, may be exercised by the Optionee within three (3) months after the Termination Date, but in no event later than the Expiration Date: 
  
 (i) Unless otherwise required by local law, the Optionee shall be deemed to be a “full-time”
employee if the Optionee works not less than 40 hours per week; 
  
 (ii) Except to the extent the Option is cancelled in accordance with subsection (b)(iii) below, the Option shall continue to vest in equal monthly amounts from the Termination Date up to fifty (50) calendar months
from the vest start date set forth in the Grant (the “Vest Start Date”), provided the Optionee is continuously employed during the period; and 
  
 (iii) The number of Option Shares under the Option that shall be cancelled in accordance with this subsection will be determined by
multiplying the total number of Option Shares by the following fraction: 
  
 40 minus [number of hours regularly worked per week] 
 40 

 (c) If the Optionee is Terminated because of the Retirement of the Optionee or disability of the Optionee
within the meaning of Section 22(e)(3) of the Code, the Option, to the extent that it is exercisable on the Termination Date, may be exercised by the Optionee at any time prior to the earlier of (i) expiration of sixty (60) months from the
Termination Date, but in any event no later than the Expiration Date. For the purposes of this subsection 7(c) “Retirement” means voluntary termination of employment with the Optionee’s employer by the Optionee if the Optionee’s
age added to the Optionee’s years of Service with the Company equals or exceeds sixty (60) and the Optionee has at least ten (10) years of service with the Company. For the purposes of this subsection 7(c), “Service” means employment
from date of hire to Termination Date plus any previous employment with the Company where the previous employment period was at least twelve (12) months (exclusive of any extended non-medical leaves of absence) and exceeded the length of time
between the Optionee’s previous and current employment with the Company. 
  
 (d) If the Optionee is Terminated because of death or if the Optionee dies within three (3) months of Termination other than Termination by reason of Disability or for Cause, the Option, to the extent it is
exercisable on the Termination Date, may be exercised by the Optionee (or the Optionee’s legal representative) at any time prior to the expiration of twelve (12) months following the death of the Optionee, but in any event no later than the
Expiration Date. 
  
 (e) Notwithstanding the provisions in
subsection 7(a) above, if the Optionee’s employment is terminated for Cause, the Option may not be exercised to any extent whatsoever and any and all rights and claims the Optionee may have to any Option Shares, or value attributable to any
Option Share upon vesting is hereby revoked. 
  
 (f)
Notwithstanding the provisions in subsection 7(a) above, if (i) the Optionee’s employment with the Company is terminated other than for Cause, (ii) the Optionee was subject to the Company’s “trading window” (as described in the
Company’s Policy on Securities Trades by Electronic Arts Personnel) at the time his or her employment was terminated, and (iii) the “trading window” was closed at the time the Optionee’s employment was terminated and remained
closed during the entire Post-Termination Exercise Period (thereby preventing the immediate resale of Shares acquired upon exercise of the Option), then the Option, to the extent it is exercisable on the Termination Date, shall remain exercisable
until ten (10) days after the date the Optionee is notified by the Company that the “trading window” has been opened; provided, however, that no Option will be exercisable later than the Expiration Date. 
  
 8. Manner of Exercise. 
  
 (a) The Option shall be exercisable by delivery to the Company a written notice in the form attached hereto as Exhibit
A, or in such other form as may be approved by the Board, which shall set forth the Optionee’s election to exercise the Option, the number of Option Shares being purchased, and such other representations and agreements as to the
Optionee’s investment intent and access to information as may be required by the Company to comply with applicable securities laws. 
  
 (b) Such notice shall be accompanied by full payment of the Exercise Price in cash in U.S. dollars. 
  
 (c) Provided that such notice and payment are in form and substance
satisfactory to counsel for the Company, the Company shall issue the Option Shares registered in the name of the Optionee or the Optionee’s legal representative. 
  
 9. Tax Consequences. Set forth below is a brief summary of the current Inland Revenue tax consequences with regard to the exercise of
the Option and the subsequent sale of the Option Shares. THIS IS A SUMMARY FOR OPTIONEE’S INFORMATION ONLY AND OPTIONEE IS ADVISED TO SEEK INDIVIDUAL TAX ADVICE. 
  
 (a) The Addendum to the Plan under which the Option has been granted has been approved by the UK Board of Inland Revenue
under paragraph 1, Schedule 9 of the UK Income and Corporation Taxes Act 1988. 
  
 (b) Unless and until approval is withdrawn, there will be no charge to UK income tax on the exercise of an Option in accordance with the UK Sub-Plan provided that at least three (3) but no more than ten (10) years
have passed from the Date of Grant of the Option. 
  
 (c) On a
subsequent sale of the Option Shares, the Optionee will be liable to pay capital gains tax on the resultant gains. 
  
 (d) The Company intends to maintain in force the UK Inland Revenue approval for the Plan. However, if it is unable or unwilling to do so, it shall be
under no liability to the Optionee as a result of any increased tax liability incurred by him or her whether on exercise of the Option, sale of the Option Shares or otherwise. 
  
 10. National Insurance Contributions Joint Election. The Optionee agrees to the terms of the Election to Transfer Employer’s
Secondary Class 1 National Insurance Liability in all circumstances where the exercise of the Option gives rise to liability for National Insurance Contributions. 
  
 11. Tax Withholding. 
  
 (a) The Company will assess its requirements regarding tax, social insurance, and other applicable taxes (“Tax Items”) in connection with the
Option. These requirements may change from time to time as laws or interpretations change. Regardless of the Company’s actions in this regard, the Optionee hereby acknowledges and agrees that the ultimate liability for Tax Items is the
responsibility of the Optionee and that the Company and/or the Optionee’s employer: 
  
 (i) make no representations or undertakings regarding the treatment of any Tax Items in connection with any aspect of the Grant, including
the grant or exercise of the purchase rights and the subsequent sale of Option Shares acquired under the UK Sub-Plan; and 
  
 (ii) do not commit to structure the terms of the Grant or any aspect of the Option to reduce or eliminate the Optionee’s liability
for Tax Items. 

 (b) Prior to the issuance of the Option Shares upon exercise of the Option in circumstances that do not
allow relief from any of the Tax Items, the Optionee must pay or make adequate provisions for the withholding of Tax Items. The Optionee authorizes the Company and/or the Optionee’s employer to withhold all applicable Tax Items legally payable
by the Optionee from the compensation paid to the Optionee by the Company and/or the Optionee’s employer or from proceeds of sale. Alternatively, or in addition, if permissible under local law, the Company may sell or arrange for the sale of
Option Shares that the Optionee is due to acquire to meet the minimum withholding obligation for Tax Items. The Company or the Optionee’s employer will repay to the Optionee any estimated withholding which is not required in satisfaction of any
Tax Items. Finally, the Optionee shall pay to the Company or the Optionee’s employer any amount of any Tax Items that the Company or the Optionee’s employer may be required to withhold as a result of the Optionee’s participation in
the UK Sub-Plan or the Optionee’s purchase of Option Shares that cannot be satisfied by the means previously described. 
  
 12. Data Privacy. As a condition of participating in the UK Sub-Plan, the Optionee: 
  
 (a) consents to the collection, use, processing, and transfer, in electronic or other form, of personal data described in
this subsection by, as applicable, the employer of the Optionee, and the Company and any of its Subsidiaries or affiliates for the exclusive purpose of administering his or her participation in the UK Sub-Plan; 
  
 (b) understands that the Company, the Optionee’s employer and any of its
Subsidiaries or affiliates may hold certain personal information about the Optionee, including the Optionee’s name, home address and telephone number, date of birth, social security number or other identification number, salary, nationality,
job title, any shares or directorships held in the Company, details of all purchase rights or any other entitlement to shares awarded, canceled, purchased, or outstanding in the Optionee’s favor, for the purpose of administering the UK Sub-Plan
(“Data”); 
  
 (c) understands that Data may be
transferred to any third parties assisting the Company in the administration of the UK Sub-Plan; 
  
 (d) understands that the recipients of Data may be located in the Optionee’s country of residence, or elsewhere, and that the recipient’s
country may have different data privacy laws and protections than the Optionee’s country of residence; 
  
 (e) authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of administering the
Optionee’s participation in the UK Sub-Plan, including any requisite transfer of such Data as may be required for the administration of the UK Sub-Plan and/or the subsequent holding of shares on the Optionee’s behalf to a broker or other
third party with whom the Optionee may elect to deposit any shares acquired pursuant to the UK Sub-Plan; 
  
 (f) understands that Data will be held only as long as necessary to administer the Optionee’s participation in the UK Sub-Plan; 
  
 (g) understands that the Optionee may, at any time, review Data, require any
necessary amendments to Data or withdraw the consents herein in writing by contacting the Company; and 
  
 (h) understands that withdrawing the Optionee’s consent may affect the Optionee’s ability to participate in the UK Sub-Plan. 
  
 13. Nontransferability of Option. No Option may be sold, pledged, hypothecated,
transferred, or disposed of in any manner other than by will or the laws of descent and distribution or as determined by the Committee and set forth in the Grant. The terms of the Option shall be binding upon the executors, administrators,
successors and assigns of the Optionee. 
  
 14. Exclusion of Option From Notice
Period. The period of continuous employment for the purposes of the Grant shall be the period commencing on the Vest Start Date and ending on the Termination Date, or if earlier, the date on which the Optionee’s employer gives notice of
Termination (the “Vest End Date”). In no event shall vesting of the Option extend beyond the Vest End Date, nor shall any potential value of the Option after the Vest End Date be considered in determining any notice or compensation in lieu
of notice that may be required or given upon Termination. The Optionee agrees that this provision is a condition to the Grant and hereby waives any and all rights and claims the Optionee may have to any Option Shares, or value attributable to any
Option Shares, which would have under any circumstances vested after the Vest End Date. 
  
 15. Authority of the Board and the Committee. Any dispute regarding the interpretation of the Grant shall be submitted by the Optionee, the Optionee’s employer, or the Company, forthwith to the Board or the Committee thereof
that administers the UK Sub-Plan, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Board or Committee shall be final and binding on the Optionee, the Optionee’s employer, and/or the Company.

  
 16. Entire Agreement. The Grant, the UK Sub-Plan, the Plan and the
written notice and agreement attached as Exhibit A constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject matter hereof. 
  
 17. Notice. Copies of the Plan, the UK Sub-Plan and prospectus are available
electronically at http://internal.ea.com (Legal&Stock/Stock Administration/Stock Option Plans). The Company’s most recent annual report and published financial statements are available electronically as soon as practicable after their
publication by clicking the “Financial Reports” link at http://investor.ea.com. The Plan, the UK Sub-Plan, prospectus, the Company’s annual report, and the Company’s financial statements are also available at no charge by
submitting a request to the Stock Administration Department at stockadministration@ea.com. 

 ELECTRONIC ARTS INC. 
 STOCK OPTION EXERCISE NOTICE AND AGREEMENT 
  
 Electronic Arts Inc. 
 209 Redwood Shores Parkway 
 Redwood City, CA 94065 
 Attention: Stock Administrator 
  
 1. Exercise of Option. The undersigned (the “Optionee”) hereby elects to exercise the Optionee’s option to purchase shares of
the Common Stock (the “Option Shares”) of Electronic Arts Inc. (the “Company”) pursuant to the following grant (the “Grant”): 
  

			
	Plan: ________________________________	 	Grant No.: __________________________________
	Date of Grant: _______________________	 	No. of Option Shares to be purchased:____________

  
 2. Representations
of Optionee. The Optionee hereby acknowledges, represents, and warrants that the Optionee has received, read, and understood the Plan and the Grant; and will abide by and be bound by the respective terms and conditions. 
  
 3. Compliance with Securities Laws. The Optionee understands and
acknowledges that the exercise of any rights to purchase any Option Shares is expressly conditioned upon compliance with the Securities Act of 1933, as amended, the Exchange Act of 1934, as amended, all applicable state securities laws, and the
requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed, as they are in effect on the date of exercise. The Optionee agrees to cooperate with the Company to ensure compliance with such
laws. 
  
 4. Stop Transfer Notices. The Optionee
understands and agrees that the Company may issue appropriate “stop transfer” instructions to its transfer agent to ensure compliance with any restrictions on transfer required by applicable laws or regulations. 
  
 5. Tax Consequences. THE OPTIONEE UNDERSTANDS THAT THE OPTIONEE MAY
SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF THE OPTIONEE’S PURCHASE OR DISPOSITION OF THE OPTION SHARES. THE OPTIONEE REPRESENTS THAT THE OPTIONEE HAS CONSULTED WITH ANY TAX CONSULTANT(S) THAT THE OPTIONEE DEEMS NECESSARY IN CONNECTION WITH
THE PURCHASE OR DISPOSITION OF THE OPTION SHARES; AND THAT THE OPTIONEE IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE. 
  
 6. Payment. The Optionee herewith delivers to the Company the aggregate exercise price of the Option Shares that the Optionee has elected to
purchase. In addition to the aggregate exercise price, the Optionee herewith delivers to the Company the amount of, or has made adequate provisions for, the withholding of applicable income tax, social insurance, and other taxes. 
  
 7. Cashless Exercise. If the cashless method of exercise is used,
payment of the aggregate exercise price shall be made through a special sale and remittance procedure pursuant to which the Optionee provides irrevocable instructions to (A) a Company-designated brokerage firm to effect the immediate sale of the
purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable income tax, social insurance, and other
taxes required to be withheld by the Company by reason of such exercise; and (B) the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale. 
  
 8. Entire Agreement. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject matter hereof. 
  
 9. Governing Law. This Exercise Notice and Agreement, the
Non-Qualified Stock Option Grant, and the Plan shall be governed by, and subject to, the laws of the State of California, United States, except for that body of law pertaining to conflicts of laws. 
  

									
	OPTIONEE	 	 	 	ELECTRONIC ARTS INC.
					
	By:	 	 	 	 	 	By:	 	 
	 Name:
	 	 	 	 	 	 Name:
	 	Stephen G. Bené
	 	 	 	 	 	 	 Title:
	 	Senior Vice President, General Counsel
	 Date:
	 	 	 	 	 	 Date:
	 	 

 ELECTRONIC ARTS INC. 
 OWNERSHIP AWARD 
 2000 EQUITY INCENTIVE PLAN 
  

			
	Participant Name	 	Employee #:
		
	Address	 	Award #:
		
	 	 	Class:
		
	Location:	 	 

  
 Electronic Arts Inc.,
a Delaware corporation, (the “Company”) hereby grants to the Participant named above an Ownership Award (the “Award”) consisting of Restricted Stock Units issued under the Company’s 2000 Equity
Incentive Plan, as amended (the “Plan”), to receive the total number of units set forth below of the Company’s Common Stock (the “Award Units”). The Award is subject to all of the terms and
conditions set forth herein, in the attached Appendix A, and in the Plan, the provisions of which are incorporated herein by reference. The principal features of the Award are as follows: 
  

			
	Award Units:	 	 
		
	Award Date:	 	 

  
 Vesting Schedule:
Subject to the terms and conditions of the Plan and of Appendix A, the Award shall vest as to twenty-five percent (25%) of the Award Units on each of the first, second, third and fourth anniversaries of the Award Date on which Participant is, and
has remained continuously since the Award Date, employed by the Company or a Subsidiary (or such later date as may result from suspended vesting as provided below). Vesting will continue in accordance with the Vesting Schedule during a leave of
absence that is protected under local law (which may include, but is not limited to, a maternity, paternity, disability, medical, or military leave), provided that such vesting shall not exceed the maximum leave of absence period protected by local
law. Vesting shall be suspended during any unpaid personal leave of absence, except as otherwise provided by local law. 
  
 PLEASE READ ALL OF APPENDIX A WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF THE AWARD. 
  

	
	ELECTRONIC ARTS INC.
	
	  
	Stephen G. Bené
	Senior Vice President, General Counsel

  
 Participant hereby
acknowledges that a copy of the Plan and a copy of the Prospectus, as amended, are available upon request from the Company’s Stock Administration department and can also be accessed electronically. Participant represents that Participant has
read and understands the terms and conditions thereof, and accepts the Award subject to all the terms and conditions of the Plan and the Award. Participant acknowledges that there may be adverse tax consequences due to the Award and that Participant
should consult a tax advisor to determine his or her actual tax consequences. Participant must accept this Award by executing and delivering a paper or electronic version to the Company within thirty (30) days otherwise the Company may, at its
discretion, rescind the Award in its entirety. 
  

	
	
	  
	 Participant Name

 APPENDIX A 
 ELECTRONIC ARTS INC. 
 EMPLOYEE SHARE OWNERSHIP AWARD 
 (U.S. EMPLOYEES) 
  
 1. Award. Each Award Unit represents the right to receive one share of Electronic Arts Inc. Common Stock, $0.01 par value per share
(“Common Stock”), subject to certain restrictions and on the terms and conditions contained in this Employee Share Ownership Award (“Award”) and the Electronic Arts’ 2000 Equity Incentive Plan, as
amended (the “Plan”). In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. 
  
 2. No Shareholder Rights. The Award does not entitle Participant to
any rights of a shareholder of Common Stock. The rights of Participant with respect to the Award shall remain forfeitable at all times prior to the date on which such rights become vested. 
  
 3. Conversion of Award Units; Issuance of Common Stock. No Shares of
Common Stock shall be issued to Participant prior to the date on which the Award Units vest. After any Award Units vest, the Company shall promptly cause to be issued in book-entry form, registered in Participant’s name or in the name of
Participant’s legal representatives, beneficiaries or heirs, as the case may be, Common Stock in payment of such vested whole Award Units; provided, however, that in the event such Award Units do not vest on a day during which the
Company’s Common Stock is quoted on the Nasdaq National Market (or traded on such other principal national securities market or exchange on which the Company’s Common Stock may then be listed) (“Trading Day”), the
Company shall cause such Common Stock to be issued on the next Trading Day following the date on which such Award Units vest; provided, further, that in no event shall the Company cause such Shares to be issued later than two (2) months after
the date on which such Award Units vest. For purposes of this Award, the date on which vested Award Units are converted into Common Stock shall be referred to as the “Conversion Date.” 
  
 4. Fractional Award Units. In the event Participant is vested in a
fractional portion of an Award Unit (a “Fractional Portion”), such Fractional Portion shall not be converted into a Share or issued to Participant. Instead, the Fractional Portion shall remain unconverted until the final
vesting date for the Award Units; provided, however, if Participant vests in a subsequent Fractional Portion prior to the final vesting date for the Award Units and such Fractional Portion taken together with a previous Fractional Portion
accrued by Participant under this Award would equal or be greater than a whole Share, then such Fractional Portions shall be converted into one Share; provided, further, that following such conversion, any remaining Fractional Portion shall
remain unconverted. Upon the final vesting date, the value of any remaining Fractional Portion(s) shall be rounded up to the nearest whole Award Unit at the same time as the conversion of the remaining Award Units and issuance of Common Stock
described in section 3 above. 
  
 5. Restriction on
Transfer. Neither the Award Units nor any rights under this Award may be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of by Participant other than by will or by the laws of descent and distribution, and any such
purported sale, assignment, transfer, pledge, hypothecation or other disposition shall be void and unenforceable against the Company. Notwithstanding the foregoing, Participant may, in the manner established by the Committee, designate a beneficiary
or beneficiaries to exercise Participant’s rights and receive any property distributable with respect to the Award Units upon Participant’s death. 
  
 6. Termination of Employment. 
  
 (a) Forfeiture of Unvested Award Units Upon Termination of Employment, Other than Death or Disability. In the event that
Participant’s employment or service is Terminated for any reason other than death or Disability and the Award Units are not yet fully vested as of the date of Termination, then the unvested Award Units shall be forfeited immediately upon such
Termination. 
  
 (b) Termination of Employment
Due to Death or Disability. If the Participant’s employment with the Company or Subsidiary is Terminated due to death or Disability after the first anniversary of the Award Date, a pro-rata portion of the Award Units, to the extent that the
Award Units are partially vested on the Termination date, will be converted into Shares and issued to the Participant, or Participant’s legal representatives, beneficiaries, or heirs, as the case may be. If the Participant’s employment
with the Company or Subsidiary is Terminated due to death or Disability, before the first anniversary of the Award Date, the entire Award shall be forfeited. In determining the pro-rata portion of the Award Units that are vested on the Termination
date, the Committee will consider the number of months worked by Participant during the 12-calendar month period preceding the next anniversary of the Award Date under the following formula: 
  

					
	Number of Award Units
scheduled to vest on the next
anniversary of the Award Date	  	multiplied by	  	[Number of calendar months worked by Participant during the 12-month period prior to the next anniversary of the Award Date] divided by 12

  
 Participant shall be deemed to have
worked a calendar month if Participant has worked any portion of that month. The Committee’s determination of vested Award Units shall be in whole Award Units only and will be binding on the Participant. 

 7. Forfeiture of Pro-Rata Portion of Award Units Upon Cessation of Full-Time Employment Status.
Except as provided in this section, the Award Units shall be forfeited in part, if Participant ceases to be a full-time employee, but remains an employee of the Company or Subsidiary. If the Participant ceases to be a full-time employee for any
reason other than Disability but remains an employee of the Company or Subsidiary, the number of Award Units shall be reduced by the result of the following formula: 
  

					
	Total number of unvested Award
Units	  	multiplied by	  	 [[X minus Y] divided by X]
  
 Where X equals the number of hours in Participant’s regularly-scheduled workweek prior to ceasing to be a
full-time employee, and Y equals the number of hours in Participant’s regularly-scheduled workweek after ceasing to be a full-time employee.

  
 Unless otherwise determined by the
Committee or required by local law, a Participant shall be deemed to be a “full-time” employee if Participant works not less than 40 hours per week or such other number of minimum hours per workweek then considered by the Company in its
sole discretion to be “full-time”. The Award shall continue to vest as set forth in the Award, provided the Participant is continuously employed by the Company or Subsidiary during the relevant vesting period. 
  
 8. No Rights of Employment. Nothing in the Plan or the Award shall
confer on Participant any right to continue in the employ of, or other relationship with, the Company or any Subsidiary or limit in any way the right of the Company or any Subsidiary to terminate Participant’s employment or other relationship
at any time, with or without cause. 
  
 9. No Acquired
Rights. The Participant agrees and acknowledges that: 
  
 (a) the Plan is discretionary and the Company can amend or cancel it at any time; 
  
 (b) participation in the Plan is voluntary and does not create any contractual or other right to receive future rights to Shares;

  
 (c) the right to Shares under the Plan is not
part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any termination, severance, resignation, redundancy, bonuses, pension or retirement benefits or similar payments; 
  
 (d) the future value of the Shares awarded under the Plan is
unknown and cannot be predicted with certainty; and 
  
 (e) no claim or entitlement to compensation or damages arises from the termination of the right to receive Shares or diminution in value of the Shares awarded under the Plan and the Participant irrevocably releases the Company and the
Participant’s employer from any such claim that may arise. 
  
 10. Tax Withholding. 
  
 (a) The
Company will assess its requirements regarding tax, social insurance, and other applicable taxes (“Tax Items”) in connection with the Award. These requirements may change from time to time as laws or interpretations change.
Regardless of the Company’s actions in this regard, the Participant hereby acknowledges and agrees that the ultimate liability for Tax Items is the responsibility of the Participant. Participant acknowledges and agrees that the Company and/or
the Participant’s employer: 
  
 (i) make no
representations or undertakings regarding the treatment of any Tax Items in connection with any aspect of the Award, including the subsequent sale of Shares acquired under the Plan; and 
  
 (ii) do not commit to structure the terms of the Award or any aspect of the Award to reduce or eliminate the
Participant’s liability for Tax Items. 
  
 (b) Prior to the delivery of Shares upon the vesting of Award Units (“Award Shares”), the Participant must pay or make adequate provisions for the withholding of Tax Items. The Participant authorizes the Company
and/or the Participant’s employer to collect the Tax Items by withholding from the delivery of the Award Shares a whole number of Shares with a Fair Market Value equal to or in excess of the minimum withholding obligation for Tax Items;
provided, however, that in order to avoid issuing fractional Shares, the Company may issue no more than a single whole Share in excess of the minimum withholding obligation for Tax Items. For example, if the minimum withholding obligation for
Tax Items is $225 and the Fair Market Value of the Common Stock is $50 per share, then the Company may withhold up to five (5) Shares from the delivery of Award Shares on the issuance date. The Company or the Participant’s employer will remit
the total amount withheld for Tax Items to the appropriate tax authorities. The Participant shall pay to the Company or the Participant’s employer any amount of any Tax Items that the Company or the Participant’s employer may be required
to withhold as a result of participation in the Plan that cannot be satisfied by the means previously described. 
  
 11. Tax Consequences. Set forth below is a brief summary as of the date the form of Award was adopted of some of the federal and California tax
consequences of the Award, the vesting of the Award Units, and disposition of the Award Shares. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. PARTICIPANT IS STRONGLY ADVISED TO CONSULT A TAX ADVISER.

  
 (a) Vesting of Award Units. Upon the issuance
of Award Shares to Participant following the vesting of Award Units, Participant will recognize compensation income (taxable at ordinary income tax rates) equal to the Fair Market Value of the Award Shares on the Conversion Date. 

 (b) Disposition of the Award Shares. For federal tax purposes, if the Award Shares are
held for less than twelve (12) months after the Conversion Date, any gain realized on the disposition of the Award Shares will be treated as a short-term capital gain. If the Award Shares are held for more than twelve (12) months any such gain will
be treated as long-term capital gain. 
  
 12. Compliance with
Laws and Regulations. The issuance and transfer of Common Stock shall be subject to compliance by the Company and the Participant with all applicable requirements of federal and state laws and with all applicable requirements of any stock
exchange or national market system on which the Company’s Common Stock may be listed at the time of such issuance or transfer. 
  
 13. Authority of the Board and the Committee. Any dispute regarding the interpretation of the Award shall be submitted by Participant,
Participant’s employer, or the Company, forthwith to either the Board or the Committee, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Board or Committee shall be final and binding on the
Participant, Participant’s employer, and/or the Company. 
  
 14. Governing Law. The Award as well as the terms and conditions set forth in the Plan shall be governed by, and subject to, the law of the State of California. 
  
 15. Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or
construction or this Award. 
  
 16. Agreement Severable. In
the event that any provision in this Award agreement is held to be invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this
Award agreement. 
  
 17. Entire Agreement. The Award,
including this Appendix A, and the Plan constitute the entire agreement of the parties and supersede all prior undertakings and agreements with respect to the subject matter hereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00088-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00088-of-00352.parquet"}]]